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1. ABBREVIATIONS      
   
 
ADM:   adrenomedullin 
BH4:  tetrahydrobiopterin 
CGRP:  calcitonin gene related peptide 
CH:  cycloheximide 
CT:  calcitonin 
CR:  CT receptor 
CRLR: CT receptor like receptor 
GH:  growth hormone 
GTPCH: guanosine triphosphate cyclohydrolase  
Isl-1:  Islet-1 
IFNγ:  interferon gamma 
IL-1β:  interleukin-1 beta 
IL-6:  interleukin-6 
LPS:  lipopolysaccharide, endotoxin  
MISRE: microbial infection-specific response-elements 
MSC:  mesenchymal stem cells 
NO:  nitric oxide 
PPARγ: peroxisome proliferator activated receptor-γ 
RAMP: receptor activity-modifying protein 
PBMC: peripheral blood mononuclear cells 
ProCT: procalcitonin 
SIRS:  systemis inflammatory response synsrome 
SRIF:  somatostatin 
SSTR: somatostatin receptor 
TNFα:  tumor necrosis factor alpha 
TZD:  thiazolidinediones 
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3. SUMMARY  
Hormones are produced by endocrine and neuroendocrine cells and mediate mainly 
systemic effects. Cytokines are produced by numerous cell types and mediate local 
effects. The production of calcitonin (CT) peptides follows either the classical 
hormonal expression which is believed important for calcium metabolism or cytokine-
like expression which is induced by inflammatory stimuli. To describe this plasticity, 
the term “hormokine” was proposed.  
The concept is based on the discovery of the ubiquitous expression of CT peptides 
(i.e., ProCT, CT gene-related peptide (CGRP) and adrenomedullin (ADM)) during 
sepsis. Using human mesenchymal stem cell (MSC) - and preadipocyte- derived 
mature adipocytes it was shown in this thesis study that different CT peptides are 
differentially regulated upon inflammatory stimuli and mediate distinct metabolic 
effects. Especially ProCT appeared to be a pivotal mediator during sepsis. Based on 
the findings, a trimodal expression pattern of the CALC I gene and a closely related 
biphasic behavior of infection-related ProCT secretion was postulated. The exact 
mode of actions of hormokines in the context of inflammation and infection remains 
enigmatic. Based on the structural homologies, different CT peptides have 
overlapping bioactivities, which they exert by binding to the same family of receptors. 
For example CGRP and ADM contribute to vasoregulation in inflammatory conditions 
and were found to modulate their own expression and bioactivities.  
In a second phase of the thesis, the concept of hormokines was extended to the 
hypothesis, that other hormones can also be regulated and act as hormokines. In this 
context, an upregulation of somatostatin (SRIF) upon inflammatory stimulation was 
observed in human adipose tissue.  
Because of the hormokine like behavior of SRIF, also an islet hormone, the idea 
arose that other islet hormones (e.g. insulin, glucagon) could be expressed 
ectopically. In this context, the plasticity of the neuro-endocrine phenotype was 
documented by experiments indicating that progenitor cells can adopt an islet-like 
phenotype upon differentiation and stimulation. Bone marrow derived MSCs and 
human adipose tissue derived preadipocytes were shown to be able to form islet-like 
clusters within days and recapitulate the sequential expression of key genes 
observed during endocrine pancreatic development.  
To better investigate hormones and hormokines a procedure to transduce mature 
human adipocytes was established using lentiviral vectors.  
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4. BACKGROUND 
a)  The Calcitonin Peptides  
Calcitonin (CT) was discovered 40 years ago, when it was assumed to be a hormone 
with a yet-to-be-determined role in human physiology (1). Since then, CT has been 
found to be only one entity among related circulating peptides which have pivotal 
roles in the metabolic and inflammatory host response to microbial infections (2). 
These peptides share marked structural homologies and include procalcitonin 
(ProCT), calcitonin gene-related peptide (CGRP) I and II, adrenomedullin (ADM), and 
amylin (Figure 1 and Figure 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Amino acid sequences of human CT, CGRP I and II, amylin and ADM. The 
prohormone, ProCT, consists of 116 amino acids, in which the midportion consists of the 33-
amino acid immature CT. Amylin is also referred to as islet amyloid polypeptide. The 
common marked amino acid homology within the calcitonin peptide superfamily suggests 
gene duplication of a common ancestral gene. 
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Figure 2: CALC genes and the CT peptides. The CALC I gene encodes three distinct 
peptides: ProCT, CT and CGRP I. ProCT and CT can not be expressed from the CALC II 
gene due to a stop codon in exon 4. CALC III (not shown) is a non-translated pseudogene. 
CALC IV encodes the peptide amylin. CALC V gene encodes ADM.  
 
 
b) CT Peptides are Ubiquitously Expressed in Sepsis 
The CALC I gene, by alternative processing of the primary RNA transcript, gives rise 
to two different so-called mature peptides: CT and CGRP I. In the absence of 
infection, the extra-thyroidal transcription of the CALC I gene is suppressed and is 
restricted to a selective expression in neuroendocrine cells found mainly in the 
thyroid and the lung. In these neuroendocrine cells, the mature CT-hormone is 
synthesized, stored in secretory granules and released after appropriate stimulation, 
such as hypercalcemia or pentagastrin (3). 
Previous studies demonstrated that the inflammatory host response during a 
bacterial infection induces an ubiquitous increase of CT mRNA expression and 
immediate release of ProCT, the precursor of CT, from all tissues and cell types 
throughout the body (4). Thus, in sepsis, the entire body could be viewed as being an 
“endocrine gland”. Interestingly, CGRP mRNA was also shown to be ubiquitously 
expressed upon bacterial infection (5). Hence, the presence of microbial infection-
specific response-elements (MISRE) in the CALC I gene promoter were proposed, 
which, upon an inflammatory stimulus, could override the endocrine tissue-selective 
expression pattern (Figure 3).  
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Figure 3: Model for the ubiquitous CALC I gene expression. Upon a stimulus released 
during the inflammatory host response, the CALC I gene expression is upregulated in all 
tissues, mediated through one or several MISRE within the promoter. Both splice variants 
are expressed in all cells: ProCT increases several thousand-fold and circulating CGRP 
levels are modestly elevated. Serum levels of mature CT are not increased. The CT peptides 
exert their bioeffects by binding to the same family of receptors, which can be modulated 
additionally by the actions of accessory proteins like receptor activity-modifying proteins 
(RAMPs). 
 
 
It is of pertinence that CGRP II, amylin, and ADM are encoded on the CALC II, IV, 
and V genes, respectively. CGRP I, CGRP II and ADM, considered as auto- and/or 
paracrine factors in many tissues are very potent vasodilatory peptides. Interestingly, 
it was found that in sepsis, mRNAs for CGRP I, CGRP II and ADM also appear to be 
ubiquitously expressed (6). Accordingly, in humans, circulating levels of CGRPs and 
ADM have been found to be elevated during bacterial infections (7, 8). In sepsis, a 
competition arises between organs for reduced systemic blood pressure and blood 
Promoter Common Exons CT CGRP 
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I II III IV 
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flow. Thus, in a teleologic perspective, due to their vasodilatory properties, the tissue-
wide production of CGRPs and ADM assures blood supply to the individual tissues 
and thereby may oppose vasoconstrictory effects of other stress hormones released 
during sepsis (e.g. catecholamines, cortisol). The importance of ADM in the 
cardiovascular system has been demonstrated in ADM knock-out mice. ADM knock-
out mice die at midgestation with severe cardiovascular abnormalities (9).  
Amylin, the fifth member of the CT superfamily is expressed and co-secreted with 
insulin from the pancreatic beta cells. Insular deposits of amylin are characteristic in 
type 2 diabetes mellitus; hence the initial nomenclature of amylin as “islet amyloid 
polypeptide”. Interestingly, in sepsis the expression of amylin remains restricted to 
human islets and circulating levels have not been found in sepsis (6). 
 
c) ProCT: a Pivotal Marker and Mediator in Sepsis and other 
Inflammatory Conditions 
In bacterial infections, circulating levels of ProCT increase several-thousand-fold. In 
sepsis, the increase of ProCT levels correlates with the severity and mortality. ProCT 
has a superior diagnostic accuracy for the diagnose of sepsis as compared to other 
markers of inflammation (e.g., interleukin-6 (IL-6) or C-reactive protein (CRP)) (10-
12). Administration of endotoxin to healthy human volunteers increased serum ProCT 
levels seen in sepsis and this increase persisted up to seven days (13). Several pro-
inflammatory mediators have been shown to induce ProCT production in vivo, e.g. 
TNF-α, IL-2 and IL-6 (14). Whatever the initiating provocative insult may be, severe 
systemic inflammation per se may manifest increased serum levels of ProCT. In 
addition to the elevated ProCT levels observed during bacterial infections, increases 
of ProCT also occured in chemical pneumonitis (14), in burns (15, 16), in heat stroke 
(17), in mechanical trauma (18), and following surgery (19). 
Several properties of ProCT favour this molecule as a therapeutic target in sepsis. In 
contrast to the transiently increased classical cytokines, for which 
immunoneutralization trials in humans have shown disappointing results, the massive 
increase of circulating ProCT persists for several days (13). ProCT is nearly always 
increased in overt sepsis; its onset is early (within 3 hrs), it is a stable peptide in 
serum samples and it can be easily measured. The excellent diagnostic accuracy 
should greatly improve patient selection for any study of ultimate therapeutic efficacy, 
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i.e., of ProCT immunoneutralization in humans. Importantly, administration of ProCT 
to septic hamsters with peritonitis doubled their death rate. Conversely, treatment 
with ProCT-reactive antiserum increased the survival in septic hamsters and pigs 
(20, 21). Recent experiments have demonstrated that such immunoneutralization is 
effective even when the ProCT- reactive antiserum is administered after the pigs 
became moribund (22). In addition, the biological activity of ProCT also appears to 
depend on the inflammatory status of the organism: in the aforementioned hamster 
model, only the injection of human ProCT to septic animals worsened the outcome 
(20), while in healthy animals the administration of similar doses of ProCT did not 
show any detrimental effects. Thus, the toxic effects of ProCT are restricted to an 
inflamed organism. 
 
d) Receptors for CT Peptides: A Functional Entity 
Based on the structural homologies, different CT peptides have overlapping 
bioactivities, which they exert by binding to the same family of receptors (3). There 
are two subgroups of these G protein-coupled receptors with seven transmembrane 
domains: CT receptors (CR) and CT receptor-like receptors (CRLR).  
Three accessory proteins, which are called receptor-activity-modifying proteins 
(RAMPs 1-3), act upon these receptors, thereby altering their specific 
responsiveness and ligand affinity. The binding affinities of the different CT peptides 
have been demonstrated to be modulated by the three RAMPs (Table 1). These 
observations appear to correlate with the diverse physiologic effects of the individual 
CT peptides (23). For example, association of CRLR with RAMP 1 on the cell surface 
results in a CGRP I or II responsive cell. The co-expression of RAMP 2 with CRLR 
on the cell surface results in an ADM responsiveness of the cells (Figure 4). RAMP-
assisted modulation of the ligand specificity of CR and CRLR is an exciting new 
principle; however, its exact physiological role remains to be determined. It is 
tempting to speculate that the extraordinary increase of circulating ProCT in sepsis 
prevents CGRP and ADM from exerting their actions, and thus acts as a competitive 
antagonist. Therefore, an outline of the pathogenic factors of the systemic 
inflammatory response with special emphasis on the role of ProCT can be 
investigated.  
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Table 1: RAMPs define ligand specificity of CR/CRLR 
2 Receptors 3 RAMPs 4 Ligands 
CR none CT 
 + RAMP-1 CGRP I or –II, Amylin >> CT 
 + RAMP-2 CT >> CGRP I or -II, Amylin 
 + RAMP-3 Amylin >> CT / CGRP I and -II 
CRLR + RAMP-1 CGRP I and -II 
 + RAMP-2 ADM 
 + RAMP-3 ADM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The role of RAMP 1 and 2 and CRLR in generating selective CGRP and ADM 
receptors. The vasodilatory actions of CGRP and ADM are brought about through two 
signaling mechanisms, direct cAMP mediated relaxation of vascular smooth muscle cells and 
the stimulation of phospholipase C in endothelial cells, resulting in an increase of [Ca2+]i and 
NO/cGMP-mediated vasodilatation.  
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e) Nitric Oxide (NO) in Inflammation: Relation with CT Peptides 
Severe illness induces a uniform systemic inflammatory response syndrome (SIRS) 
independently of an infection. SIRS is clinically defined by white blood count higher 
than 12,000 or lower than 4,000 cells/µl; a heart rate higher than 90 beats/min; a 
respiratory rate higher than 20 breaths/min; and a body temperature higher than 38 
ºC or lower than 36 ºC. When SIRS is present, and infection is proven or suspected 
and the term sepsis is used. Metabolically, SIRS, with or without infection, is 
characterized by a catabolic state, with insulin resistance as a key feature. 
Insulin resistance, with or without hyperglycemia, is common in critically ill patients, 
even in those without preexisting diabetes (24). Hyperglycemia or relative insulin 
deficiency (or both) during critical illness, and especially sepsis, confer a 
predisposition to complications, and death (25, 26). In vitro, the responsiveness of 
leukocytes stimulated by inflammatory mediators is inversely correlated with glycemic 
control (27). Importantly, aggressive insulin infusion therapy to counter the insulin 
resistance and improve glycemic control reduced mortality by 50% in surgical 
patients requiring prolonged intensive care (28). Notably, this beneficial effect 
occurred regardless of whether there was a history of diabetes or hyperglycemia, and 
the greatest reduction of mortality was found in septic patients. 
During sepsis, large amounts of NO are produced (29, 30). NO is an important 
second messenger molecule implicated in a wide variety of physiological functions, 
including vascular relaxation, cytotoxicity and immune response (31). The conversion 
of L-arginine to L-citrulline and NO is catalyzed by enzymes of the nitric oxide 
synthase (NOS) family. The mandatory cofactor tetrahydrobiopterin (BH4) is rate-
liming on NO synthesis in most cell types. Its synthesis is co-induced to inducible  
NOS (iNOS) by enhanced expression of guanosine triphosphate cyclohydrolase 
(GTPCH). BH4 was proposed as a possible regulator of iNOS mRNA stability. Two of 
the three known NOS isoforms, the neuronal and endothelial NOS (nNOS and 
eNOS) are Ca2+-dependent. The inducible, Ca2+-independent iNOS is implicated in 
host defense and vasodilation. iNOS is expressed in numerous cell types including 
macrophages, liver, vascular smooth muscle and adipose tissue following induction 
by cytokines or bacterial lipopolysacharide (LPS). Interestingly, targeted disruption of 
iNOS protects against obesity-linked insulin resistance in mouse muscle (32). 
Exaggerated NO production following iNOS induction causes insulin resistance by 
interfering with insulin action on glucose transport into muscle cells (33). In contrast, 
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a number of studies, mostly performed with muscle cells, suggest that NO 
contributes to insulin-mediated glucose uptake (34, 35). The role of NO in adipose 
tissue mediated insulin resistance in humans is largely unknown.  
Several CT peptides have been found to induce insulin resistance, to decrease 
peripheral glucose clearance, and to increase hepatic glucose output (36, 37). 
CGRPs and ADM reduced the glucose-stimulated insulin secretion in the pancreas 
(38). Early reports indicated that both human pancreatic amylin and rat CGRP I are 
potent inhibitors of both basal and insulin-stimulated glucose uptake and glycogen 
synthesis in the skeletal muscle and in liver (36, 39). Furthermore, amylin is known to 
inhibit stimulated insulin secretion through a paracrine effect in islet cells (38). Hence, 
it is tempting to speculate that in inflammatory conditions CT peptides could 
modulate this insulin resistance.  
Both CGRP and ADM have anti-inflammatory, metabolic and vascular actions which 
are beneficial in inflammation and sepsis (3). The vasodilatory actions of CGRP and 
ADM are mostly the result of NO-mediated relaxation of vascular smooth muscle 
cells (30, 40, 41). Conversely, the endotoxin triggered release of CGRP is NO- and 
prostaglandin-dependent (42). Thus, NO mediates both the production and the action 
of CT peptides. Importantly, recombinant human ProCT is a potent suppressor of 
cytokine-induced iNOS expression and NO synthesis in rat vascular smooth muscle 
cells in a dose-dependent manner, with a maximal effect at ProCT levels of 100ng/ml 
(43). However, at the highest concentration utilized (5000ng/ml), ProCT did not inhibit 
iNOS expression or NO production. Furthermore, ProCT had no effect on 
unstimulated cells. It was hypothesized that in inflammatory conditions, and 
especially in sepsis, CT peptides modulate insulin resistance in a NO-dependent 
manner. 
 
f) Somatostatin and its receptors 
Somatostatin (SRIF) was initially described as a secreted product of the 
hypothalamus acting as a potent inhibitor of growth hormone (GH) secretion (44). 
Subsequently, high densities of SRIF-producing neuroendocrine cells have been 
localized throughout the central and peripheral nervous systems, in the endocrine 
pancreas and in the gut, and to a lower extent in the thyroid, adrenals, 
submandibular glands, kidneys, prostate and placenta (45-47). SRIF expression and 
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secretion was also described in murine inflammatory and immune cells upon 
activation (45). In the gastrointestinal tract SRIF inhibits the secretion of numerous 
peptide hormones (insulin, glucagon, gastrin and cholecystokinin), gastric emptying, 
gallbladder contraction and exocrine gut secretion (46, 48). Induction of SRIF by 
inflammatory cytokines IL-1β, TNF-α and IL-6 was demonstrated in vitro in rat 
diencephalic cells (46, 49, 50). Increased SRIF-mRNA expression has been 
described in murine macrophage cell lines upon cytokine stimulation (51). 
Accordingly, increased plasma SRIF levels were measured in jugular and portal 
veins in endotoxin-injected sheep and in septic pigs (52, 53). Five distinct receptors 
mediating SRIF activity are widely expressed in many tissues. As a neurotransmitter, 
SRIF inhibits the release of GH, dopamine, norepinephrine, thyreotropin-releasing-
hormone (TRH) and corticotropin-releasing-hormone (CRH). Further modulatory 
roles have been ascribed to SRIF in inflammatory conditions and lymphocyte function 
(54-56).  
 
g) Adipose Tissue 
Adipose tissue is capable of producing hormones, cytokines and other proteins 
involved in inflammation and insulin resistance and thereby rendering it the body’s 
largest “endocrine organ”. Obesity is a major reason for insulin resistance (57). The 
prevalence of obesity is increasing worldwide, not only in industrialized but also in 
developing countries. The obesity related, so-called “metabolic syndrome” with its 
cluster of disorders such as diabetes, dyslipidemia and arterial hypertension, leads to 
an array of inflammatory complications related to atherosclerosis and characterized 
by a high morbidity and mortality. Importantly, critically ill obese patients have been 
found to be at increased risk of morbidity and mortality compared to the non-obese 
patients. Overall mortality was 30% for the morbidly obese patients and 17% for the 
non-obese group, mostly due to pulmonary infections and sepsis (58). It was 
previously reported that with the exception of amylin, all members of the CT peptide 
superfamily were expressed on the mRNA level in adipose tissue in vivo during the 
systemic inflammatory host response to an infection in an animal model (4, 6). 
Improvement of the understanding of the physiological function of adipocytes is a 
prerequisite for understanding the molecular mechanisms that underpin these 
diseases (59).  
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5. AIM OF THE THESIS 
The aim of the thesis was: 
• to study the hormokine properties of ProCT in humans with emphasis 
on its gene expression regulation and physiological effects 
• to establish if the other members of the CALC gene family display 
hormokine properties in humans 
• to investigate if other classical hormones display hormokine properties 
• to unravel if the hormokine phenomenon extends to a cell biological 
mechanism of tissue plasticity that provides tissues with the capacity to 
adapt and respond to physiological perturbations (e.g. inflammation) 
 
These aims were primarily investigated using a multi-disciplinary approach that 
combined a novel human adipocyte cell culture model, with gene expression profiling 
upon inflammatory stimuli, gene expression profiling following treatment with CT 
peptides to delinaete paracrine properties, and biochemical assays to underpin the 
funtional roles of hormokines in sepsis.   
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6. MAIN FINDINGS AND CONCLUSION 
 
Here is presented a summary of the major findings and conclusions of the thesis 
study. The results are based on the papers presented in the subsequent chapters.  
The hormokine properties of ProCT were initially built on findings with rodents 
subjected to sepsis (4). Since then, observations from patients with sepsis indicated 
that the hormokine behavior of ProCT is a common principle that extend from rodents 
to humans (60). A novel cell culture system utilising human adipocytes was 
developed to allow detailed studies of the molecular mechanisms controlling the 
expression of ProCT and other CT peptides, and their biological activities during 
sepsis. 
In human adipocyte primary cultures and in adipose tissue samples from infected 
and non-infected patients with different levels of serum ProCT inflammation-mediated 
CALC I gene expression was analyzed. In ex vivo differentiated adipocytes, 
expression of CT mRNA increased 24-fold (p<0.05) by the administration of LPS and 
37-fold (p<0.05) by interleukin-1β (IL-1β) after 6 hours. ProCT secretion into culture 
supernatant increased 13.5-fold (p<0.01) with LPS treatment and 15.2-fold (p<0.01) 
by IL-1β after 48 hours. In co-culture experiments, adipocyte CT mRNA expression 
was evoked by E. coli activated macrophages, in which CT mRNA was undetectable. 
The marked IL-1β-mediated-ProCT release was inhibited by 89% during co-
administration with IFNγ. In patients with infection and markedly increased serum 
ProCT, CT mRNA was detected in adipose tissue biopsies. Hence, the experiments 
carried out to answer the hypothesis lead to the conclusion that ProCT, which is 
suspected to mediate deleterious effects in sepsis and inflammation, is a novel 
product of adipose tissue secretion. The inhibiting effect of IFNγ on IL-1β-induced CT 
mRNA expression and on ProCT secretion might explain previous observations that 
serum ProCT concentrations increase less in systemic viral as compared to bacterial 
infections. Figure 5 presents a schematic diagram of the different expression pattern 
of ProCT as a hormokine and CT as classical hormone. (Linscheid P, Seboek D, 
Nylen ES, Langer I, Schlatter M, Keller U, Becker KL, Muller B 2003: In vitro and in 
vivo calcitonin-I gene expression in parenchymal cells: a novel product of human 
adipose tissue Endocrinology 144(12):5578-5584) 
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Figure 5: Schematic diagram of CALC I expression in adipocytes as hormokines and 
thyroidal C cells as hormones. In the classical neuroendocrine paradigm, the expression of 
CT mRNA is restricted to neuroendocrine cells, mainly C cells of the thyroid. Initially, the 116-
amino acid prohormone ProCT is synthesized and subsequently processed to the 
considerably smaller mature CT. In sepsis and inflammation, proinflammatory mediatiors 
induce CT mRNA. In contrast to thyroidal cells, adipocytes lack secretory granules, and 
hence, unprocessed ProCT is released in a nonregulated, constitutive manner.  
 
These observations led to the hypothesis, that ProCT guidance could limit antibiotic 
overuse in mostly viral acute respiratory tract infections (61). Clinical investigations 
showed, that ProCT guided treatment reduced the use of antibiotics, without 
jeopardazing clinical outcome (60). Knowing the clinical usefulness of ProCT, the 
interest in understanding the regulation and biological role grew. Therefore, we 
investigated the crosstalk of classical immune cells (i.e., monocytes and 
macrophages) with adipocytes during inflammation and bacterial infection in vitro 
(62). Interestingly, no CT mRNA was found in leukocytes from septic patients and in 
peripheral blood mononuclear cell (PBMC) -derived macrophages after incubation 
with E. coli, LPS, IL-1β or TNFα. Conversely, in co-culture experiments, stimulated 
human macrophages were able to induce ProCT and CGRP I induction in 
adipocytes. In monocytes only a transient expression of CT mRNA during the initial 
18 h during attachment was observed. It could be concluded that the adhesion-
  19 
induced, transient expression and secretion of ProCT and CGRP I in vitro may play 
an important role during monocyte adhesion and migration in vivo. PBMC-derived 
macrophages may contribute to the marked increase in circulating ProCT by 
recruiting parenchymal cells within the infected tissue, as exemplified with adipocytes 
(Figure 6). (Linscheid P, Seboek D, Schaer JD, Zulewski H, Keller U, Müller B 2004: 
Expression and secretion of procalcitonin and calcitonin gene-related peptide by 
adherent monocytes and by macrophage-activated adipocytes  Crit Care Med 
32(8):1715-1721) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Macrophage-mediated CT mRNA expression in human adipocytes. PBMC-
derived macrophages in cell culture inserts with 0.4-um pores were prestimulated for 2 hrs 
with cytokines/LPS or E. coli. Inserts were thoroughly washed and added to nonstimulated 
adipocytes. After 24 hrs in co-culture, RNAs of macrophages and adipocytes were separately 
isolated. 
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Based on the first two publications, a trimodal expression pattern of the CALC I gene 
and a closely related biphasic behavior of infection-related ProCT secretion was 
postulated (Table 2).  
 
Table 2: Trimodal expression pattern of the CALC I gene 
 Thyroid Adipose tissue Monocytes 
mRNA constitutive 
regulated 
sustained by cytokines and 
LPS detectable > 6 hrs 
regulated 
rapid, transient 
upon adhesion 
detectable > 2 hrs 
Peptide 
regulated 
e.g. by Ca2+ or 
gastrin 
constitutive 
detectable after> 10 hrs 
persistent (>24 hrs) 
constitutive 
detected > 4 hrs 
transient (< 18 hrs) 
Main function endocrine sepsis-associated ProCT increase local vasodilation 
Tissue mass low high low 
 
For further investigations a steadier source of human adipocytes than surgical 
explants was needed. To this aim, human MSCs were differentiated into an 
adipocyte phenotype. The MSC-derived adipocytes were comparable to adipocytes 
derived from preadipocytes as assessed by light microscopy, fat accumulation, 
lipolysis and glucose uptake (62, 63). Having this models established the next aim of 
the thesis was to explore the expression, interactions and potential roles of 
adipocyte-derived CT peptide production. Expression of CT peptide-specific 
transcripts was analyzed by RT-PCR and quantitative real-time PCR in human 
adipose tissue biopsies and in three different inflammation-challenged human 
adipocyte models. ProCT, CGRP and ADM secretions were assessed by 
immunological methods. Adipocyte transcriptional activity, glycerol release and 
insulin-mediated glucose transport were studied after exogenous CGRP and ADM 
exposure. With the exception of amylin, CT peptides were expressed in adipose 
tissue biopsies from septic patients, inflammation-activated mature explanted 
adipocytes and macrophage-activated preadipocyte-derived adipocytes. ProCT and 
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CGRP productions were significantly augmented in IL-1β and LPS-challenged MSC-
derived adipocytes, but not in undifferentiated MSC. In contrast, ADM expression 
occurred before and after adipogenic differentiation. IFNγ co-administration inhibited 
IL-1β-mediated ProCT and CGRP secretion by 78% and 34%, respectively, but 
augmented IL-1β-mediated ADM secretion by 50%. Exogenous CGRP and ADM 
administration induced CT, CGRP I and CGRP II mRNAs and dose-dependently (10-
10 and 10-6 M) enhanced glycerol release. In contrast, no CGRP- and ADM-mediated 
effects were noted on ADM, TNFα and IL-1β mRNA abundances.  
In summary, CGRP and ADM are two differentially regulated novel adipose tissue 
secretion factors exerting autocrine/paracrine roles. Their lipolytic effect (glycerol 
release) suggests a metabolic role in adipocytes during inflammation. The induction 
of CALC I and II mRNAs with exogenous CGRP and ADM, suggests a positive 
autocrine feedback loop. This feedback loop was markedly enhanced by incubation 
with cycloheximide, an unspecific inhibitor of protein synthesis (Figure 7). This 
“superinduction” suggests the presence of one or several short-lived proteins, which 
suppresses CALC gene expression in non-inflamed non-neuroendcrine cells, 
suggesting a hormokine silencing factor. (Linscheid P*, Seboek D*, Zulewski H, 
Keller U and Müller B 2005: Autocrine/paracrine role of inflammation-mediated 
CGRP and ADM expression in human adipose tissue Endocrinology 146(6):2699-
2708). 
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Figure 7: CALC-gene mRNA induction in MSC derived adipocytes: autoregulation and 
superinduction. ADM and CGRP lead to a similar induction of CALC I and II gene as 
compared to pro-inflammatory IL-1β. Incubation with cycloheximide (CH) markedly 
potentiated this effect, resulting in a superinduction of CALC gene mRNAs after 6 hours. 
 
 
 
After investigating adipose tissue as a source of CT peptides and discover it also as 
a target of CT peptides, the aim of the thesis was to invesitgate the hypothesis if 
there is an influence of CT peptides on NO synthesis in inflammed adipocytes. eNOS 
mRNA was highly expressed in omental and to a lesser extent in human 
subcutaneous adipose tissue biopsies, but not in purified adipocytes, in MSC- and in 
preadipocyte-derived adipocytes, respectively. Trace amounts of iNOS mRNA was 
detected in adipose tissue samples of donors with abdominal infection, as opposed 
to non-infected subjects. IFNγ in combination with IL-1β or LPS, evoked a transient 
(4 h < t < 24 h) iNOS mRNA expression in human MSC- and preadipocyte-derived 
adipocytes, respectively. This induction was preceded by cytokine-specific mRNAs. 
In addition, it was accompanied by an activation of the tetrahydrobiopterin (BH4) 
synthesis pathway and by inhibition of peroxisome proliferator-activated receptor-γ 2 
(PPARγ2). In contrast to murine 3T3-L1-derived adipocytes, iNOS protein and NO 
oxidation products remained undetectable in iNOS mRNA positive human 
adipocytes. Accordingly, co-administration of NOS inhibitors (i.e. L-NAME, L-NMMA, 
1400W) had no effects on insulin-mediated glucose uptake and lipolysis, 
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respectively. It was concluded that in human adipocytes endogenous NO is not 
involved in metabolic regulation during both basal and cytokine-activated conditions 
(Figure 8). (Linscheid P, Seboek D, Zulewski H, Scherberich A, Blau N, Keller U and 
Müller B 2005: Cytokine-induced metabolic effects in human adipocytes are 
independent of endogenous nitric oxide Am J Physiol Endocrinol Metab- in press) 
 
 
 
 
 
 
 
Figure 8: iNOS and PPARγ protein expression in MSC-derived adipocytes 
Adipocytes were subjected to iNOS mRNA inducing treatments as indicated. Whole cell 
lysates (or cytosolic lysates where indicated) containing 40 µg (MSC-derived adipocytes) or 
10 µg (3T3-L1) total protein were subjected to iNOS and PPARγ2 detection by Western blot. 
Adipocytes were treated for 10 h with IFNγ/IL-1β/TNFα. Results are representatives from four 
two separate experiments. 
 
 
 
 
The results of the above mentioned investigations show, that in contrast to all other 
CALC genes, the CALC IV gene amylin was never induced by inflammatory 
stimulation. However, amylin is co-secreted with insulin from differentiated β cells of 
the endocrine pancreas. During the thesis the hypothesis arose, if other hormones, 
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e.g. pancreatic hormones could also act as hormokines. For evaluation of this 
hypothesis expression and secretion of SRIF and its receptors were investigated in 
human adipose tissue upon inflammatory stimulation in vitro and in tissues from 
patients with septic disease.  
Preadipocyte-derived adipocytes, MSC-derived adipocytes and mature explanted 
adipocytes expressed SRIF mRNA upon LPS or IL-1β treatments. LPS- and IL-1β-
mediated SRIF mRNA induction was blocked by pretreatment with dexamethasone. 
Using co-cultures and quantitative real-time PCR we demonstrate adipocyte SRIF 
induction by secretion factors from activated PBMC-derived macrophages. In 
contrast to basal adipocytes, SRIF protein was detected in culture supernatants of 
LPS- and of combined TNFα/IL-1β/LPS-treated adipocytes. SRIF protein was 
visualized by immunohistochemistry in explanted minced adipose tissue upon 
overnight incubation in culture medium supplemented with combined IL-1β and LPS. 
In septic patients expression of SRIF-mRNA and SRIF protein was found in visceral 
but not in subcutaneous adipose tissue. Adipocyte mRNA abundance of SRIF 
rezeptors (SSTR) 1-5 were differentially regulated by inflammatory treatments. 
In summary, human visceral adipose tissue secretes SRIF during inflammation and 
sepsis and expresses several SSTR. It is tempting to speculate that visceral adipose 
tissue-derived SRIF plays a modulatory role in the immunological and metabolic 
response to inflammation, e.g., relative insulin hyposecretion and hyperglycemia. 
With this study a novel hormokine, e.g., SRIF was described (Figure 9). (Seboek D, 
Linscheid P, Zulewski H, Langer I, Christ-Crain M, Keller U, Muller B 2004: 
Somatostatin is expressed and secreted by human adipose tissue upon infection and 
inflammation J Clin Endocrin Metab 89(10): 4833-4839) 
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Figure 9: SRIF immunohistochemical staining in human adipose tissue. Adipose tissue 
sections were immunohistochemicaly stained to determine the presence of SRIF. A) 
Subcutaneous adipose tissue biopsies obtained from non-infected individuals were taken as 
control tissue. B) Subcutaneous adipose tissue biopsies obtained from non-infected 
individuals were stimulated with LPS and IL-1β over night in cell culture medium. C) 
Subcutaneous and D) visceral adipose tissue biopsies were obtained intra-operatively from a 
septic patient. All magnifications 1:400. 
 
 
Thereafter, I became interested in the plasticity of hormokines and. Because of the 
hormokine like behavior of somatostatin, the hypothesis arose that other islet 
hormones, namely insulin or glucagon could be expressed ectopically. The idea was 
that non-endocrine cells might produce islet derived hormones upon adequate 
stimulation and/or differentiation, comparable to the ubiquitous expression of CT 
peptides during infections. Multipotential stem cells form various organs appear to 
share this particular property of CT peptide secreting cells as they are able to induce 
the expression of gene products that were initially not produced by their respective 
tissue of origin. Insulin expressing cells were generated form stem cells originated 
from the pancreas, bone marrow, liver and embryonic stem cells. Extrapanctreatic 
insulin expression was seen in bone marrow as well as liver and adipose tissue in 
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response to hyperglycemia in mice. Human islet derived stem cells were shown to 
adopt a hepatic phenoptype in vitro (64) and in vivo (65). 
The study presented herein shows that bone marrow derived human MSC and 
human adipose tissue derived preadipocytes express the stem cell markers nestin 
and ABCG2 as well as the transcription factor islet-1 (Isl-1). Upon induction of 
differentiation with defined culture conditions these cells adopt a pancreatic 
endocrine phenotype with up-regulation of the crucial pancreatic transcription factors 
Isl-1, Ipf-1, Ngn3, Pax-4, Pax-6, Nkx-2.2 and Nkx-6.1. In parallel an up-regulation of 
the islet proteins insulin, glucagon, somatostatin and the glucose transporter glut-2 
was observed. Similar gene expression profile was found in MSC of type 1 diabetic 
patients without residual insulin secretion. The ability of human MSC to adopt a 
pancreatic endocrine phenotype indicates a developmental potential of these cells 
that may help to develop new stem cell based therapies for type 1 diabetes using an 
autologous transplantation approach (Figure 10). (Seboek D, Timper K, Eberhardt M, 
Linscheid P, Keller U, Müller B and Zulewski H: Human bone marrow-derived 
mesenchymal stem cells differentiate into insulin, somatostatin and glucagon 
expressing cells (submitted) and (Timper K*, Seboek D*, Eberhardt M, Linscheid P, 
Keller U, Müller B and Zulewski H 2006: Human adipose tissue-derived 
mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon 
expressing cells Biochem Biophys Res Commun 341(4)1135-40). 
 
 
 
 
Figure 10: Islet like clusters generated from MSC. Phase contrast image of islet like 
clusters after differentiation of MSC. For immunocytochemistry islet-like clusters were 
collected after 3 days in differentiation medium. Staining of differentiated clusters for c-
peptide. Nuclear staining in blue with DAPI. 
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The findings might have important implications. Therefore, promoter studies with 
hormokine promoters were planned to be carried out. However, human mature 
adipocytes are difficult to transduce or transfect. The final aim of the thesis was to 
establish a procedure for introducing genetic information into MSC- and 
preadipocyte-derived adipocytes. Expression of the GFP reporter gene was 
assessed after exposure to lentiviruses. Preserved adipocyte function was evaluated 
by insulin-induced glucose uptake. 
Adipocytes expressed GFP after 5 days post-transduction. Up to 60% of mature 
adipocytes were GFP positive. Transduction of undifferentiated bone marrow-derived 
MSCs and preadipocytes did not affect their capacity to adopt an adipocyte 
phenotype upon differentiation. Insulin-induced glucose uptake was not affected in 
transduced mature adipocytes. Transfection efficiency by adenoviral-mediated gene 
transfer into both differentiated and undifferentiated cells was similar to lentiviral 
infection, as evaluated by cell counts. However, this procedure was associated with 
over 50% cell death within the first 5 days. 
Lentiviral vectors provide an effective gene transfer techniques for the genetic 
modification of MSC- and preadipocyte-derived human adipocytes without apparent 
loss of cell-specific functions. This technique may provide a basis for further studies 
on the biology of adipose tissue and has the potential to become a target for gene 
therapy in obesity-related disorders (Figure 11). (Seboek D, Linscheid P, Firm C, 
Zulewski H, Salmon P, Russo AF, Keller U, Müller B: Lentiviral vectors efficiently 
transduce human mesenchymal stem cell- and preadipocyte derived mature 
adipocytes (submitted)) 
 
 
 
 
 
 
 
Figure 11: Transduction of human MSC- derived adipocytes. Mature MSC derived 
adipocytes were exposed to lentiviral vectors containing GFP under a PGK promoter (53RPA 
PGK GFP). Picture was taken 4 days after transduction with the Olympus IX 50 fluorescent 
microscope.  
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Taking the data together, the ubiquitous expression of CT peptides upon sepsis and 
showing expression of pancreatic endocrine genes in stem cells of different origin, it 
can be suggested that a mechanism may be present in both cases that unlocks the 
tissue specific boundary. 
This work anticipates that the interdisciplinary approach will clarify shared 
mechanisms of metabolic dysfunctions (i.e. insulin deficiency and resistance, 
respectively) of allegedly distinct diseases, namely obesity, type 2 diabetes and 
sepsis with their ensuring complications characterized by a high morbidity and 
mortality. 
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7.  FUTURE PERSPECTIVES 
In spite of these important findings, it is as yet unclear how ProCT and the other CT 
peptides may influence the complex events occurring in systemic inflammation. The 
ubiquitous expression of CT peptides and other hormones upon sepsis suggest that 
a mechanism may be present that unlocks the tissue specific boundary. Detailed 
intracellular mechanisms underlying the regulation, function and plasticity of 
hormokines using human adipocytes can be achieved with the virus techniques. 
Furthermore, to understand the phenomenon of trans-differentiation may become 
very useful in the development of innovative strategies for generation of insulin 
expressing cells from non-pancreatic tissues, like bone marrow and adipose tissue. 
Excited by the plasticity of hormokines in human cells, it is tempting to speculate that 
mesenchymal stem cells and fat precursor cells can be turned into islets. The 
concept of hormokines implies unforseen possibilities in the regulation of the insulin 
gene and for the treatment of diabetes. Stem cells could be isolated from tissue 
biopsies of diabetic patients e.g. bone marrow or adipose tissue, expanded ex vivo 
and re-transplanted into the donor/recipient, curing his diabetes without the need for 
immunosuppressive therapy.  
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Circulating levels of calcitonin precursors (CTpr), including
procalcitonin (ProCT), increase up to several thousand-fold in
human sepsis, and immunoneutralization improves survival
in two animal models of this disease. Herein, we analyzed
inflammation-mediated calcitonin I gene (CALC I) expression
in human adipocyte primary cultures and in adipose tissue
samples from infected and noninfected patients with different
levels of serum ProCT. In ex vivo differentiated adipocytes, the
expression of CT mRNA increased 24-fold (P < 0.05) after the
administration of Escherichia coli endotoxin (lipopolysaccha-
ride) and 37-fold (P < 0.05) after IL-1 administration by 6 h.
ProCT protein secretion into culture supernatant increased
13.5-fold (P < 0.01) with lipopolysaccharide treatment and
15.2-fold (P < 0.01) with IL-1 after 48 h. In coculture exper-
iments, adipocyte CT mRNA expression was evoked by E. coli-
activated macrophages in which CT mRNA was undetectable.
The marked IL-1-mediated ProCT release was inhibited by
89% during coadministration with interferon- (IFN). In pa-
tients with infection and markedly increased serum ProCT,
CT mRNA was detected in adipose tissue biopsies. Hence, we
demonstrate that ProCT, which is suspected to mediate del-
eterious effects in sepsis and inflammation, is a novel product
of adipose tissue secretion. The inhibiting effect of IFN on
IL-1-induced CT mRNA expression and on ProCT secretion
might explain previous observations that serum ProCT con-
centrations increase less in systemic viral compared with bac-
terial infections. (Endocrinology 144: 5578–5584, 2003)
ADIPOSE TISSUE IS increasingly recognized as a majorendocrine organ in humans. The numerous peptide
hormones released by adipocytes have been proposed to
affect energy homeostasis, glucose and lipid metabolism,
immune response, and reproduction (1). Most of these sig-
naling molecules appear to be deregulated when mass is
markedly altered, being increased in the obese state or de-
creased in lipoatrophy.
In systemic microbial infections, circulating levels of cal-
citonin (CT) precursors (CTpr), including procalcitonin
(ProCT), increase up to several thousand-fold, and this in-
crease correlates with the severity of the illness and with
mortality (2–4). Furthermore, CTpr may contribute to the
deleterious effects of systemic infection as shown in exper-
imental animals (5–7).
CTpr originate from the calcitonin I (CALC I) gene on
chromosome 11. Similar to many peptide hormones, mature
CT is initially biosynthesized as a larger prohormone, ProCT,
which is subsequently processed into smaller peptides, in-
cluding CT (8, 9). The classical neuroendocrine paradigm
limits the expression of CALC I exclusively to neuroendo-
crine cells, mainly the C cells of the thyroid. However, in-
creased plasma ProCT levels have been reported in thyroid-
ectomized patients with inflammation (10, 11). We recently
documented the generalized, tissue-wide, nonneuroendo-
crine expression of CT-mRNA in animal models of sepsis (12,
13). To elucidate the source of ProCT in human sepsis, we
studied the effects of cytokines and lipopolysaccharide (LPS)
on CALC I induction and ProCT secretion in human adipo-
cytes. In addition, we examined CT-mRNA expression in
adipose tissue samples obtained from infected and nonin-
fected patients.
Materials and Methods
Adipocyte cultures
For ex vivo stimulation, after informed consent was granted, 50–500
g adipose tissue were obtained from noninfected patients undergoing
plastic surgery. Primary cultures of human adipocytes were performed
as previously described (14, 15) with modifications. Briefly, adipose
tissue was minced, digested in 1 mg/ml collagenase 2 (Worthington
Biochemical Corp., Freehold, NJ), filtered (150-m pore size nylon mesh)
and centrifuged at 200  g. The cell pellet was resuspended twice in
erythrocyte lysis buffer, washed, and seeded at a density of approxi-
mately 33,000 cells/cm2 in 6- or 12-well plates. After 18-h incubation in
DMEM/Ham’s F-12 with 10% fetal calf serum allowing attachment, cells
were washed in PBS and cultured in serum-free medium supplemented
with agents (isobutylmethylxanthine, dexamethasone, insulin, trans-
ferrin, and T3) that induce differentiation of preadipocytes to adipocytes.
During the first 2 d, 1 m rosiglitazone (provided by GlaxoSmithKline,
Worthing, UK) was also present. Triglyceride-storing adipocytes, rep-
resenting 40–80% of cultured cells, are visible within 5–10 d. Differen-
tiation was confirmed by RT-PCR analysis for adipocyte-specific per-
oxisome proliferator-activated receptor 2 expression (16). Adipocytes
were maintained for an additional 4 d in DMEM/Ham’s F-12 with 10%
FCS before experiments.
Abbreviations: CT, Calcitonin; CTpr, calcitonin precursors; HPRT,
hypoxanthine-guanine phosphoribosyltransferase; IFN, interferon-;
IMDM, Iscove’s modified Dulbecco’s medium; LPS, lipopolysaccharide;
ProCT, procalcitonin.
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In addition, floating mature adipocytes obtained after the centrifu-
gation step were washed, inoculated into 50-ml flasks (BD Biosciences,
Franklin Lakes, NJ) completely filled with medium (DMEM/Ham’s F-12
with 10% FCS), and allowed to attach to the upper surface for 72 h at 37
C (17, 18). Flasks were subsequently turned around, and the attached
purified, triglyceride-storing adipocytes were cultured in 5 ml medium
for experiments.
Adipocytes were stimulated for time periods ranging from 2–60 h
with the following agents: 1 g/ml lipopolysaccharide (LPS), 100 U/ml
interferon- (IFN), 10 ng/ml TNF, and 20 U/ml IL-1. Human-
specific cytokines were purchased from PeproTech (London, UK), and
LPS (Escherichia coli 026:B6) was obtained from Sigma-Chemie (Buchs,
Switzerland).
The viability of adipocytes after stimulation was assessed via trypan
blue staining: viable cells exclude trypan blue; dead cells stain blue.
Adipocytes and macrophages in cocultures
White blood cells were isolated by Ficoll-Plaque Plus (Amersham
Pharmacia Biotech, Uppsala, Sweden) and washed four times with
Hanks’ buffered salt solution (Invitrogen, Basel, Switzerland) supple-
mented with 0.5% human albumin (Blutspendedienst SRK, Bern, Swit-
zerland). Cells were resuspended in Iscove’s Modified Dulbecco’s Me-
dium (IMDM) with 20% human serum and seeded in cell culture inserts
with 0.4-m pore size (BD Biosciences). After 1-h incubation to allow
attachment of monocytes, inserts were washed four times with Hanks’
buffered salt solution supplemented with 0.5% human albumin. Fresh
IMDM with 20% human serum was supplied, and monocytes were
cultured for 5 d, allowing differentiation to macrophages. For experi-
ments, inserts with macrophages were added to wells containing ex vivo
differentiated adipocytes, which were previously kept for 2 d in IMDM
with 20% human serum. Upper chambers containing macrophages were
supplemented for 2 h with live E. coli and kept in coculture with adi-
pocytes for an additional 22 h.
RT-PCR
Total RNA from homogenized tissues or adipocyte cultures was
extracted by the single step guanidinium isothiocyanate method with a
commercial reagent (Tri-Reagent, Molecular Research Center, Inc., Cin-
cinnati, OH) according to the manufacturer’s protocol. Extracted RNA
was quantified spectrophotometrically, and the quality was assessed by
gel electrophoresis. Equal amounts of RNA per tissue or in vitro treat-
ment were subjected to RT (Omniscript RT kit, Qiagen, Basel, Switzer-
land). PCR was performed on a conventional thermal cycler (TGradient,
Biometra, Gottingen, Germany) using the PCR Taq core kit (Qiagen) and
the following intron border-spanning oligonucleotides: CT (232-bp
product; GenBank accession no. X00356), 5-TGAGCTGGAGCAGGAG-
CAAG-3 (sense) and 5-GTTGGCATTCTGGGGCATGCTAA-3 (anti-
sense); IL-6 (284-bp product; GenBank accession no. NM_000600),
5-GCAAAGAGGCACTGGCAGAAA-3 (sense) and 5-CAGGCTG-
GCATTTGTGGTTG-3 (antisense); TNF (310-bp product; GenBank ac-
cession no. M10988), 5-GGCCCAGGCAGTCAGATCAT-3 (sense) and
5-GGGGCTCTTGATGGCAGAGA-3 (antisense); and -actin (198-bp
product; GenBank accession no. AF076191), 5-TTCTGACCCATGC-
CCACCAT-3 (sense) and 5-ATGGATGATGATATCGCCGCGCTC-3
(antisense). The annealing temperature was 65 C, except for CT (67 C).
Thirty-five cycles of PCR were used for CT and TNF detection. Cycles
were reduced to 28 for IL-6 and -actin to stop the reaction in the linear
phase of amplification. IL-6 and TNF were used as controls of inflam-
matory stimulation, and -actin was used to verify equal quantities of
RNA loading in each reaction. PCR products were separated and vi-
sualized on 1.5% agarose gels containing 0.5 g/ml ethidium bromide.
PCR product identity was confirmed by direct nucleotide sequencing of
the PCR products by dye deoxy terminator cycle sequencing.
Quantitative analyses of CT-mRNA expression
cDNA obtained as described above was subjected to quantitative
real-time PCR analysis using the ABI 7000 sequence detection system
(PerkinElmer, Branchburg, NJ). Specific primers yielding short PCR
products suitable for SYBR-Green detection were designed using Primer
Express software (version 1.0, PE Applied Biosystems, Foster City, CA).
Sequences of primers were as follows: CT (92-bp product; GenBank
accession no. X00356), 3-GTGCAGATGAAGGCCAGTGA-5 (sense)
and 3-TCAGATTACCACACCGCTTAGATC-5 (antisense); and hypo-
xanthine-guanine phosphoribosyltransferase (HPRT; 85-bp product;
GenBank accession no. M26434), 3-TCAGGCAGTATAATCCAAA-
GATGGT-5 (sense) and 3-AGTCTGGCTTATATCCAACACTTCG-5
(antisense). The reaction volume was 22 l, and the conditions were set
as suggested by the manufacturer. Each cDNA sample tested for quan-
titative CT mRNA expression was also subjected to HPRT mRNA anal-
ysis. Results were expressed as the ratio of the respective CT mRNA and
HPRT mRNA threshold values. Product identity was confirmed by
sequence analysis and electrophoresis on a 2.5% agarose gel containing
ethidium bromide.
CT precursor concentrations
ProCT concentrations were determined in supernatants by an ultra-
sensitive chemiluminometric assay with a functional sensitivity of 6
pg/ml (ProCa-S Assay, B.R.A.H.M.S. GmbH, Hennigsdorf-Berlin,
Germany).
Patients
Adipose tissue samples were obtained from four infected patients
with elevated serum ProCT requiring laparotomy (mean age, 44 yr;
range, 19–65 yr). The septicemia was due to peritonitis because of
perforated sigmoid diverticulitis, perforated appendicitis, ischemic co-
litis of the sigmoid colon, and necrotizing proctocolitis with perforation
of the rectum and descending colon. Also, adipose tissue was collected
from noninfected patients requiring elective surgery (mean age, 53 yr;
range, 29–71 yr). Informed consent was obtained. Harvested tissues
were immediately incubated in RNA-later (Ambion, Inc., Austin, TX) to
prevent RNA degradation. The samples were snap-frozen and stored at
FIG. 1. Induction of the CALC I gene in
cultured adipocytes. RT-PCR analysis
was performed with RNA obtained from
ex vivo differentiated adipocytes and
from mature adipocytes kept in so-
called ceiling cultures after 6-h stimu-
lation with or without cytokines (IFN,
100 U/ml; TNF, 10 ng/ml; IL-1, 20
U/ml) and LPS (1 g/ml), denoted as
mix. Alternatively, ex vivo differenti-
ated adipocytes were kept in cocultures
with macrophages activated with E. coli
(Ec). Presented data are one represen-
tative from at least five independent ex-
periments.
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70 C. Tissues were powdered under liquid nitrogen before RNA ex-
traction using Tri-Reagent.
Statistical analysis
Results are presented as the mean sem. Groups of experiments were
compared statistically using t tests. In addition, two group comparisons
corrected for multiple testing, i.e. one-way ANOVA with post hoc anal-
ysis for least square difference, were performed.
Results
CALC I gene induction in vitro
We first analyzed the effects of inflammatory mediators on
CT mRNA expression in adipose tissue-derived cells. In ex
vivo differentiated adipocytes and in mature explanted adi-
pocytes obtained from noninfected patients undergoing
plastic surgery, CT mRNA was not detected by conventional
RT-PCR analysis using 35 amplification cycles (Fig. 1). After
45 cycles of real-time PCR using specifically designed prim-
ers, trace amounts of CT mRNA were detected on a 2.5%
agarose gel (Fig. 2A). Accordingly, analysis of ProCT content
in supernatants of ex vivo differentiated unstimulated, con-
trol adipocytes was below or around the detection limit of 5
pg/ml (Fig. 2B). After 6-h exposure to a combination of LPS
and inflammatory cytokines (IFN, TNF, and IL-1), both
the ex vivo differentiated as well as the mature adipocytes
revealed induced CT mRNA expression (Fig. 1). CT mRNA
induction was also observed in adipocytes kept in coculture
with E. coli activated macrophages (Fig. 1). In contrast, CT
mRNA induction was not observed in macrophages stimu-
lated with E. coli.
cDNAs obtained from adipocytes treated with LPS or sin-
gle cytokines were subjected to quantitative real-time PCR
analysis. Threshold values of CT mRNA were normalized
using the HPRT mRNA value obtained from the respective
cDNA preparation during the same PCR run. IFN alone had
no effect on CT mRNA induction (Fig. 2A), whereas TNF
provoked a 13.2-fold increase compared with nonstimulated
control adipocytes. After treatments with mixed cytokines or
LPS alone, the increases in CT mRNA induction were 23.2-
FIG. 2. Quantitative analysis of CT mRNA expression and ProCT
release by ex vivo differentiated adipocytes. A, Quantitative real-time
PCR analysis was performed with cDNA obtained from ex vivo dif-
ferentiated adipocytes using SYBR-Green detection. Incubation time
was 6 h, and the following concentrations were used: IFN, 100 U/ml;
TNF, 10 ng/ml; IL-1, 20 U/ml; and LPS, 1 g/ml. CT mRNA thresh-
old values were normalized with HPRT mRNA values and amplifi-
cation products were visualized on 2.5% agarose gels. B, After 48-h
cytokine treatments, supernatants of ex vivo differentiated adipocytes
were subjected to chemiluminometric ProCT protein analysis. Ran-
dom values between 0 and 5 were generated for measurements below
the detection limit of 5 pg/ml. The data shown are the mean  SEM
from three (A) or four (B) independent experiments. *, P  0.05 vs.
control. †, P  0.01 for the comparison of LPS and IL-1 vs. control,
respectively. §, P 0.01 for the comparison of IL-1 plus IFN vs. IL-1
alone.
FIG. 3. Time course of CALC I expression and ProCT secretion. Ex
vivo differentiated adipocytes were treated with 20 U/ml IL-1 alone
or together with 100 U/ml IFN. After 2-, 4-, 6-, 8-, 10-, 24-, 48-, or 60-h
incubation periods, total RNA was extracted and analyzed for CT
mRNA abundance with quantitative real-time PCR and conventional
RT-PCR (A). ProCT secretion into culture supernatant was analyzed
by chemiluminometric assay (B). Results are presented as the mean
SD of two independent experiments.
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and 24-fold (P  0.01), respectively. Interestingly, the stron-
gest induction of CT mRNA was observed after treatment
with IL-1, resulting in a 37-fold (P  0.01) increase. The
marked induction of CT mRNA by IL-1 was confirmed in
explanted mature adipocytes (Fig. 1).
Subjecting undifferentiated preadipocytes to cytokine
treatment did not result in CT mRNA expression (not shown)
ProCT secretion in vitro
In supernatants of control or IFN-treated adipocytes, the
ProCT protein concentration was below or at the detection
limit of 5 pg/ml after 48-h incubation (Fig. 2B). In contrast,
ProCT protein secretion was increased to 13  6.0 pg/ml in
supernatants of TNF-treated cells (Fig. 2B). Administration
of LPS or IL-1 alone or of combined cytokines led to average
ProCT protein concentrations of 53.6 17.3 pg/ml (P 0.01),
61.0  20.5 pg/ml (P  0.01), and 28.4  14.9 pg/ml, re-
spectively (n  4 for each agent). IL-1 induced ProCT se-
cretion at concentrations as low as 0.2 U/ml (not shown). The
viability of adipocytes after 48-h exposure to LPS, IFN,
TNF, and IL-1, alone or in combination, was unchanged
as assessed by trypan blue staining (not shown).
Interestingly, in ex vivo differentiated adipocytes, antag-
onistic effects of IFN on IL-1 activity were noted. Admin-
istration of 100 U/ml IFN for 48 h reduced IL-1-mediated
ProCT secretion by 89% (Fig. 2B). Accordingly, mRNA anal-
ysis by both conventional RT-PCR and quantitative real-time
PCR revealed a strong transcriptional inhibition of CT
mRNA expression by IFN over time periods ranging up to
60 h (Fig. 3A). ProCT release, which was measurable starting
from 10 h of stimulation, was strongly inhibited in the pres-
ence of IFN at all time points (Fig. 3B).
CT mRNA expression in adipose tissue obtained from septic
and nonseptic humans
In several patients with infection and elevated serum
ProCT we found CT mRNA expression in sc and omental fat
depots (Fig. 4). Control experiments confirmed that, as ex-
pected, the CALC I gene was not expressed in adipose tissues
from noninfected control patients. Average CT mRNA ex-
pression in adipose tissue was enhanced 1962-fold in RNAs
obtained from infected vs. noninfected patients, as assessed
by real-time PCR.
Discussion
The present studies are the first demonstration of ProCT
production and secretion by human adipocytes in the pres-
ence of inflammatory mediators. It also confirms the extra-
thyroidal production of human ProCT previously shown in
animal studies (12). Our initial adipocyte model consisted of
ex vivo differentiated preadipocytes, in which other cell types
(e.g. endothelial cells) were potentially present in the cul-
tures; these could provide a nonadipose source of CT mRNA
expression and ProCT release. Hence, the experiments were
successfully repeated using mature and purified adipose
cells cultured in adipocyte-selecting ceiling cultures (17, 18).
The density of adherent adipocytes obtained by this tech-
nique is relatively low, but suitable for RT-PCR analysis. The
experiments using adipocytes and macrophages in coculture
FIG. 4. Extrathyroidal nonneuroendocrine expression of CT mRNA in humans with infection. Subcutaneous (s) and omental (o) adipose tissue
biopsies were obtained intraoperatively from patients with infection and markedly increased circulating ProCT levels as indicated. Noninfected
tissues were obtained from patients with normal levels of serum ProCT as controls. Total RNA extractions were subjected to CT mRNA analysis
by RT-PCR. Amplification products were visualized on agarose gels containing 0.5 g/ml ethidium bromide. Verification of mRNA as the source
of amplification template was obtained by omitting the RT in reactions for pooled infected samples (rt), resulting in no bands after PCR. RNA
extracted from a medullary thyroid carcinoma cell line was taken as a positive control (c). The results of quantitative real-time PCR analysis
are presented in arbitrary units as the mean  SEM. The data shown are from four infected and four control patients, respectively. n.d., ProCT
concentration less than 0.5 ng/ml.
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demonstrated that molecules of endogenous origin have the
capacity to induce the CALC I gene in adipocytes. Interest-
ingly, CT mRNA was not detectable in activated macro-
phages. Furthermore, CT mRNA could not be induced in
nondifferentiated preadipocytes and in numerous human
cell lines. This suggests that infection-mediated CALC I gene
expression is limited to differentiated parenchymal cells,
here exemplified by adipocytes.
Among the inflammatory cytokines tested in the present
report, IL-1 acted as a potent stimulator of CT mRNA ex-
pression and ProCT synthesis. TNF moderately stimulated
CT mRNA expression and ProCT release. Both IL-1 and
TNF have been ascribed significant roles in the cytokine
mediation of sepsis and septic shock (19). Interestingly, par-
enterally administered recombinant TNF was reported to
increase serum ProCT levels into the septic range in non-
infected humans, and ProCT could be measured in super-
natants from TNF and IL-6 stimulated liver slices, tissue
which is composed of various cell types (20). However, in
these studies the cellular source and mechanisms could not
be determined, because no further molecular analyses had
been performed. Presumably, the increase in CT mRNA gene
transcription is mediated by one or several microbial-specific
response elements in the CALC I gene promoter (21). During
bacterial infections, a combined stimulation by microbial
products (e.g. LPS) and of proinflammatory mediators of the
host response (e.g. TNF and IL-1) results in a generalized
tissue-wide induction of CT mRNA and a consequent secre-
tion of CTpr, including ProCT. LPS treatment alone also
strongly induced ProCT synthesis. Hence, infection-related
CALC I gene expression in adipocytes appears not to depend
on inflammatory mediators from other cell types. This is in
accordance with CD14 expression in human adipocytes (22)
as well as LPS activity mediated via Toll-like receptors in
murine adipocytes (23).
In several adipose tissue biopsies from infected subjects
with high circulating ProCT we demonstrated in vivo extra-
thyroidal expression of CT mRNA. As expected, in fat sam-
ples from noninfected control patients CT mRNA was not
present. Due to the large mass of adipose tissue in the human
FIG. 5. Schematic diagram of CALC I expression in adipocytes and thyroidal C cells. In the classical neuroendocrine paradigm, the expression
of CT mRNA is restricted to neuroendocrine cells, mainly C cells of the thyroid. Initially, the 116-amino acid prohormone ProCT is synthesized
and subsequently processed to the considerably smaller mature CT. In sepsis and inflammation, proinflammatory mediators induce CT mRNA.
In contrast to thyroidal cells, adipocytes and other parenchymal cells lack secretory granules, and hence, unprocessed ProCT is released in a
nonregulated, constitutive manner.
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organism, we postulate that adipocytes contribute substan-
tially to the systemic elevation of circulating ProCT in in-
fected patients. Increased morbidity and mortality were re-
cently reported in critically ill morbidly obese patients
compared with nonobese patients (24). It is tempting to spec-
ulate that adipose tissue-derived ProCT contributes to the
complications reported in obese intensive care units patients.
In this context it is notable that the administration of human
ProCT worsened the outcome, whereas immunoneutraliza-
tion of endogenous ProCT improved survival in septic ham-
sters (5). In septic pigs, iv immunoneutralization of ProCT
reduced mortality and improved physiologic and metabolic
parameters even when administered after the animals were
moribund (6). However, at present in humans no clinical data
are available on this issue. Mortality rates in sepsis are very
dependent on multiple host- and pathogen-related factors
(e.g. comorbidities of the patient, virulence of the bacteria,
among others). Hence, a presumed harmful effect of the
additional ProCT secretion by the abundant adipose tissue
mass in obese patients might be masked by these powerful
infection-related factors. Possible roles of other cell types and
tissues in humans are currently under investigation in our
laboratory.
The present finding of CT mRNA in stimulated adipocytes
and adipose tissue from septic patients is in contrast to the
conventional endocrine concept of a tissue-specific CALC I
expression restricted mostly to thyroidal C cells. Previously,
the hypothesis was advanced, that CALC I gene products are
a prototype of hormokine mediators (12). As such, they may
follow either a classical hormonal expression or, alterna-
tively, a cytokine-like expression pathway (Fig. 5). In sepsis,
the predominance of serum ProCT as opposed to serum
mature CT is indicative of a constitutive pathway within cells
lacking secretory granules and, hence, a bypassing of much
of the classic neuroendocrine enzymatic processing. Conse-
quently, as is the case for most cytokines, in sepsis there is
little to no intracellular storage of ProCT within nonneu-
roendocrine cells (12).
Our findings provide a molecular basis for the utility of
circulating ProCT in the clinical diagnosis of systemic bac-
terial infections. Costimulation experiments using the stron-
gest CT mRNA inducer, IL-1, revealed that IFN acts as a
potent inhibitor of IL-1-mediated CALC I gene induction.
IFNs, including IFN, play a pivotal role in early antiviral
defense mechanisms (25). In contrast to bacterial infection,
viral infections usually induce only a modest increase in
circulating ProCT (2, 10). This phenomenon is clinically rel-
evant; for example, one can expedite the diagnosis and treat-
ment of a meningitis of bacterial origin and distinguish it
from viral meningitis (26, 27). Our finding of an antagonistic
effect of IL-1 and IFN on CT-mRNA induction and ProCT
release might explain this clinically important phenomenon.
During the host response to a viral infection, IFN secretion
might inhibit CT mRNA induction, thereby reducing the
increase in ProCT levels in response to an inflammatory
stimulus (Fig. 5). Other studies previously described oppos-
ing effects of IL-1 and IFN (28). Activation of nuclear
factor-B plays a central role in inflammatory signaling (29),
but cytokine-specific activation of upstream factors, includ-
ing signal transducers and activators of transcription and
Janus kinases, are possible mediators of the antagonistic ac-
tivities described herein.
In conclusion, the present report is the first demonstration
of human extrathyroidal CT mRNA expression and ProCT
release from parenchymal tissue. Furthermore, we have
demonstrated that adipose tissue-derived cell cultures are
useful for the investigation of inflammatory CT mRNA ex-
pression and ProCT release. It is hoped that this new exper-
imental model will provide a tool to further study mecha-
nisms and action of sepsis-related extrathyroidal ProCT
production.
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Expression and secretion of procalcitonin and calcitonin
gene-related peptide by adherent monocytes and by
macrophage-activated adipocytes*
Philippe Linscheid, PhD; Dalma Seboek, MSc; Dominik J. Schaer, MD; Henryk Zulewski, MD;
Ulrich Keller, MD; Beat Müller, MD
Serum concentrations of cal-citonin-I (CALC I) gene prod-ucts including procalcitonin(ProCT) and, to a lesser extent,
the splice variant calcitonin gene-related
peptide (CGRP) are increased during sys-
temic inflammatory diseases (1–5). Re-
cent findings suggest ProCT to be a mod-
ulator of the inflammatory reaction (6).
Accordingly, immunoneutralization of
ProCT markedly improved survival in
septic hamsters and pigs (7–9).
The classic neuroendocrine paradigm
limits the expression of CALC I and CALC
II genes to neuroendocrine cells (10). The
CALC II gene, a gene duplication of the
CALC I gene, contains a stop codon in
exon IV and thus expresses exclusively
CGRP II protein. In thyroidal C-cells, ma-
ture calcitonin (CT) is initially biosynthe-
sized as a precursor protein (i.e., ProCT)
that is subsequently processed into
smaller peptides and finally amidated into
mature CT (10). Upon infection, circulat-
ing ProCT concentrations are also in-
creased in thyroidectomized patients,
suggesting nonthyroidal sources of in-
flammation and sepsis-mediated ProCT
(1, 11). Accordingly, we recently reported
extrathyroidal expression of CALC I in
septic humans and the release of ProCT
by human adipocytes upon inflammatory
stimulation (12).
CGRP is mainly detected in perivascu-
lar nerve terminals (13). Being the most
potent endogenous vasodilator identified
thus far (14, 15), CGRP is thought to be a
critical mediator of neuromicrovascular
regulation in models of neurogenic in-
flammation (16). Proposed modes of va-
sodilating action include endothelium
and nitric oxide-dependent (17) as well as
endothelium-independent mechanisms
(18).
Peripheral blood mononuclear cells
(PBMCs) and PBMC-derived macro-
phages orchestrate the inflammatory re-
action by secretion of immunomodula-
tory mediators and are thus important
candidate sources of inflammation- and
sepsis-related nonneuroendocrine ProCT
production. Expression of CALC I gene
*See also p. 1801.
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Objective: To explore the roles of peripheral blood mononu-
clear cells (PBMCs) and PBMC-derived macrophages in sepsis-
related increased procalcitonin and calcitonin gene-related pep-
tide (CGRP) I production.
Design: Prospective, in vitro primary human cell culture study
and human tissue samples gene expression analysis.
Setting: University hospital research laboratories.
Patients: Cells from healthy donors and septic patients.
Interventions: PBMCs were obtained from healthy donors. Iso-
lation of pure monocyte cultures was performed by magnetic
depletion of nonmonocyte cells from PBMCs. Adipose tissue bi-
opsies and circulating leukocytes were collected from septic
patients. Expressions of calcitonin messenger RNA and CGRP I
messenger RNA were analyzed using reverse transcriptase-poly-
merase chain reaction and quantitative real-time polymerase
chain reaction. Supernatant procalcitonin and CGRP protein con-
tent were determined by ultrasensitive chemiluminometric and
radioimmunoassays, respectively.
Measurements and Main Results: PBMCs expressed and se-
creted procalcitonin and CGRP within 3–5 hrs after adherence to
endothelial cells or plastic surfaces. This induction was transient,
as it was not detectable after 18 hrs. No calcitonin or CGRP I
messenger RNA was observed in leukocytes obtained from septic
patients with markedly increased serum procalcitonin concentra-
tions. Stimulation with cytokines, endotoxin, or Escherichia coli
did not induce expression of calcitonin and CGRP I messenger
RNA in PBMC-derived macrophages. However, inflammatory fac-
tors released from activated macrophages induced a marked
expression of procalcitonin and CGRP in co-cultured human adi-
pocytes.
Conclusions: The adhesion-induced, transient expression and
secretion of procalcitonin and CGRP in vitro may play an impor-
tant role during monocyte adhesion and migration in vivo. PBMC-
derived macrophages may contribute to the marked increase in
circulating procalcitonin by recruiting parenchymal cells within
the infected tissue, as exemplified with adipocytes. (Crit Care Med
2004; 32:1715–1721)
KEY WORDS: sepsis; procalcitonin; adipocytes; peripheral
blood mononuclear cell; calcitonin gene-related peptide; mac-
rophages
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products in PBMCs has been reported by
some authors (19 –21). However, no
ProCT was detected in blood cells sub-
jected to endotoxin and cytokines in a
whole blood model (22). In an attempt to
approach this problem, we studied ProCT
and CGRP expression in adherent PB-
MCs, PBMC-derived macrophages, and
macrophage-activated adipocytes. In ad-
dition, CT and CGRP I messenger RNA
(mRNA) were analyzed in white blood
cells from patients with septic disease and
increased serum ProCT.
MATERIALS AND METHODS
Isolation and Culture of Human PBMCs.
Buffy coats were obtained from healthy do-
nors. PBMCs were isolated by Ficoll gradient
separation and washed three times in cold
Hanks’ buffered salt solution (Gibco BRL,
Basel, Switzerland) supplemented with 0.2%
albumin (Blutspendedienst SRK, Bern, Swit-
zerland). Cells were plated in six-well plates
(BD Falcon, Bedford, MA) after resuspension
in Iscove’s-modified Dulbecco’s medium
(Gibco BRL) containing 20% human pooled
serum (PAA laboratories, Linz, Austria) or
10% fetal bovine serum (FBS; Gibco BRL),
respectively. In some experiments, 20
units/mL human-specific interleukin (IL)-1
(Peprotech, London, UK) and 1 g/mL lipopoly-
saccharide (LPS; Sigma, Buchs, Switzerland)
were added. After 1 hr, adherent cells were
washed three times with Hanks’ buffered salt
solution and further kept in culture medium.
Purification and Culture of Monocytes.
PBMCs obtained as described previously were
subjected to magnetic cell sorting using MACS
Monocyte Isolation Kit (Miltenyi Biotec, Ber-
gisch Gladbach, Germany). Purified mono-
cytes were seeded in six-well plates, repeatedly
washed after 1 hr, and used for experiments as
described for adherent PBMCs.
Adhesion Experiments on Vascular Endo-
thelial Monolayer. ECV304 endothelial cells
(23) and human umbilical vein endothelial
cells were activated with 10 ng/mL human-
specific tumor necrosis factor (TNF)- (Pep-
rotech, London, UK) for 5 hrs. Fresh culture
medium was supplied, and PBMCs isolated as
described previously were subsequently added
and allowed to attach for 1 hr. Nonadherent
cells were removed by thoroughly washing
with Hanks’ buffered salt solution. Total RNA
was harvested after incubation periods rang-
ing up to 18 hrs.
Macrophage and Adipocyte Co-Culture
Experiments. Preadipocytes were isolated
from adipose tissue samples and differentiated
to adipocytes as previously described (12).
Five-day-old PBMC-derived macrophages cul-
tured in cell culture inserts with 0.4-m pore
size (BD Falcon, Bedford, MA) were treated for
2 hrs with combined cytokines/LPS or live
Escherichia coli. Thereafter, cell culture in-
Figure 1. Transient expression of calcitonin (CT)-I (CALC-I) and CT-II (CALC-II) genes in monocytes
upon adhesion to plastic or activated endothelial monolayer. Peripheral blood mononuclear cells
(PBMCs) obtained from healthy subjects by Ficoll separation were seeded either on previously tumor
necrosis factor (TNF)--activated ECV304 (E) or on umbilical vein endothelial cells (H), endothelial
monolayers (A), or plastic surfaces (B). Alternatively, pure monocytes were obtained from PBMCs by
magnetic depletion sorting of T cells, NK cells, B cells, dendritic cells, and basophils before seeding on
tissue culture dishes (C). Total RNA was extracted from cells after incubation periods as indicated.
Specific messenger RNAs relevant to procalcitonin and calcitonin gene-related peptide expression were
analyzed by reverse transcriptase-polymerase chain reaction, and amplicons were visualized on 1.5%
agarose gels containing ethidium bromide. To confirm activation of monocytes, TNF- and interleukin
(IL)-1 messenger RNAs were also analyzed. Shown data are one representative of at least two (A), five
(B), or three (C) independent experiments. CGRP, calcitonin gene-related peptide; bp, base pairs.
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serts containing the activated macrophages
were washed three times and added to six-well
plates with adipocytes for 24 hrs. Macrophage
and adipocyte total RNAs were isolated sepa-
rately and subjected to reverse transcriptase-
polymerase chain reaction analysis.
Collection of Leukocytes and Adipose Tis-
sue Samples. Leukocytes were isolated by Fi-
coll gradient separation from infected patients
with elevated serum ProCT requiring laparot-
omy (mean age, 44 yrs; range, 19–65 yrs). In
addition, adipose tissue biopsies were obtained
from the same patients. The septicemias were
due to peritonitis because of perforated sig-
moid diverticulitis, ischemic colitis of the sig-
moid colon, and necrotizing proctocolitis with
perforation of the rectum and descending co-
lon, respectively. As controls, leukocytes and
adipose tissue samples were collected from
noninfected patients requiring elective sur-
gery (mean age, 53 yrs; range, 29–71 yrs). The
procedure was approved by the institutional
ethical committee, and informed consent was
obtained. Harvested tissues were immediately
incubated in RNAlater (Ambion, Austin, TX) to
prevent RNA degradation. The samples were
snap frozen and stored at 70°C. Tissue ali-
Figure 2. Quantitative analysis of transient calcitonin (CT)-I (CALC-I) gene expression in adherent monocytes. Peripheral blood mononuclear cells (PBMCs) were
seeded in the presence or absence of combined 20 units/mL interleukin (IL)-1 and 1 g/mL lipopolysaccharide (LPS). After 1 hr, nonadherent cells were removed
by repeated washing. Fresh medium with supplements was provided. Total RNA was extracted from freshly isolated PBMCs and from adherent monocytes after
3 and 18 hrs of incubation, respectively. Complementary DNA was generated and subjected to calcitonin (CT; A) and calcitonin gene-related peptide (CGRP) I
messenger RNA (mRNA; C) analysis by quantitative real-time polymerase chain reaction using specifically designed primers yielding 92 base pair (bp) and 83 bp
products, respectively. Results were confirmed by conventional linear range reverse transcriptase-polymerase chain reaction yielding 232 bp and 204 products,
respectively, visualized on ethidium bromide agarose gel. Procalcitonin (ProCT) secretion into culture supernatants containing human serum was analyzed after
18 hrs of incubation and during the subsequent 24 hrs into fresh medium (B). CGRP was analyzed in culture supernatants after 18 hrs of incubation (D). Data
are mean  SEM (n  4). *p  .05 compared with basal medium. HPRT, hypoxanthine-guanine phosphoribosyltransferase.
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quots were powdered under liquid nitrogen
before RNA extraction using TRI Reagent (Mo-
lecular Research Center, Cincinnati, OH).
RT-PCR. Total RNA was isolated using a
commercial reagent TRI Reagent (Molecular
Research Center) according to the manufac-
turer’s protocol. Aliquots of 1 g of RNA
were subjected to reverse transcription
(Omniscript RT kit, Qiagen, Basel, Switzer-
land). PCR was performed on a conventional
thermal cycler (Whatman Biometra Tgradi-
ent, Göttingen, Germany) using the follow-
ing intron border-spanning oligonucleo-
tides: CT (232 base pair [bp] product,
GenBank 00356): 5'-TGAGCTGGAGCAG-
GAGCAAG-3' (sense) and 5'-GTTGGCATTCT-
GGGGCATGCTAA-3' (antisense); CGRP I
(204 bp product, GenBank 02330): 5'-
TGAGCTGGAGCAGGAGCAAG-3' (sense) and
5'TCAGCTGCTCAGGCTTGAAGG-3' (anti-
sense); CGRP II (737 bp product, GenBank
NM_000728): 5'-CGGCCGCTCGCGCTGC-
CCTG-3' (sense) and 5'-GGTGGAGCTGCAT-
GATCAAC-3' (antisense); IL-1 (298 bp
product, GenBank BC008678): 5'-TTCCCT-
GCCCACAGACCTTC 3' (sense) and 5'- AG-
GCCCAAGGCCACAGGTAT-3' (antisense);
TNF- (310 bp product, GenBank 01394):
5'- GGCCCAGGCAGTCAGATCAT 3' (sense)
and 5'- GGGGCTCTTGATGGCAGAGA-3' (an-
tisense); guanosine triphosphate cyclohy-
drolase (226 bp product, GenBank U19523):
5'- TTGGTTATCTTCCTAACAAG 3' (sense)
and 5'-GTGCTGGTCACAGTTTTGCT-3' (anti-
sense); CD-163 (295 bp product, GenBank
NM004344): 5'-ACATAGATCATGCATCTGT-
CATTTG 3' (sense) and 5'- CATTCTCCTT-
GGAATCTCACT TCTA 3' (antisense); -ac-
tin (198 bp product, GenBank AF076191):
5'-TTCTGACCCATGCCCACCAT-3' (sense)
and 5'-ATGGATGATGATATCGCCGCGCTC
3' (antisense). Annealing temperature was
65°C, except for CT (67°C), CGRP I (touch-
down 68.8 – 65°C), and guanosine triphos-
phate cyclohydrolase (55°C). Thirty-five cy-
cles of PCR were used, except for CGRP I (38
cycles). Cycles were reduced to 28 for -ac-
tin to stop the reaction in the linear phase of
amplification. PCR products were separated
and visualized on 1.5% agarose gels contain-
ing 0.5 g/mL ethidium bromide. PCR prod-
uct identity was confirmed by direct nucle-
otide sequencing of the PCR products by dye
deoxy terminator cycle sequencing.
Quantitative Analyses of CT and CGRP I
mRNA Expression. Complementary DNA ob-
tained as described previously was subjected to
quantitative real-time PCR analysis using the
ABI 7000 Sequence detection system (Perkin
Elmer, Boston, MA). Specific primers yielding
short PCR products suitable for Sybr-Green de-
tection were designed using Primer Express soft-
ware (version 1.0, PE Applied Biosystems). Se-
quences of primers were as follows: CT (92 bp
product, GenBank 00356): 3'-GTGCAGAT-
GAAGGCCAGTGA-5' (sense) and 3'-TCAGAT-
TACCACACCGCTTAGATC-5' (antisense); CGRP
I (83 bp product, GenBank 02330): 3'-
CCCAGAAGAGAGCCTGTGACA-5' (sense) and
3'-CTTCACCACACCCCCTGATC-5' (antisense);
hypoxanthine-guanine phosphoribosyltrans-
ferase (HPRT; 85 bp product, GenBank M26434):
3'-TCAGGCAGTATAATCCAAAGATGGT 5'
(sense) and 3'-AGTCTGGCTTATATCCAACACT-
TCG- 5' (antisense). Reaction volume was 22 L,
and the conditions were set as suggested by
the manufacturer. Each complementary
DNA sample tested for quantitative CT
mRNA and CGRP I mRNA was also subjected
to HPRT mRNA analysis. Results were ex-
pressed as the ratio of CT or CGRP I mRNA
with HPRT mRNA threshold values, respec-
tively. Product identity was confirmed by
sequence analysis and electrophoresis on a
2.0% agarose gel containing ethidium bro-
mide.
Peptide Measurements. ProCT concentra-
tions were determined in supernatants by an
ultrasensitive chemiluminometric assay
(ProCa-S Assay, B.R.A.H.M.S. AG, lowest
standard 5 pg/mL). Two monoclonal anti-
bodies bind at sites within two peptides: CT
and CT carboxy peptide I (previously re-
ferred to as katacalcin).
CGRP concentrations were determined in
supernatants using CGRP radioimmunoassay
Kit (Phoenix Pharmaceuticals, Belmont, CA).
Statistical Analysis. Quantitative data were
analyzed using Graph Pad Prism software.
Groups of experiments were compared statis-
tically using Mann-Whitney U tests. In addi-
tion, multiple comparisons were performed
using Kruskal-Wallis test.
RESULTS
CALC I gene was never expressed in
freshly isolated PBMCs from healthy,
noninfected individuals (Figs. 1 and 2).
Upon adhesion to TNF--activated
ECV304 endothelial cells and umbilical
vein endothelial cells, respectively, CT
mRNA and CGRP I mRNA were faintly
detectable after 3 hrs but not after pro-
longed (18-hr) incubation (Fig. 1A). This
transient phenomenon was not specific to
adherence on endothelial monolayers as
both CALC I and CALC II transcripts were
present in PBMCs attached directly to
tissue culture dishes for 3–5 hrs but not
after 18-hr incubation periods (Fig. 1B).
Induction of IL-1 and TNF- mRNA
confirmed the activated state of adherent
PBMCs between 3 and 18 hrs of culture.
In contrast to adherent PBMCs, only
trace amounts of CT mRNA were detected
in the nonadherent lymphocytic fraction
of PBMC (not shown). PBMCs attached to
culture dishes are most likely monocytes;
thus, the observed transient adhesion-
induced expression of CALC genes is
most likely a property of monocytes. To
confirm this notion, we next evaluated
isolated pure monocyte cultures and ob-
served the same pattern of transient ad-
hesion-activated expression of CT and
CGRP mRNAs (Fig. 1C).
After 3 hrs of incubation, the CT and
CGRP I mRNA threshold values normal-
ized to HPRT mRNA obtained by quanti-
tative real-time PCR increased approxi-
mately 106-fold and 103-fold, respectively,
Figure 3. Calcitonin (CT) and calcitonin gene-related peptide (CGRP) I messenger RNA expression in
white blood cells and adipose tissue biopsies from septic patients. CT and CGRP I messenger RNAs
were analyzed by reverse transcriptase-polymerase chain reaction in white blood cells (w) and adipose
tissue (at) samples obtained from septic patients with markedly increased serum procalcitonin (ProCT)
as indicated. Verification of messenger RNA as the source of amplification template was obtained by
omitting the reverse transcriptase in reactions for adipose tissue, resulting in no bands after poly-
merase chain reaction (rt-). Amplicons were visualized on 1.5% agarose gel containing ethidium
bromide. Serum procalcitonin (ProCT) was as indicated in respective patients. n.d., ProCT 0.5
ng/mL. Shown data are one representative out of five noninfected patients and three infected patients
with elevated serum procalcitonin. bp, base pairs.
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compared with freshly isolated PBMCs
(Fig. 2, A and C). CT and CGRP I mRNA
concentrations returned to preculture
concentrations following 18 hrs of incu-
bation. Accordingly, immunoreactive
ProCT accumulated in supernatants only
during the first 18 hrs of monocyte cul-
ture (Fig. 2B), and almost no secretion
was observed into fresh culture medium
during the subsequent 24-hr incubation.
Immunoreactive CGRP accumulated in
FBS-containing culture medium during
the initial 18-hr culture period (Fig. 2D).
Due to high background concentrations,
culture medium containing human se-
rum did not allow measurement of CGRP
concentrations. Culture medium supple-
mented with FBS does not allow pro-
longed culturing of human PBMCs. Con-
sequently, CGRP secretion could not be
determined in subsequent culture period.
No effects were noted on CT and CGRP
mRNA expression and ProCT secretion in
the presence of exogenous IL-1 and
LPS. Similar results were obtained when
experiments were performed in FBS-
containing medium instead of human se-
rum (not shown).
In patients with bacterial sepsis and
markedly increased serum ProCT con-
centration, CT and CGRP I mRNAs were
not detectable in white blood cells. In
contrast, CT and CGRP I mRNA were
expressed in adipose tissue biopsies of
these patients (Fig. 3).
In contrast to adhesion-activated
monocytes, neither CT nor CGRP I
mRNA expression could be detected in
mature PBMC-derived macrophages (day
5) under basal conditions or after stimu-
lation with various inflammatory media-
tors (Fig. 4A). Expression of CD 163
mRNA confirmed macrophage differenti-
ation (24), and guanosine triphosphate
cyclohydrolase I mRNA induction served
as a positive control for the inflammatory
activation of macrophages (25). Although
CT and CGRP I mRNA was not detectable
in E. coli or cytokines/LPS-activated
macrophages themselves, the phagocytes
were able to induce a marked expression
of both mRNAs in adipocytes. This is
demonstrated by co-culture experiments
using cell culture inserts with 0.4-m
pores, which allow diffusion of soluble
factors (Fig. 4B). A 103-fold increase in
CT-mRNA abundance was detected by
quantitative real-time PCR in adipocytes
kept in co-culture with activated macro-
phages. CGRP I mRNA was expressed in
parallel to CT mRNA in adipocytes. In
some experiments, trace amounts of CT
and CGRP I mRNA were detected in the
macrophages after E. coli treatment.
DISCUSSION
Monocytes and macrophages repre-
sent a relevant source of acute phase me-
diators. However, the potential role of
these cells as sources of sepsis- and in-
flammation-induced CALC I gene prod-
ucts is controversial (19–22). Herein, we
demonstrate that ProCT and CGRP are
indeed PBMC-derived secretion factors.
However, this phenomenon is transient
and occurs exclusively during a short pe-
riod following attachment of cells. Since
Figure 4. Macrophage-mediated calcitonin (CT)-I (CALC-I) gene induction in adipocytes. Five-day-old
peripheral blood mononuclear cell-derived macrophages in cell culture inserts with 0.4-m pores were
prestimulated for 2 hrs with cytokines/lipopolysaccharide (LPS) or Escherichia coli as indicated.
Inserts were thoroughly washed and added to nonstimulated adipocytes in six-well plates. After 24 hrs
in co-culture, RNAs of macrophages and adipocytes were separately isolated. Complementary DNA
obtained by reverse transcription was subjected to CT and calcitonin gene-related peptide (CGRP) I
messenger RNA (mRNA) analysis by reverse transcriptase-polymerase chain reaction. In addition,
hypoxanthine-guanine phosphoribosyltransferase (HPRT)-normalized quantitative real-time polymer-
ase chain reaction analysis was performed for CT mRNA. Shown data are one representative of six
similar experiments (conventional polymerase chain reaction) and mean  SEM (n  4) (real-time
polymerase chain reaction). GTPCH, guanosine triphosphate cyclohydrolase; IL, interleukin; TNF,
tumor necrosis factor; bp, base pairs.
1719Crit Care Med 2004 Vol. 32, No. 8
we obtained virtually identical results
upon PBMC adhesion to both endothelial
monolayers and plastic surfaces, the tran-
sient ProCT and CGRP expression de-
scribed herein does not depend on spe-
cific PBMC-endothelial interaction but
rather on adhesion-induced activation.
The spontaneous expression of CT and
CGRP I mRNA in cultured PBMCs was
previously reported, and a significant role
in sepsis-related increased ProCT and
CGRP was proposed (20, 21). However,
these reports do not provide data on PB-
MCs kept in culture for time periods 	4
hrs, and questions regarding specific
roles of adherent and nonadherent PB-
MCs were not addressed. Our data clearly
demonstrate that purified monocytes
transiently express CALC I gene, al-
though contributions from other cell
types cannot be ruled out. Detachment of
activated monocytes might explain why
in some experiments trace amounts of CT
mRNA were detected in the nonadherent
lymphocytic fraction of PBMCs. In con-
trast to previous reports (20, 21), we were
unable to observe amplifying effects me-
diated by the addition of exogenous IL-1
and LPS on ProCT and CGRP expres-
sions. Neutralization of TNF- results in
lower ProCT, as measured by flow cytom-
etry in PBMCs (19). Thus, we hypothesize
that inflammatory cytokines play a role in
the herein demonstrated transient ex-
pression and that in our hands, maximal
stimulation was already achieved by
endogenous cytokine production (e.g.,
IL-1, TNF-). Initially, we performed
experiments using 20% human serum
allowing prolonged (	24 hrs) culture
of adherent PBMCs and to obtain
PBMC-derived macrophages. As FBS-
supplemented media were used in the
previously mentioned PBMC studies,
experiments were repeated using this
serum. However, no significant differences
between human and bovine serum were
noted on transient CT and CGRP mRNA
expressions in adherent PBMCs during the
initial 18-hr incubation period.
PBMCs represent a leukocyte sub-
population and circulate in the vascular
bed before potential adherence to an en-
dothelial wall. Thus, we analyzed CALC I
gene expression in these cells in humans
with septic disease. In accordance with
previous reports on septic animals (26–
28) and humans (12), the septic patients
participating in the present study had
markedly elevated serum ProCT, and
both CT and CGRP I mRNA were detected
in adipose tissue biopsies. Despite the fact
that in human sepsis leukocytes are ex-
posed to numerous inflammatory media-
tors, we found neither CT nor CGRP I
mRNA in these cells. This is in accor-
dance with the lack of LPS-stimulated
leukocyte ProCT production in vitro, as
reported in a whole blood model (22).
The absence of CT mRNA in white blood
cells is in striking contrast to the high
expression of classic cytokines (e.g.,
TNF-) within these cells during sepsis.
Moreover, evidence from case reports of
septic patients with high serum concen-
trations of ProCT, even after near-
complete eradication of the leukocyte
population by chemotherapy, suggests
that white blood cells are not a major
source of the increased ProCT concentra-
tions found in human sepsis (29, 30).
PBMC-derived macrophages play im-
portant roles in the host defense and are
a relevant source of inflammatory medi-
ators. Even though CALC I gene is tran-
siently expressed during the initial phase
of differentiation, inflammatory activa-
tion of macrophages on day 5 did not
induce CT or CGRP I mRNA. In contrast,
we demonstrate that in the activated
state, macrophages secrete inflammatory
mediators that subsequently induce
CALC I gene expression in adipocytes
kept in co-culture. Thus, macrophages
appear to play a role in sepsis-related
increased serum ProCT by recruiting and
stimulating surrounding parenchyme tis-
sue, as herein exemplified by adipocytes.
We recently identified IL-1 and TNF-
as potent inducers and interferon-
 as an
effective attenuator of CT mRNA and
ProCT in human primary adipocytes (12).
Being well-known secretion products of
activated macrophages, roles of IL-1
and TNF- in the previously mentioned
process appear likely.
ProCT was proposed to amplify in-
flammation-mediated nitric oxide synthe-
sis (6) and to promote monocyte che-
moattraction (31). CGRP, a well-known
neuroendocrine peptide released from
perivascular nerve terminals (13), was
recognized as the most potent endoge-
nous vasodilating molecule (14, 15).
Thus, the PBMC-derived release of im-
munoreactive ProCT and CGRP described
herein suggests a thus far not recognized
role of adherent PBMCs in mediating va-
sodilation and consecutive migration of
mononuclear cells into the infected tis-
sue.
The conflicting results of previous
studies (19–22) regarding expression of
ProCT and CGRP in leukocytes can be
explained by the herein described dynam-
ics of CALC I gene expression in PBMCs.
Compared with adipose tissue, PBMCs
represent a small tissue mass. In addi-
tion, the short-lived adhesion-induced
CALC I gene expression in PBMCs is in
contrast to the sustained ProCT release
by IL-1- and LPS-challenged adipocytes
(12). Hence, even though local effects of
PBMC-derived ProCT and CGRP can be
hypothesized, a significant role of these
Table 1. Trimodal pattern of calcitonin-I gene expression occurring in neuroendocrine cells, parenchymal cells (e.g., adipocytes), and monocytes
Neuroendocrine Adipose Tissue Monocytes
Transcription of mRNA Constitutive Regulated; protracted, sustained
by cytokines and LPS
detectable after 	6 hrs
Regulated; rapid, transient upon
adhesion detectable after 	2
hrs
Splicing of mRNA Specific; CT mRNA in thyroidal C-cells;
CGRP I mRNA in sensory nerves
Nonspecific Nonspecific
Secretion of protein Regulated; CT by S-Ca2 or gastrin in
thyroid; CGRP by bradykinin, capsain, or
heat in sensory nerves
Constitutive; detectable after
	10 hrs
Persistent (	24 hrs)
Constitutive; detectable after 	4
hrs
Transient (18 hrs)
Tissue mass Low Very high Low
Main function S-Ca2 2 (CT); neurogenic inflammation
(CGRP)
Sepsis-associated ProCT increase Local vasodilation (CGRP,
ProCT?)
mRNA, messenger RNA; LPS, lipopolysaccharide; CT, calcitonin; CGRP, calcitonin gene-related peptide; ProCT, procalcitonin.
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cells as sources of sepsis-related circulat-
ing ProCT and CGRP appears unlikely. A
major, although indirect, role of macro-
phages lies in the induction of ProCT and
CGRP expression in nearby parenchyme
cells, as exemplified by adipocytes. To-
gether with our previously published
findings (12, 26, 28), we propose a trimo-
dal pattern of CALC I gene expression
occurring in neuroendocrine cells, pa-
renchymal cells (e.g., adipocytes), and
monocytes (Table 1). The herein outlined
description of the distinct expression pat-
tern of the CALC I gene is helpful in the
further understanding of the concept of
“hormokines” (10).
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Human adipose tissue is a contributor to inflammation- and
sepsis-induced elevation of serum procalcitonin (ProCT).
Several calcitonin (CT) peptides, including ProCT, CT gene-
related peptide (CGRP), and adrenomedullin (ADM) are sus-
pected mediators in human inflammatory diseases. There-
fore, we aimed to explore the expression, interactions, and
potential roles of adipocyte-derived CT peptide production.
Expression of CT peptide-specific transcripts was analyzed
by RT-PCR and quantitative real-time PCR in human adi-
pose tissue biopsies and three different inflammation-
challenged human adipocyte models. ProCT, CGRP, and
ADM secretions were assessed by immunological methods.
Adipocyte transcriptional activity, glycerol release, and
insulin-mediated glucose transport were studied after ex-
ogenous CGRP and ADM exposure. With the exception of
amylin, CT peptides were expressed in adipose tissue biop-
sies from septic patients, inflammation-activated mature
explanted adipocytes, and macrophage-activated preadipo-
cyte-derived adipocytes. ProCT and CGRP productions
were significantly augmented in IL-1 and lipopolysaccha-
ride-challenged mesenchymal stem cell-derived adipocytes
but not in undifferentiated mesenchymal stem cells. In con-
trast, ADM expression occurred before and after adipogenic
differentiation. Interferon- coadministration inhibited IL-
1-mediated ProCT and CGRP secretion by 78 and 34%, re-
spectively but augmented IL-1-mediated ADM secretion by
50%. Exogenous CGRP and ADM administration induced
CT, CGRP I, and CGRP II mRNAs and dose-dependently
(1010 and 106 M) enhanced glycerol release. In contrast, no
CGRP- and ADM-mediated effects were noted on ADM,
TNF, and IL-1mRNAabundances. In summary, CGRPand
ADM are two differentially regulated novel adipose tissue
secretion factors exerting autocrine/paracrine roles. Their
lipolytic effect (glycerol release) suggests a metabolic role
in adipocytes during inflammation. (Endocrinology 146:
2699–2708, 2005)
THE CALCITONIN (CT) gene family presumably evolvedfrom a common ancestor gene because calcitonin pep-
tides share amino acid homologies anddisplay related receptor
binding and biological activities (1). The calcitonin I (CALC I)
gene gives rise to two distinct peptides by tissue-specific alter-
native splicing of the pre-mRNA: CT encoded in exon 4 in
thyroidal C-cells and calcitonin gene-related peptide (CGRP) I
encoded in exons 5 and 6 in sensory nerves (2). CALC II pro-
ducesCGRP II but not CT because exon 4 contains a stop codon
(1). CALC III is a pseudogene (3). Adrenomedullin (ADM) is
encoded by CALC IV and amylin by CALC V genes (1).
CT was named after its postulated role in calcium ho-
meostasis (4). CGRP I and II are almost identical neurotrans-
mitters with potent vasodilatory properties (5). ADM, an-
other vasoactive peptide, was originally discovered in
human pheochromocytoma (6). Amylin is a 37-amino acid
peptide hormone that is cosecreted with insulin by the pan-
creatic -cells in response to a nutrient stimulus (7). CT-,
CGRP-, ADM-, and amylin-mediated signaling occurs via
calcitonin receptor (CTR) and CR-like receptor (CRLR) with
receptor activity-modifying proteins (RAMPs) 1–3 determin-
ing specific binding (8).
Serum concentrations of CT peptides, including procalci-
tonin (ProCT), CGRP, and ADM are markedly elevated in
severe inflammation, systemic infections, sepsis, and sepsis-
like conditions (9–11). Importantly, recent data suggest del-
eterious sepsis-related effects of ProCT, CGRP, and ADM
(12–16). In contrast to the classic neuroendocrine paradigm,
CT and CGRP I mRNA are ubiquitously expressed in septic
hamsters and baboons (17–19). In humans, we recently dem-
onstrated nonneuroendocrine CALC I expression and ProCT
secretion in adipose tissue of sepsis patients and cytokine-
challenged primary adipocytes (20, 21). Herein we sought
to further elucidate the dynamics and metabolic effects of
inflammation- and sepsis-related CGRP and ADM production
in human adipose tissue. Because primary adipocyte availabil-
ity is often scarce, mesenchymal stem cell (MSC)-derived adi-
pocyteswere also used as amodel of functional adipocytes (22).
Specifically, we aimed to clarify whether different CT peptides
are differentially expressed and secreted on inflammatory stim-
ulation and whether their production is dependent on the dif-
ferentiation status. In addition, we studied transcriptional ac-
tivity, glycerol release, and insulin-mediated glucose transport
in adipocytes after exposure to exogenous CGRP and ADM.
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Materials and Methods
Adipocyte cultures
Human mature explanted adipocytes and preadipocyte-derived adi-
pocytes were obtained as previously described (20).
Human MSCs between passages 4 and 10 (Cambrex Bio Science
Verviers, S.p.r.l., Verviers, Belgium) were seeded in 6-well plates and
grown in MSC basal medium (Cambrex) until confluent. Adipogenic
differentiation was induced by incubating the cells in DMEM/F12
(Invitrogen, Basel, Switzerland) containing 3% fetal bovine serum
(FBS, Invitrogen) and the following supplements: 250 m 3-isobutyl-
1-methylxanthine, 1 m dexamethasone, 0.2 nm 3,3,5-triiodo-l-
thyronine, 5 m transferrin (all from Sigma, Buchs, Switzerland), 100
nm insulin (Novo Nordisk, Ku¨snacht, Switzerland), 1 m rosiglita-
zone (GlaxoSmithKline, Worthing, UK). After 15–18 d, supplements
were removed by washing three times with warm PBS, and exper-
iments were started 2–4 d after completing differentiation. MSC-
derivedadipocyteshadvisible lipiddroplets andexpressedadipocyte-
specific mRNAs, e.g. peroxisomal proliferator-activated receptor
(PPAR)2, leptin, adiponectin, or GLUT4. IL-1 and lipopolysaccha-
ride (LPS) administration induced glycerol release and glucose up-
take was stimulated by insulin addition.
Adipocytes were subjected to treatments using the following agents:
100U/ml interferon (IFN)-, 10 ng/ml TNF, 20U/ml IL-1 (all human-
specific cytokines from PeproTech, London, UK). CGRP, CGRP(8–37),
ADM, and ADM(22–52) were purchased from Phoenix Europe GmbH
(Karlsruhe, Germany), LPS (Escherichia coli 026:B6), and cycloheximide
(ready made) were from Sigma.
Viability of adipocytes after stimulation was assessed with trypan
blue staining: viable cells excluding trypan blue; dead cells staining blue.
Adipocytes and macrophages in coculture
White blood cells were isolated by Ficoll-Paque PLUS (Amersham,
Uppsala, Sweden) and used for adipocyte macrophages coculture ex-
periments as previously described (21).
RT-PCR
Total RNA from homogenized tissues or adipocyte cultures was
extracted by the single-step guanidinium-isothiocyanate method with a
commercial reagent (Tri Reagent; Molecular Research Center, Inc., Cin-
cinnati, OH) according to the manufacturer’s protocol. Extracted RNA
was quantified spectrophotometrically at 260 nm (BioPhotometer;
Vaudaux-Eppendorf AG, Scho¨nenbuch, Switzerland). Ratio of extinc-
tion at 260 and 280 nm was between 1.5 and 2.0, and the quality was
assessed by gel electrophoresis. One microgram total RNA was sub-
jected to reverse transcription (Omniscript reverse transcription kit;
QIAGEN, Basel, Switzerland). PCR was performed on a conventional
thermal cycler (Tgradient; Biometra, Go¨ttingen, Germany) using PCR
Taq core kit (QIAGEN). Human gene-specific primers and conditions
were as indicated in Table 1. Amplification products were separated and
visualized on 2% agarose gels containing 0.5 g/ml ethidium bromide.
A 100-bp molecular ruler (Bio-Rad Laboratories, Reinach, Switzerland)
was run as reference marker. PCR product identity was confirmed by
direct nucleotide sequencing of the PCR products by dye deoxy termi-
nator cycle sequencing.
Quantitative analysis of CT, CGRP, and ADM
mRNA expression
cDNA obtained as described above was subjected to quantitative
real-time PCR analysis using the ABI 7000 sequence detection system
(PerkinElmer, Norwalk, CT). Specific primers yielding short PCR prod-
ucts suitable for Sybr-Green detection were designed using Primer Ex-
press software (version 1.0; Applied Biosystems, Rotkreuz, Switzer-
land). Sequences of primers were as indicated in Table 1. Reaction
volume was 22 l, and the conditions were set as suggested by the
manufacturer. For quantitative mRNA estimations, results were ex-
pressed as the ratio of the respective CT mRNA, CGRP mRNA, and
ADM mRNA, respectively, to hypoxanthine-guanine phosphoribosyl-
transferase mRNA threshold values. Product identity was confirmed by
sequence analysis and electrophoresis on a 2.5% agarose gel containing
ethidium bromide.
Protein measurements
MSC-derived adipocytes were incubated for 48 h with treatments.
Supernatant aliquots were kept at 70 C until analyzed.
ProCT concentrations were determined in supernatants by an ultra-
sensitive chemiluminometric assay with a functional sensitivity of 6
pg/ml (ProCa-S assay; B.R.A.H.M.S. GmbH, Hennigsdorf-Berlin,
Germany).
ADM and CGRP concentrations were determined in supernatants by
human-specific RIAs (Phoenix Europe). The CGRP kit (IC50 10–20 pg/
TABLE 1. List of human gene-specific primers in RT-PCR analysis
mRNA Sense primer Antisense primer Size GeneBank no. Annealing temp (C) No. of cycles
Conventional PCR
CT TGAGCTGGAGCAGGAGCAAG GTTGGCATTCTGGGGCATGCTAA 232 X00356 67 35
CGRP I TGAGCTGGAGCAGGAGCAAG TCAGCTGCTCAGGCTTGAAGG 204 X02330 65 35
CGRP II CGGCCGCTCGCGCTGCCCTG GGTGGAGCTGCATGATCAAC 737 NM_000728 65 35
ADM CGGATGTCCAGCAGCTACCC GTAGCCCTGGGGGCTGATCT 300 NM_001124 65 28
Amylin TGAGAAGCAATGGGCATCCTG GGGGCAAGTAATTCAGTGGCTCT 273 X68830 65 35
PPAR2 GCGATTCCTTCACTGATAC GCATTATGAGACATCCCCAC 580 NM_015869 55 28
IL-6 GCAAAGAGGCACTGGCAGAAA CAGGCTGGCATTTGTGGTTG 284 M54894 60 25
TNF GGCCCAGGCAGTCAGATCAT GGGGCTCTTGATGGCAGAGA 310 M10988 65 35
IL-1 TTCCCTGCCCACAGACCTTC AGGCCCAAGGCCACAGGTAT 298 BC008678 65 35
CTR TGACCGAATGCAGCAGTTAC TTCAACCAGGTGGATGATGA 492 NM_001742 65 35
CRLR ACCAGGCCTTAGTAGCCACA ACAAATTGGGCCATGGATAA 296 NM_005795 65 35
RAMP1 CTGCCAGGAGGCTAACTACG GACCACGATGAAGGGGTAGA 298 NM_005855 65 30
RAMP2 GGGGGACGGTGAAGAACTAT GTTGGCAAAGTGGATCTGGT 227 NM_005854 65 30
RAMP3 AACTTCTCCCGTTGCTGCT GACGGGTATAACGATCAGCG 165 NM_005856 65 35
NEP TTGTAGGTTCGGCTGAGGCT TGTGGCCAGATTGATTCGTC 410 NM_007289 65 35
-actin TTCTGACCCATGCCCACCAT ATGGATGATGATATCGCCGCGCTC 198 NM_001101 65 28
Quantitative real-time PCR
CT GTGCAGATGAAGGCCAGTGA TCAGATTACCACACCGCTTAGATC 92 X00356 60 45
CGRP I CCCAGAAGAGAGCCTGTGACA CTTCACCACACCCCCTGATC 83 X02330 60 45
ADM ACTTGGCAGATCACTCTCTTAGCA ATCAGGGCGACGGAAACC 72 NM_001124 60 45
HPRT TCAGGCAGTATAATCCAAAGATGGT AGTCTGGCTTATATCCAACACTTCG 85 M26434 60 45
HPRT, Hypoxanthine-guanine phosphoribosyltransferase.
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tube) cross-reacts 0.09% with amylin and 0.004% with ADM. The ADM
kit (IC50 6–20 pg/tube) cross-reacts 0.032% with CGRP I as indicated by
the manufacturer.
Glycerol release into culture medium
On d 1 differentiation medium was removed from MSC-derived
adipocytes. Cells were washed three times in warm PBS and kept in
phenol red-free DMEM:F12 containing 3% FBS. Medium was changed
on d 2 and supplementswere added. On d 3, 800-l supernatant aliquots
were collected and kept frozen at 20 C until used for glycerol mea-
surement (glycerol UV-method, Roche Molecular Biochemicals/R-Bio-
pharm, Darmstadt, Germany).
Insulin-mediated glucose uptake
On d 1 differentiation medium was removed from MSC-derived
adipocytes. Cells were washed three times in warm PBS and kept in
DMEM/F12 containing 5 mm glucose and 3% FBS. Supplements were
added on d 2. On d 3 at t  0 min, 100 nm insulin were added to some
wells. At t  20 min, 1 C deoxy-d-glucose, 2-[3H(G)] [PerkinElmer
(Schweiz) AG, Schwerzenbach, Switzerland] was added to all wells.
After 15 min cells were washed three times in ice-cold PBS and lysed in
0.1% sodium dodecyl sulfate. Radioactivity was measured in a scintil-
lation counter.
Patients
Adipose tissue biopsies were obtained from healthy patients under-
going abdominal plastic surgery. Adipose tissue samples were also
obtained from four infected patients, as documented with elevated se-
rum ProCT (23), requiring laparotomy (mean age 44 yr, range 19–65 yr).
The septicemia were due to peritonitis because of perforated sigmoid
diverticulitis, perforated appendicitis, ischemic colitis of the sigmoid
colon, and necrotizing proctocolitis with perforation of the rectum and
descending colon. In addition, adipose tissue was collected from non-
infected patients requiring elective surgery (mean age 53 yr, range 29–71
yr). Informed consent was obtained. Harvested tissues were immedi-
ately incubated in RNA-later (Ambion, Inc., Austin, TX) to prevent RNA
degradation. The sampleswere snap frozen and stored at70 C. Tissues
were powdered under liquid nitrogen before RNA extraction.
All patients gavewritten informed consent to participate in the study.
The study protocol was reviewed and approved by the Human Ethics
Committee of Basel.
Statistical analysis
Results are presented as means  sem. Groups of experiments were
compared statistically using Student’s t tests. In addition, two group
comparisons corrected for multiple testing, i.e. one-way ANOVA with
post hoc analysis for least-square differences, were performed.
Results
Sepsis-induced expressions of CT mRNAs in adipose tissue
CGRP I, CGRP II, and ADM mRNAs were detected in
adipose tissue biopsies obtained from four septic patients
with elevated serum ProCT (Fig. 1A). In contrast, the re-
spective transcriptswere not detected in normal, noninfected
subjects (Fig. 1B). Amylin mRNA was found in neither con-
trol nor septic adipose tissue biopsies.
Inflammation-induced expressions of CT mRNAs in
primary adipocytes
Expressions of CGRP I, CGRP II, and ADM mRNAs were
analyzed by RT-PCR in explanted mature adipocytes kept in
ceiling cultures (20). Endothelial cells represent an important
fraction of nonadipose cells in adipose tissue (24). Previously
published PCR primers for endothelial nitric oxide synthase
mRNA (25) showed expression in whole adipose tissue but
not adipocytes (not shown). This verified the absence of
contaminating stromal cells in explanted mature adipocyte
preparations. Compared with basal conditions, CGRP I and
ADM mRNA expression were markedly induced after 24 h
of exposure to TNF, IL-1, and LPS treatments, respectively
(Fig. 2). In some experiments a weak inflammatory CGRP II
mRNA induction was also observed. In contrast, amylin
mRNA was never detected in mature adipocytes.
Next, we studied CT peptide gene induction in preadipo-
cyte-derived adipocytes cocultured with peripheral blood
mononuclear cell (PBMC)-derived macrophages. In some
experiments coincubation with unstimulated macrophages
resulted in weak induction of CGRP I, CGRP II, and ADM
mRNAs in adipocytes. Conversely, adipocyte CGRP I, CGRP
II, and ADM mRNA expressions were markedly increased
when macrophages were activated with live E. coli before
coculture with adipocytes. ADM mRNA was detected in
macrophages but not CGRP I and CGRP II mRNAs. Amylin
mRNAwas detected in neither adipocytes normacrophages.
Inflammatory CT peptide expression and secretion in MSC-
derived adipocytes
Production of CT peptides was analyzed in MSCs before
and after adipogenic differentiation. PPAR2mRNA, an adi-
pocyte-specific marker, was present in MSC-derived adipo-
cytes but not in undifferentiatedMSCs (Fig. 3). ADMmRNA
was induced by IL-1, LPS, or combined IL-1/TNF/LPS
treatments in undifferentiated MSCs but not the mRNAs of
CT, CGRP I, and CGRP II. In contrast, cytokine treatment of
MSC-derived adipocytes induced CT, CGRP I, and CGRP II
as well as ADM mRNA expression. Amylin mRNA was
detected in neither MSCs nor MSC-derived adipocytes.
In addition to conventional PCR, abundance of CT, CGRP
I, and ADM mRNAs on inflammatory treatments was ana-
lyzed in MSC-derived adipocytes by quantitative real-time
PCR. Compared with controls, CT mRNA was increased
79-fold (P  0.05) on IL-1 treatment, 111-fold (P  0.05) on
LPS treatment, and 61-fold (P  0.05) on combined IL-1/
TNF/LPS treatment (Fig. 4A). CGRP I mRNA was in-
creased 1.4-fold on IL-1 treatment, 2.4-fold (P 0.05) onLPS
treatment, and 3.2-fold (P 0.05) on combined IL-1/TNF/
LPS treatment. ADM mRNA was increased 8.4-fold on IL-
1-treatment, 18-fold on LPS treatment, and 80-fold (P 
0.05) on combined IL-1/TNF/LPS treatment.
Concentrations of ProCT, CGRP, and ADM in basal cul-
ture supernatants after 48 h were 9.7  1.4, 11.1  0.8, and
221 31.8 pg/ml, respectively (Fig. 4B). ProCT secretionwas
increased 4.8-fold to 47.4  8.0 pg/ml (P  0.05) on IL-1
treatment, 5.0-fold to 48.2  3.3 pg/ml (P  0.05) on LPS
treatment, and 4.5-fold to 43.9  2.6 pg/ml (P  0.05) on
combined IL-1/TNF/LPS treatment. CGRP protein secre-
tion was increased 2.5-fold to 28.7 1.8 pg/ml (P 0.05) on
IL-1 treatment, 3.2-fold to 35.3  2.2 pg/ml (P  0.05)
on LPS treatment, and 4.1-fold 45  1.0 pg/ml (P  0.05) on
combined IL-1/TNF/LPS treatment. ADM protein secre-
tion was increased 3.1-fold to 683 40.9 pg/ml (P 0.05) on
IL-1 treatment, 3.7-fold to 815  50.1 pg/ml (P  0.05) on
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LPS treatment, and 6.8-fold to 1495  75.1 pg/ml (P  0.05)
on combined IL-1/TNF/LPS treatment.
IFN administration alone had no influence on CT peptide
expression and secretion (Figs. 3 and 4). IL-1-induced CT,
CGRP, and CGRP II mRNAs were potently blocked when
IFN was coadministered. Accordingly, IL-1-mediated
ProCT and CGRP release was inhibited by 78% to 10.1 1.5
pg/ml (P 0.05) and 34% to 18.6 4.2 pg/ml, respectively,
by IFN coadministration (Fig. 4B). In contrast, combined
IFN and IL-1 administration resulted in 4.0-fold increased
ADM mRNA abundance, compared with IL-1 alone. Ac-
cordingly, IL-1-mediated ADM secretion into culture su-
pernatants was increased 2.0-fold to 1347 64.2 pg/ml (P
0.05) in the presence of IFN.
Combined IL-1/TNF/LPS treatment evoked maximal
CGRP I and ADM induction and was therefore chosen for
short-term induction analysis. CT, CGRP I, and CGRP II
mRNAs were present after 2-h incubations (Fig. 4C). Low-
level ADM mRNA was markedly augmented after 1 h.
Distinct CGRP- and ADM-mediated autoregulatory and
metabolic effects in adipocytes
mRNAs of CTR, CRLR, RAMP1, RAMP2, and RAMP3 as
well as neutral endopeptidase (NEP) were detected by RT-
PCR in basal MSC-derived adipocytes (Fig. 5A). Exogenous
CGRP and ADM were administered to MSC-derived adipo-
cytes in concentrations ranging from 1010 to 106 m. After
24 h, induction of CT, CGRP I, and CGRP II mRNA was
observed, even at low concentrations (Fig. 5B). In contrast,
FIG. 1. CGRP I, CGRP II, andADMmRNAexpressions in adipose tissue biopsies of septic patients. Omental (o) and sc (s) adipose tissue biopsies
were obtained from four septic patients and subjected to RT-PCR analysis for CT peptide transcripts (A). Serum ProCT level of each donor is
indicated on top. Samples from noninfected donors were used as controls (B). n.d., Not detected; rt, no reverse transcriptase controls to exclude
genomic DNA contamination; c, positive control.
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the samemRNAswere not induced in adipocytes exposed to
truncated peptides CGRP(8–37) and ADM(22–52). One-
nanomolar ADM-mediated mRNA inductions were blocked
by 1 h preadministration of 1 m CGRP(8–37) and ADM(22–
52), alone or in combination (Fig. 5C). One-micromolar
ADM(22–52) did not antagonize mRNA inductions when 10
nm ADM was added instead of 1 nm (not shown). Ten-
nanomolar CGRP-mediatedmRNA inductionswere blocked
by 1 m CGRP(8–37) but not by 1 m ADM(22–52). IL-6
mRNAwas induced by ADM at high concentrations but not
by CGRP (Fig. 5B). mRNAs of ADM, IL-1, and TNF mR-
NAs were induced by 1 ng/ml LPS but not by 106 m CGRP
or ADM (Fig. 5D).
In preliminary experiments, 6 h had been determined as
the minimal incubation time needed for detecting CT pep-
tide mRNA induction in MSC-derived adipocytes treated
with IL-1 alone. Therefore, possible effects of cyclohex-
imide-mediated protein synthesis inhibition on CT pep-
tide mRNA induction were studied after 6-h incubation
periods. Five micromalar cycloheximide alone had no ef-
fect on CT mRNA induction (Fig. 5E). When coadminis-
tered to 100 nm ADM, 100 nm CGRP, or 20 U/ml IL-1, a
FIG. 3. CTpeptidemRNA inductions inMSCs
and MSC-derived adipocytes. Total RNA was
isolated from MSCs and MSC-derived adipo-
cytes on 24-h inflammatory treatments as in-
dicated and reverse-transcribed. cDNA was
subjected to RT-PCR analysis. Shown results
are representatives of four independent exper-
iments. RT, Negative control lacking reverse
transcriptase; C, positive control.
FIG. 2. InflammatoryCGRP I,CGRP II, andADMmRNA inductions in humanprimary adipocytes.Human explanted adipocyteswere subjected
to 24 h TNF, IL-1, and LPS treatments, respectively. Preadipocyte-derived adipocytes were kept in coculture with activated PBMC-derived
macrophages for 24 h. Total RNA was separately isolated and induction of CT peptide transcripts was analyzed by RT-PCR analysis. mac,
Macrophages. Shown results are representatives of three independent experiments.
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potentiating effect was noted on CT, CGRP I, CGRP II, and
ADM mRNAs.
Lipolytic activity was assessed by measuring glycerol re-
lease into culture medium. Addition of CGRP and ADM
between 1 nm and 1 m evoked a dose-dependent activation
of lipolysis. In contrast, addition of truncated peptides
CGRP(8–37) or ADM(22–52) did not induce lipolysis (Fig. 6).
However, preadministration of 1 m CGRP(8–37) or
ADM(22–52) alone or in combination did not antagonize
ADM and CGRP effects on lipolysis.
Potential effects of CGRP and ADM on insulin sensitivity
were studied by comparing basal and insulin-mediated glu-
cose uptake after their administration. Adipocytes were rel-
atively insulin resistant on 24 h TNF exposure (Fig. 7).
Coadministered CGRP or ADM did not further impair in-
sulin action. In some experiments, presence of CGRP and
FIG. 4. Quantitative analysis of inflammation-
induced ProCT, CGRP, and ADM productions.
MSC-derived adipocytes were subjected to treat-
ments as indicated. Abundance of CT, CGRP I,
and ADM mRNAs was analyzed after 48 h by
quantitative real-time PCR using primers specif-
ically designed for sybr green detection (A). Re-
lease of corresponding peptides was determined
by supersensitive chemiluminometric assay
(ProCT) or RIA (CGRP and ADM) (B). CT peptide
mRNA inductions by combined IL-1/TNF/LPS
were analyzed byRT-PCRafter short incubations
up to 8 h. Shown results are means  SEM from
at least three independent experiments (A, B) or
representatives from four independent observa-
tions (C). *, P  0.05, compared with controls; §,
P  0.05 compared with IL-1 alone.
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ADM alone resulted in reduced insulin-mediated glucose
uptake. However, statistical significance was not reached.
Discussion
Herein we demonstrate the sepsis-related production and
potential functions of the two novel human adipose tissue
secretion products CGRP and ADM. Lethal outcome of sep-
sis correlates with high serum levels of CT peptides includ-
ing ProCT,CGRP, andADM(15, 16, 23). Septic shock, amajor
cause of mortality and morbidity in intensive care units, is
mainly characterized by hypotension and multiple organ
failure, and the underlying cellular and molecular mecha-
nisms are still poorly understood (26). Recent in vivo data
suggest that high ProCT concentrations mediate deleterious
effects: ProCT immunoneutralization increased survival rate
in septic hamsters and pigs, whereas exogenous ProCT ad-
ministration worsened the outcome (12–14). Immunomodu-
lating properties of ProCT might be partially responsible for
these observations (27, 28). Further activities to be unveiled
might include some of the numerous properties found for
other CT peptideswithwhich ProCT shares a common struc-
ture. CGRP and ADM are potent vasodilators and modula-
tors of nitric oxide production (29–32). In addition, pharma-
cological CGRP and amylin doses induce insulin resistance
in rat model in vivo and in vitro (33, 34).
We recently identified human adipose tissue depots as
major sepsis-related nonneuroendocrine CT mRNA expres-
sion sites leading to increased serumProCT (20, 21). By using
adipose tissue biopsies from septic patients and three dif-
ferent human adipocyte models, we extend our previous
findings on CGRP and ADM production in response to in-
flammatory stimuli. To assure that the observed cytokine-
mediated CT peptide mRNA expressions do indeed occur in
adipocytes, experiments were successfully performed in adi-
pocyte ceiling cultures obtained by negative buoyancy se-
lection of lipid-laden cells. The limited availability of primary
adipose cell cultures was overcome by using bone marrow-
derived MSCs as adipocyte precursors (22). In accordance
with our first report on in vitro ProCT expression in human
primary adipocytes (20), IL-1 and LPS potently induced
FIG. 5. CGRP- and ADM-mediated effects in MSC-derived adipocytes. MSC-derived adipocytes were subjected to RT-PCR analysis of genes
known to mediate CT peptide-signaling (A). CT peptide mRNAs were analyzed by RT-PCR in MSC-derived adipocytes after 24 h exposure to
indicated concentrations of exogenous CGRP and ADM (B). To test specificity of observations, truncated peptides CGRP(8–37) and ADM(22–52)
were administered alone (B) or in combination with ADM and CGRP (C). Effect of high CGRP and ADM concentrations, respectively, were
analyzed on ADM, TNF, and IL-1 mRNAs (D). One nanogram per milliliter LPS was administered alone as a positive stimulation control.
Protein synthesis was blocked by cycloheximide (CH) administration in CGRP-, ADM-, and IL-1-treated cells, and RT-PCR analysis was
performed after 6-h incubations (E). Shown results are representative of at least three separate experiments.
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CALC I gene expression in MSC-derived adipocytes. Similar
kinetics of CT peptide mRNA induction was observed in
both adipocyte models: IL-1-induced CT mRNA was de-
tectable after at least 6-h incubations and long lasting (t 
48 h). Furthermore, the previously shown potent inhibition
by IFN on ProCT productionwas herein confirmed inMSC-
derived adipocytes (20). In addition, the present data extend
IFN-mediated gene repression to CGRP I and CGRP II.
Undifferentiated MSCs as well as preadipocytes do not
respond with ProCT and CGRP production on any inflam-
matory treatment. This observation indicates that sepsis-
related ProCT and CGRP production in adipose tissue de-
pends on final differentiated adipocytes. We previously re-
ported tissue-wide CT and CGRP mRNA expression (17, 18)
in septic hamsters. The precise cellular origin and mecha-
nisms of ProCT and CGRP production in nonadipose tissues
will need to be addressed in future studies, but based on our
findings, it is likely that the widespread up-regulation of CT
and CGRP mRNA is limited to differentiated cells.
The positive effect of IFN on CALC IV gene-derived
ADM mRNA expression and ADM protein secretion indi-
cates major differences in gene expression in comparison
with CALC I and CALC II. In contrast to ProCT and CGRP,
inflammation-induced ADM expression was reported in nu-
merous tissues and in vitro models, including vascular en-
dothelial cells, vascular smooth muscle cells, fibroblasts, neu-
rons, macrophages, TNF-treated 3T3-L1 murine adipocytes,
and very recently basal rat adipocytes (6, 35–38). Accordingly,
besides differentiated adipocytes, we found ADM mRNA in-
duction in undifferentiated MSCs and PBMC-derived macro-
phages. Thus, in contrast to CALC I and CALC II products
ProCT andCGRP, sepsis- and inflammation-relatedADMpro-
duction appears to occur ubiquitously in all cell types inde-
pendently of the differentiation state. Therefore, nonadipose
cells possibly contribute in cytokine-mediated ADM mRNA
expression and ADM peptide secretion shown herein. An ap-
proximately 10-fold induction in ADMmRNA abundance was
recently shown in rat adipose tissues from obese high-fat-fed
rats (38). Obesity is related to increased presence of macro-
phages inmice adipose tissue (39, 40). In coculture experiments
we herein demonstrate ADM and CGRP mRNA induction by
macrophage-secreted factors. Thus, a potential role of inflam-
mation-mediated CT peptide expression in human obesity will
need to be addressed.
The presence of CTR, CRLR, RAMP1, RAMP2, and
RAMP3mRNAs inMSC-derived adipocytes is in accordance
with recent data from rat adipocytes (38). This indicates
possible expression of functional CT peptide receptors,
which may be responsible for the herein reported CGRP and
FIG. 6. CGRP- and ADM-mediated lipolysis induction in MSC-derived adipocytes. MSC-derived adipocytes were subjected to exogenous CGRP
and ADM exposure between 1 nM and 1 M for 24 h. Release of glycerol into supernatant was measured as an indicator of lipolytic activity.
Results are presented as means  SEM. n, Number of separate wells.
FIG. 7. Insulin-mediated glucose uptake. MSC-derived adipocytes
were subjected to indicated treatments for 24 h. One hundred nano-
moles insulin were applied to cells for 20 min. Then 3H-deoxy-glucose
was added and uptake was monitored after 15 min. Insulin stimu-
lation indices were expressed as the ratio of basal and insulin-medi-
ated 3H-deoxy-glucose uptake. Results are expressed asmeans SEM.
n, Number of independent triplicate experiments. *, P  0.05, com-
pared with controls; **, P  0.01, compared with controls.
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ADM effects (8). NEP mRNA expression in MSC-derived
adipocytes is in line with a previous report on active NEP
found in human adipocytes (41). NEP actively degrades
CGRP and ADM (42, 43). Furthermore, ADM and NEP are
inversely correlated in septic rats (44). Therefore, adipocyte
NEP functions might include clearance of CT peptides in the
vicinity of adipocytes.
Induction of CALC I and CALC II gene transcription was
observed on exposure of adipocytes to exogenous CGRP and
ADM in concentrations ranging from 1 nm to 1 m. This
induction was selective because the mRNAs of ADM, TNF,
and IL-1 were not affected by high CGRP and ADM con-
centrations. In contrast, the mentioned transcripts were in-
duced by 1 ng/ml LPS administration in the present adipo-
cytemodel. This excludes that CGRP andADMeffects onCT,
CGRP I, and CGRP II mRNAs are endotoxin-mediated ar-
tifacts from the recombinant peptide preparation. The
CGRP(8–37)- and ADM(8–22)-mediated antagonism on
mRNA inductions is a further indicator of specific CGRP and
ADM effects.
When maximally stimulated with combined IL-1/
TNF/LPS treatment, CT, CGRP I, and CGRP II mRNA
appeared already after 2 h. Cycloheximide-mediated protein
synthesis inhibition had positive additive effects on ADM-,
CGRP-, and IL-1-mediated CT peptide mRNA inductions,
respectively. Thus, inflammatory CALC gene mRNA induc-
tions appear not to depend on intermediate gene expression.
Moreover, based on the presented data, the existence of a
CALC gene transcription repressing factor with a high turn-
over rate may be hypothesized.
In addition to transcriptional activation, a positive dose-
dependent effect of CGRP and ADM was observed on glyc-
erol release. Thus, in analogy to proinflammatory cytokines
(e.g. TNF), CGRP and ADM possibly enhance lipolytic ac-
tivity (45). Control experiments with ADM(22–52) or
CGRP(8–37) remained negative on glycerol release. How-
ever, in contrast to mRNA inductions, preadministration of
truncated peptides did not antagonize ADM and CGRP ef-
fects on lipolysis. This might be explained by a very sensitive
and/or an alternative signaling pathway leading to en-
hanced lipolysis (46). Future studies will need to address this
issue.
Intensive insulin therapy reduces mortality in intensive
care unit patients, but themechanisms responsible for sepsis-
related insulin resistance induction are still poorly under-
stood (47). Herein we assessed adipocyte insulin sensitivity
by monitoring insulin-dependent glucose transport. The
demonstrated TNF-induced insulin resistance is in accor-
dance with currently recognized concepts and expands the
knowledge on MSC-derived adipocyte in vitro metabolic
functionality (22, 48). Previous data suggested glucose trans-
port-related antiinsulin effect by CGRP (33, 34). Herein at-
tenuation of insulin-mediated glucose uptake by CGRP and
ADM, however, was quite variable, indicating that other
factors that are not yet well understood may play an impor-
tant role. Therefore, a final conclusion cannot be drawnbased
on our data.
The process of adipocyte differentiation is characterized
by increasing IL-6 production and nuclear factor-B-related
inflammation (49, 50). Cultured adipocytes are known to
express inflammatory genes (51, 52). Accordingly, in MSC-
derived adipocytes, we found low-level basal IL-6, TNF,
and IL-1mRNA expression. CGRP and ADM are known to
potentate inflammatory events in several cells and tissues
(29, 53). Therefore, the herein shown CGRP- and ADM-
mediated effects in basal adipocytes might be interpreted as
modulatory events, rather than culprit inductions. Sepsis-
related adipocyte CT peptide expression in vivo occurs in the
presence of numerous proinflammatory factors, which
might be significantly influenced by local CT peptide pro-
duction. The precise mechanisms of inflammatory CT pep-
tide expression and action have to be addressed in future
experiments.
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Somatostatin Is Expressed and Secreted by Human
Adipose Tissue upon Infection and Inflammation
DALMA SEBOEK, PHILIPPE LINSCHEID, HENRYK ZULEWSKI, IGOR LANGER,
MIRJAM CHRIST-CRAIN, ULRICH KELLER, AND BEAT MU¨LLER
Department of Research (D.S., P.L.), Division of Endocrinology, Diabetology and Clinical Nutrition (H.Z., M.C.-C., U.K.,
B.M.), and Department of Visceral Surgery (I.L.), University Hospitals, CH-4031 Basel, Switzerland
Somatostatin (SRIF) is a well-known neuroendocrine secre-
tion product. SRIF expression and secretion are induced after
inflammation in murine macrophages and in endotoxin-
injected sheep and pigs. Because adipocytes have been dem-
onstrated to produce numerous cytokines and peptide hor-
mones, we investigated the expression of SRIF and its
receptors (SSTR1–5) in human adipose tissue after inflamma-
tory stimulation in vitro and in tissues from patients with
septic disease.
Preadipocyte-derived adipocytes, mesenchymal stem cell-
derived adipocytes, and mature explanted adipocytes ex-
pressed SRIF-mRNA after endotoxin [lipopolysaccharide
(LPS)] or IL-1 treatments. LPS- and IL-1-mediated SRIF-
mRNA induction was blocked by pretreatment with dexa-
methasone. Using cocultures and quantitative real-time PCR,
we demonstrate adipocyte SRIF induction by secretion
factors from activated peripheral blood mononuclear cell-
derived macrophages. In contrast to basal adipocytes, SRIF
protein was detected in culture supernatants of LPS-treated
and of combined TNF/IL-1/LPS-treated adipocytes. SRIF
protein was visualized by immunohistochemistry in ex-
planted minced adipose tissue after overnight incubation in
culture medium supplemented with combined IL-1 and LPS.
In septic patients, expression of SRIF-mRNA and SRIF pro-
tein was found in visceral, but not in sc, adipose tissue. Adi-
pocyte mRNA abundance of SSTR 1–5 was differentially reg-
ulated by inflammatory treatments.
Thus, human visceral adipose tissue secretes SRIF during
inflammation and sepsis and expresses several SSTRs. It is
tempting to speculate that visceral adipose tissue-derived
SRIF plays a modulatory role in the immunological and met-
abolic response to inflammation. (J Clin Endocrinol Metab 89:
4833–4839, 2004)
SOMATOSTATIN (SRIF) WAS described initially as a se-cretory product of the hypothalamus acting as a potent
inhibitor of GH secretion (1). Subsequently, high densities of
SRIF-producing neuroendocrine cells have been localized
throughout the central and peripheral nervous systems, in
the endocrine pancreas and in the gut, and to a lower extent
in the thyroid, adrenals, submandibular glands, kidneys,
prostate, and placenta (2–4). SRIF expression and secretion
was also described in murine inflammatory and immune
cells after activation (2). In the gastrointestinal tract, SRIF
inhibits the secretion of numerous peptide hormones (insu-
lin, glucagon, gastrin, and cholecystokinin), gastric empty-
ing, gallbladder contraction, and exocrine gut secretion (3, 5).
The induction of SRIF by inflammatory cytokines IL-1,
TNF, and IL-6 was demonstrated in vitro in models of rat
diencephalic cells (6, 7). SRIF-mRNA expression has been
described in murine macrophage cell lines after cytokine
stimulation (8). Accordingly, increased plasma SRIF levels
were measured in jugular and portal veins in endotoxin-
injected sheep and in septic pigs (9, 10).
Five distinct receptors mediating SRIF activity are widely
expressed in many tissues. As a neurotransmitter, SRIF in-
hibits the release of GH, dopamine, norepinephrine, TRH,
and CRH. Among others, additional modulatory roles have
been ascribed to SRIF in inflammatory conditions and lym-
phocyte function (11–13). Adipose tissue emerged as a major
endocrine organ in humans. Numerous peptide hormones
released by adipocytes affect energy homeostasis, glucose
and lipid metabolism, immune response, and reproduction
(14). In addition, adipose tissue participates in the release of
mediators of low-grade inflammation, which cause insulin
resistance, relative impairment of insulin secretion, and, ul-
timately, hyperglycemia (15, 16). Knowledge of mechanisms
underlying these processes is scarce. In view of the variety
of endocrine factors involved in these processes, we inves-
tigated the expression of SRIF as a potential modulator in
adipose tissue exposed to inflammatory cytokines. Here, we
present in vivo and in vitro evidence for SRIF expression in
adipose tissue in response to inflammation.
Patients and Methods
Patients
Permission was obtained from the local ethics committee for all ex-
periments with patients. Adipose tissue samples were obtained from
seven septic patients requiring laparotomy (mean age, 56 yr; range,
19–75 yr), after giving informed consent. Septicemias were due to peri-
tonitis because of perforated sigmoid diverticulitis, perforated sigmoid
carcinoma, perforated appendicitis, ischemic colitis of the sigmoid colon,
and necrotisizing proctocolitis with perforation of the rectum and de-
scending colon, respectively. In addition, adipose tissue was collected
from noninfected patients undergoing elective surgery (mean age, 53 yr;
range, 29–71 yr). Informed consent was obtained. Harvested tissues
were incubated immediately in RNA-later (Ambion, Inc., Austin, TX) to
Abbreviations: DEX, Dexamethasone; FCS, fetal calf serum; HPRT,
hypoxanthine-guanine phosphoribosyltransferase; LPS, lipopolysac-
charide; MSC, mesenchymal stem cell; ProCT, procalcitonin; SRIF,
somatostatin.
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prevent RNA degradation. The samples were snap-frozen and stored at
70 C. Tissues were powdered under liquid nitrogen before RNA ex-
traction using TRIzol reagent (Life Technologies, Inc., Gaithersburg,
MD). Alternatively, tissues were stored in 4% formaldehyde for immu-
nohistochemical analyses. Circulating levels of SRIF were assessed in six
septic patients (mean age, 54.7 yr; range, 36.1–73.3 yr; body mass index,
28.1 6.1 kg/m2). The underlying diagnosis of these patients was sepsis
due to pneumonia (n  5) and staphylococcal infection (n  1), respec-
tively. In addition, we investigated SRIF plasma concentrations in four
healthy subjects (mean age, 49.5 yr; range, 38–59 yr; body mass index,
24.4  2.4 kg/m2), all staff members.
Adipocyte cultures and isolation of preadipocytes
After informed consent, 50- to 500-g sc adipose tissue samples were
obtained from noninfected obese patients undergoing plastic surgery.
Primary cultures of human adipocytes were performed as described
previously (17, 18), with modifications. Briefly, adipose tissue was
minced, digested in 1 mg/ml collagenase 2 (Worthington Biochemical
Corp., Freehold, NJ), filtered (150-m nylon mesh), and centrifuged at
200 g. The cell pellet was resuspended twice in erythrocyte lysis buffer,
washed, and seeded in six-well plates. After a 24-h incubation in
DMEM/F12 with 10% fetal calf serum (FCS; Life Technologies, Inc.,
Basel, Switzerland) allowing attachment, cells were washed in PBS and
cultured in serum-free medium supplemented with agents [isobutyl-
methyl-xanthine, dexamethasone (DEX), insulin, transferrin, rosiglita-
zone, and triiodothyronine] that induce differentiation of preadipocytes
to adipocytes. Triglyceride-storing adipocytes, representing 40–80% of
cultured cells, are visible within 5–10 d. Differentiation was confirmed
by RT-PCR analysis for adipocyte-specific peroxisome proliferator-ac-
tivated receptor 2 expression (19). Adipocytes were maintained for an
additional 4 d in DMEM/F12 with 10% FCS before experiments, without
supplementation with the above listed agents, namely rosiglitazone. In
addition, floating mature adipocytes obtained after the centrifugation
step were washed twice in medium (DMEM/F12 with 10% FCS). Packed
adipocytes (0.5 ml) were inoculated into 50-ml flasks (Becton Dickinson
Labware, Rutherford, NJ) completely filled with medium and allowed
to attach to the top surface for 72 h at 37 C (20, 21). Flasks were sub-
sequently turned around, and non-adherent cells, representing the bulk
of initially inoculated cells, were removed. The adherent, triglyceride-
storing mature adipocytes were cultured in 5 ml medium for 2 additional
days before experiments.
Adipocytes were stimulated for 6 or 24 h with 1 g/ml lipopolysac-
charide (LPS) and 20 U/ml IL-1, respectively. In selected experiments,
cells were pretreated for 2 h with 1m DEX before IL-1 or LPS addition.
Human-specific IL-1 was purchased from PeproTech (London, UK).
LPS (Escherichia coli 026:B6) and DEX were from Sigma (Buchs,
Switzerland).
The viability of adipocytes after stimulations was assessed via trypan
blue staining, in which dead cells stain blue.
Human mesenchymal stem cells (MSCs)
Human MSCs were purchased from BioWhittaker Europe, S.p.r.l.
(Verviers, Belgium). Differentiation into adipogenic lineage was per-
formed as recommended by the manufacturer’s protocol. Differentiated
cells were exposed to LPS, IL-1, and DEX as described above.
Adipocytes and macrophages in cocultures
Peripheral blood mononuclear cells were isolated by Ficoll-Plaque
PLUS (Amersham, Uppsala, Sweden) and washed four times with
Hank’s balanced salt solution (Invitrogen, Basel, Switzerland) supple-
mented with 0.5% human albumin (Blutspendedienst SRK, Bern, Swit-
zerland). Cells were resuspended in Iscove’s modified Dulbecco’s
medium with 20% human serum and seeded in cell culture inserts with
0.4-m pore size (Becton Dickinson Labware, Dietikon, Switzerland).
After 1 h, non-adherent cells were removed by thorough washing with
Hank’s balanced salt solution and 0.5% human albumin. Adherent
monocytes were cultured for 5 d. The obtained monocyte-derived macro
phages were activated with live E. coli or combined 1 g/ml LPS,
20 U/ml IL-1, 10 ng/ml TNF administration. After 2 h, stimulants
were removed by repeated washing, and the inserts containing activated
macrophages were added to ex vivo differentiated adipocytes kept in
six-well plates for an additional 22 h. Then, adipocytes and macrophages
were separately subjected to SRIF-mRNA analysis as described below.
RT-PCR
Total RNA from homogenized tissues, adipocyte cultures, or MSCs,
respectively, was extracted by the single-step guanidinium-isothiocya-
nate method with a commercial reagent (TRIzol reagent; Life Technol-
ogies, Inc.) according to the manufacturer’s protocol. Extracted RNA
was quantified spectrophotometrically, and the quality was assessed by
gel electrophoresis. Equal amounts of RNA per tissue or in vitro treat-
ment were subjected to RT (Omniscript RT kit; Qiagen, Basel, Switzer-
land). PCR was performed on a conventional thermal cycler (TGradient;
Biometra, Go¨ttingen, Germany) using the PCR Taq core kit (Qiagen) and
the following intron border-spanning oligonucleotides (22): SSTR1
(318-bp PCR product; GenBank accession no. BC035618), 5-ATGGTG-
GCCCTCAAGGCCGG-3 (sense) and 5-CGCGGTGGCGTAATAGT-
CAA-3 (antisense); SSTR2 (318-bp PCR product; GenBank accession no.
AY236542), 5-TCCTCTGGAATCCGAGTGGG-3 (sense) and 5-TTGTC-
CTGCTTACTGTCACT-3 (antisense); SSTR3 (332-bp PCR product; Gen-
Bank accession no. AY277678), 5-TGCCACCCTGGGCAACGTGT-3
(sense) and 5-CAGGCAGAATATGCTGGTGA-3 (antisense); SSTR4
(323-bp PCR product; GenBank accession no. NM_ 001052), 5-GCGCGCG-
GCGACCTACCGGC-3 (sense) and 5-GCCTGGTGATTTTCTTCTCC-3
(antisense); SSTR5 (222-bp PCR product; GenBank NM_ 001053), 5-
CGTCTTCATCATCTACACGG-3 (sense) and 5-GGCCAGGTTGAC-
GATGTTGA-3 (antisense); SRIF (Ref. 23; 356-bp PCR product; GenBank
accession no. BC032625), 5-GATGCTGTCCTGCCGCCTCCAG-3 (sense)
and 5-ACAGGATGTGAAAGTCTTCCA-3 (antisense); -actin (198-bp
product; GenBank accession no. AF076191), 5- TTCTGACCCATGC-
CCACCAT-3 (sense) and 5-ATGGATGATGATATCGCCGCGCTC-3
(antisense).
The annealing temperature was 62 C for SSTR1–4, 58 C for SSTR5, 60
C for SRIF, and 65 C for -actin. Thirty-five cycles of PCR were used for
detection. Cycles were reduced to 28 for -actin, to stop the reaction in
the linear phase of amplification. -Actin was used to verify equal
quantities of RNA loading in each reaction. PCR products were sepa-
rated and visualized on 1.5% agarose gels containing 0.5 g/ml
ethidium bromide. PCR product identity was confirmed by direct nu-
cleotide sequencing of the PCR products by dye deoxy terminator cycle
sequencing. The absence of genomic DNA contamination was confirmed
by RT-negative control reactions for all RNA preparations.
Quantitative analyses of SRIF-mRNA expression
cDNA, obtained as described above, was subjected to quantitative
real-time PCR analysis using the ABI 7000 Sequence detection system
(PerkinElmer Life Sciences, Emeryville, CA). Specific primers yielding
short PCR products suitable for Sybr-Green detection were designed
using Primer Express software (version 1.0; PE Applied Biosystems,
Foster City, CA). Sequences of primers were as follows: SRIF (82-bp
product; GenBank accession no. BC032625), 3-GATGCCCTGGAAC-
CTGAAGA-5 (sense) and 3-CCGGGTTTGAGTTAGCAGATC-5 (an-
tisense); hypoxanthine-guanine phosphoribosyltransferase (HPRT;
85-bp product; GenBank accession no. M26434), 3-TCAGGCAGTATA-
ATCCAAAGATGGT-5 (sense) and 3-AGTCTGGCTTATATCCAA-
CACTTCG-5 (antisense). The reaction volume was 22 l, and the con-
ditions were set as suggested by the manufacturer. Each cDNA sample
tested for quantitative SRIF-mRNA expression was also subjected to
HPRT-mRNA analysis. Results were expressed as the ratio of the re-
spective SRIF-mRNA and HPRT-mRNA threshold values. The product
identity was confirmed by sequence analysis and electrophoresis on a
2.5% agarose gel containing ethidium bromide.
Peptide measurement
SRIF concentrations were determined in EDTA plasma and super-
natants using a commercially available SRIF RIA kit (functional assay
sensitivity, 5 pg/ml; Phoenix Pharmaceuticals Inc., Belmont, CA).
Procalcitonin (ProCT) concentrations were determined in sera by an
ultra-sensitive chemiluminometric assay with a functional sensitivity of
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5 pg/ml (ProCa-S assay; B.R.A.H.M.S. GmbH, Hennigsdorf-Berlin,
Germany).
Immunohistochemistry
Adipose tissue biopsies were formalin fixed and paraffin wax em-
bedded. The slides were dewaxed in xylene and rehydrated through
graded ethanols. Heat-induced epitope retrieval was performed by im-
mersing the slides in citrate buffer (10 mm, pH 6) and microwaving at
98 C for 30 min before cooling and rinsing with PBS. Immunohisto-
chemical staining was performed using the Vectastain Elite ABC kit
(Vector Laboratories, Burlingame, CA) as recommended by the manu-
facturer’s protocol. SRIF rabbit polyclonal antibody was purchased from
Novocastra Laboratories Ltd. (Newcastle, UK).
Density measurements
Density measurements of PCR amplification products were per-
formed using Scion Image 4.02 Beta for Windows (Scion Corp., Fred-
erick, MD).
Statistical analysis
All data are presented as means  sem. Unpaired t tests (two-sided)
or Mann-Whitney U tests in case of nonparametric distributions were
used to identify differences among the groups. For multigroup com-
parisons, one-way ANOVA with post hoc analysis for least-square dif-
ferences was performed. Data were analyzed using Statistica for Win-
dows (version 6; StatSoft Inc., Tulsa, OK).
Results
SRIF-mRNA induction in vitro and in vivo
In ex vivo differentiated adipocytes and in mature ex-
planted adipocytes obtained from noninfected patients un-
dergoing plastic surgery, SRIF-mRNA expression was al-
most not detectable by conventional RT-PCR analysis using
35 amplification cycles (Fig. 1). SRIF-mRNA expression was
found after a 6-h exposure to LPS or the proinflammatory
cytokine IL-1 in ex vivo differentiated adipocytes, adipo-
genic differentiated MSCs, and mature adipocytes. Induction
of SRIF-mRNA expression was repressed after preincubation
of ex vivo differentiated adipocytes and MSCs with DEX for
2 h (Fig. 1). Stimulation with 0.004% dimethylsulfoxide, the
carrier for DEX, alone had no effect on the SRIF induction
(data not shown). SRIF-mRNA induction was also observed
in adipocytes kept in coculture with E. coli-activated or com-
bined cytokine/LPS-activated macrophages (Fig. 2). In con-
trast, no SRIF-mRNA induction was observed in macro-
phages per se stimulated with E. coli or with combined
cytokines/LPS, respectively.
In several patients with severe bacterial infection, mir-
rored in markedly elevated serum ProCT levels (24), we
found SRIF-mRNA expression in visceral fat depots but not
in sc biopsies (Fig. 3A). The SRIF gene was not expressed in
FIG. 1. Induction of SRIF-mRNA expression in
cultured adipocytes and MSCs. Explanted ma-
ture adipocytes kept in so-called “ceiling cul-
tures,” ex vivo differentiated adipocytes, and
MSCs differentiated into the adipogenic lineage
were subjected to 6-h IL-1 (20 U/ml) and LPS (1
g/ml) treatments, respectively. Ex vivo differen-
tiated adipocytes and MSCs differentiated into
the adipogenic lineage were preincubated with
DEX for 2 h. SRIF-mRNA expression was ana-
lyzed by RT-PCR. Data are one of at least four
independent experiments.
FIG. 2. Quantitative analysis of SRIF-mRNA expression in
ex vivo differentiated adipocytes kept in coculture with
macrophages. Peripheral blood mononuclear cell-derived
macrophages kept in cell culture inserts with 0.4-m pores
were activated for 2 h with live E. coli. After repeated
washing with PBS, inserts were added to ex vivo differen-
tiated adipocytes in six-well plates for an additional 22 h.
Total RNA from macrophages and adipocytes were sepa-
rately isolated and subjected to quantitative real-time PCR
analysis using specifically designed primers yielding an
82-bp product suitable for Sybr-Green detection. SRIF-
mRNA threshold values were normalized with HPRT-
mRNA values. In addition, conventional PCR was per-
formed and visualized on a 2.5% agarose gel. Results are
means  SEM (n  4) or one of four independent experi-
ments.
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adipose tissue samples from noninfected control patients,
neither of visceral nor of sc origin (Fig. 3, B and C).
SRIF secretion in vitro and in vivo
In supernatants of ex vivo differentiated unstimulated adi-
pocytes, the SRIF protein concentration was below or at the
detection limit of 5 pg/ml after a 24-h incubation (Fig. 4). In
contrast, SRIF protein secretion was increased to 31  5.0
pg/ml in supernatants of LPS-treated cells. The administra-
tion of LPS, IL-1, and TNF combined led to an average
SRIF protein concentration of 24.3 3.9 pg/ml (n 6 for each
treatment; ANOVA for least-square differences, P  0.001).
The viability of adipocytes after a 24-h exposure to LPS,
IL-1, and TNF was unchanged as assessed by trypan blue
staining (data not shown). No significant differences in pe-
ripheral blood levels of SRIF were found between infected
and noninfected patients. Infected patients had a plasma
SRIF level of 89.55  24.1 pg/ml, and noninfected individ-
uals had a level of 158  73.73 pg/ml (P  0.21).
Immunohistochemistry for the SRIF protein was negative
in adipose tissue biopsies obtained from noninfected control
patients (Fig. 5A) with nondetectable circulating ProCT lev-
els. In contrast, the SRIF protein was detected in visceral
adipose tissue biopsies from healthy individuals after an
overnight incubation in LPS- and IL-1-supplemented cul-
ture medium (Fig. 5B). Similarly, in visceral adipose tissue
biopsies obtained from septic patients documented by in-
creased circulating ProCT levels, the SRIF protein was
detected by immunohistochemistry (Fig. 5D). No protein
expression was seen in biopsies of sc origin from the same
subjects (Fig. 5C).
SSTR1–5 gene expression in vitro
SSTR-mRNA expression was assessed using RT-PCR. In
unstimulated human adipocytes, SSTR subtypes 1 and 2
were expressed, in contrast to subtypes 3, 4, and 5. SSTR1
down-regulation was observed in adipocytes kept in cocul-
ture with E. coli-activated macrophages (Fig. 6). SSTR3 and
FIG. 3. SRIF-mRNA expression in adipose tissue obtained from septic and nonseptic humans. A, Subcutaneous (s) and visceral (v) adipose tissue
biopsies were obtained intraoperatively from patients with markedly increased circulating ProCT levels indicating bacterial infection. B,
Noninfected tissues were obtained from patients with nondetectable levels of serum ProCT as controls. SRIF-mRNA analysis was assessed by
RT-PCR. Amplification products were visualized on agarose gels. Verification of mRNA as the source of amplification template was obtained
by omitting the RT in reactions for pooled infected samples (rt-), resulting in no bands after PCR. RNA extracted from human islet cells was
taken as a positive control (c). C, Quantitative real-time PCR analysis using specifically designed primers yielding an 82-bp product suitable
for Sybr-Green detection was performed. SRIF-mRNA threshold values were normalized with HPRT-mRNA values and are presented as
means  SEM (n  4). Shown are data from four infected and four control patients, respectively. n.d., Not detected.
FIG. 4. SRIF release by ex vivo differentiated adipocytes. Ex vivo
differentiated adipocytes were subjected to inflammatory treatment
(20 U/ml IL-1, 10 ng/ml TNF, 1 g/ml LPS) for 2 h in the presence
of 10% fetal bovine serum. Thereafter, medium was replaced by
serum-free medium containing the same inflammatory agents and
incubated for an additional 22 h. SRIF protein content was analyzed
by RIA. Random values between 0 and 5 were generated for mea-
surements below the detection limit of 5 pg/ml. Data are means SEM
(n  6). *, P  0.01, comparison of LPS alone and combined IL-1/
TNF/LPS vs. control, respectively.
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SSTR4 were induced in the same experiments. SSTR2 re-
mained unchanged, and SSTR5 was never detected.
Discussion
The present study shows that SRIF is expressed and se-
creted in human adipose tissue in response to inflammation.
Thus, adipose tissue represents a novel site of SRIF expres-
sion besides the well-described neuroendocrine cells in the
brain and the gastrointestinal tract.
Ex vivo differentiated preadipocytes could be contami-
nated by other adipose tissue-derived cell types (e.g. mac-
rophages, endothelial cells), which could provide a non-
adipocyte source of SRIF expression. Therefore, we repeated
the experiments with MSC-derived adipocytes, with virtu-
ally identical results. However, due to the very nature of
developing MSCs, contribution of other not yet finally dif-
ferentiated cells cannot be excluded. In a third model, SRIF
expression in adipocytes clearly validated the initial findings
using mature and purified adipocytes cultured in adipocyte-
selecting “ceiling cultures” (20, 21). Accordingly, SRIF-
mRNA was detectable in visceral adipose tissue of septic
patients but not in noninfected subjects.
In confirmation of the transcriptional data, immunoreac-
tive SRIF was also detected in supernatants of cytokine-
stimulated adipocytes, indicating that SRIF is transcribed,
processed, and secreted in fat cells. In addition, using im-
munohistochemistry, SRIF-positive cells were found in the
visceral fat of septic patients as well as in cytokine-stimulated
explants of adipose tissue.
In a coculture system, activated macrophages induced adi-
pocyte SRIF gene expression in a similar way as did IL-1
and LPS, suggesting macrophage-derived stimulants are key
FIG. 5. SRIF immunohistochemical stain-
ing in human adipose tissue. Adipose tis-
sue sections were immunohistochemically
stained to determine the presence of SRIF.
A, Subcutaneous adipose tissue biopsies
obtained from noninfected individuals were
taken as control tissue. B, Subcutaneous
adipose tissue biopsies obtained from non-
infected individuals were stimulated with
LPS and IL-1 overnight in cell culture
medium. Subcutaneous (C) and visceral
(D) adipose tissue biopsies were obtained
intraoperatively from a septic patient. All
magnifications, 400.
FIG. 6. Semiquantitative analysis of SSTR1–5-
mRNA expression in ex vivo differentiated adipo-
cytes kept in coculture with macrophages. Periph-
eral blood mononuclear cell-derived macrophages
kept in cell culture inserts with 0.4-m pores
were activated for 2 h with live E. coli. After
repeated washing with PBS, inserts were added
to ex vivo differentiated adipocytes in six-well
plates for an additional 22 h. Total RNA from
adipocytes was separately isolated and subjected
to RT-PCR analysis using specifically designed
primers for each SSTR subtype. Amplification
products were visualized on agarose gels. Semi-
quantitative analysis was performed by density
measurements of the bands on the agarose gels.
Results are presented as means  SEM (n  4) or
one of four independent experiments. *, P 0.05,
comparison of stimulated (S) vs. control (C),
respectively.
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components for this induction. Interestingly, we were not
able to confirm the previously reported SRIF-mRNA expres-
sion by macrophages after inflammatory activation. This
may be due to species differences between rodent and hu-
man macrophages and macrophage-like cell lines (25).
SRIF was found in visceral, but not sc, adipose tissue of
patients with septic disease. It could be argued that SRIF
expression in visceral fat was related to the proximity of
visceral fat to the site of bacterial infection in our patients
(bowel infections). In this respect, secretion of cytokines in
response to septic disease was sufficient to induce ProCT
expression in both visceral and sc tissue in the same patients
(26). Therefore, we hypothesized another modulatory factor
that suppressed SRIF expression in sc adipose tissue in vivo
despite cytokine stimulation (e.g. innervations).
Venous blood from visceral fat is drained via the hepatic
portal vein, where SSTRs have been characterized at the
nerve endings of afferent fibers of the vagal nerve (27). These
receptors translate humoral SRIF signals into neural signals
in the central nervous system that may contribute to the
responses of the brain to sepsis and inflammation. Hence,
SRIF released from visceral fat after inflammatory stimula-
tion during infections could modulate hepato-pancreatic
perfusion and/or metabolic function, thereby augmenting
the relative insulin deficit and/or resistance observed in
septic patients (16). Furthermore, in obese patients, enhanced
inflammation-related adipose tissue SRIF production might
participate in the obesity-related complications reported in
patients in the intensive care unit (28). SRIF has a short
plasma half-life of approximately 2–3 min and shows a di-
urnal rhythm (2). This may explain the present observation
that there was no difference in peripheral-venous plasma
SRIF levels between infected and noninfected subjects. These
findings make other systemic endocrine effects of adipose
tissue-derived SRIF less likely but do not rule them out
because only single samples were obtained. In rats, SRIF
administration lowers inflammatory markers and mediators
(29). Furthermore, endogenous SRIF may participate in an-
tiinflammatory actions of glucocorticoids (11). In this respect,
the negative effect of DEX on SRIF expression in adipocytes
is noteworthy. It is tempting to speculate that sepsis-induced
SRIF expression described here exerts feedback effects on
inflammation.
Interestingly, mRNAs for SSTR1, 3, and 4 are differentially
expressed in the presence or absence of inflammatory me-
diators in human adipocytes. In isolated rat adipocytes, SRIF
surface binding and lipolytic action has been reported (30).
Hence, adipocyte-derived, inflammation-induced SRIF may
exert multiple effects in an autocrine or paracrine manner,
e.g. down-regulation of leptin secretion because plasma lep-
tin levels decreased in human subjects after SRIF adminis-
tration (31). A lipolytic effect of SRIF was also demonstrated
in chicken adipocytes after prolonged exposure to the pep-
tide (32).
Assuming that lower grades of inflammation also result in
preferential SRIF expression in visceral adipose tissue, these
observations may explain several previous human data on
reduced GH secretion in association with visceral adiposity.
Indeed, there is a highly significant negative correlation be-
tween the visceral fat mass and 24-h GH secretion in human
subjects; this association was stronger than the influence of
age, gender, and total body fat on GH secretion (33). In
addition, GH concentrations were reduced in parallel with
visceral adiposity among patients with HIV-lipodystrophy,
and an increased SRIF tone in these patients was postulated
(34, 35).
Visceral adipose tissue is more closely associated with the
insulin resistance syndrome than sc fat. In comparison, vis-
ceral adipocytes have higher lipolytic rates, are under dis-
tinct sympathetic nervous system regulation, secrete larger
amounts of IL-6 and plasminogen activator inhibitor-1, and
secrete smaller amounts of adiponectin and leptin (36).
In conclusion, SRIF is secreted by human adipocytes, both
ex vivo after stimulation with activated macrophages, LPS,
and IL-1 and in vivo in visceral adipose tissue harvested
from septic patients. Human adipose tissue expresses several
SSTRs that are differentially regulated by inflammatory stim-
uli. It remains to be elucidated whether in sepsis visceral
adipose tissue-derived SRIF plays a role as a classical hor-
mone, thereby suppressing insulin or GH secretion, or al-
ternatively, interferes by paracrine or autocrine action with
the release of other adipocytokines.
Acknowledgments
We are grateful to Prof. G. Pierer for providing adipose tissue, to Prof.
M. Oberholzer for SRIF immunohistochemical staining, to Kaethi Dem-
binski and Susanne Vosmeer for excellent technical assistance, and to
Isabelle Widmer and Caroline Koenig for providing EDTA plasma
samples.
Received February 12, 2004. Accepted June 30, 2004.
Address all correspondence and requests for reprints to: Dalma Se-
boek, Department of Research, University Hospitals, Hebelstrasse 20,
CH-4031 Basel, Switzerland. E-mail: Dalma.Seboek@unibas.ch.
This work was supported by grants from the Swiss National Science
Foundation (32-59012.99 and 32-068209.02), the “Sonderprogramm zur
Fo¨rderung des akademischen Nachwuchses der Universita¨t Basel,” the
Nora van Meeuwen-Ha¨fliger Foundation, and the Krokus Foundation
and by unconditional research grants from Novartis AG.
D.S. and P.L. contributed equally to this work.
References
1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J 1973 Hypothalamic
polypeptide that inhibits the secretion of immunoreactive pituitary growth
hormone. Science 179:77–79
2. Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol
20:157–198
3. Reichlin S 1983 Somatostatin. N Engl J Med 309:1495–1501
4. Patel YC, Greenwood M, Kent G, Panetta R, Sricant C 1993 Multiple gene
transcripts of the somatostatin receptor SSTR2: tissue selective distribution and
cAMP regulation. Biochem Biophys Res Commun 192:288–294
5. Hahn R 1986 Treatment of malignant carcinoid syndrome: evaluation of a
long-acting somatostatin analogue. N Engl J Med 315:663–666
6. Scarborough D, Lee S, Dinarello C, Reichlin S 1989 Interleukin-1 stimulates
somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology
124:549–551
7. Scarborough D 1990 Somatostatin regulation by cytokines. Metabolism 39:
108–111
8. Elliott DE, Blum AM, Li J, Metwali A, Weinstock JV 1998 Preprosomatostatin
messenger RNA is expressed by inflammatory cells and induced by inflam-
matory mediators and cytokines. J Immunol 160:3997–4003
9. Briard N, Guillaume V, Frachebois C, Rico-Gomez M, Sauze N, Oliver C,
Dutour A 1998 Endotoxin injection increases growth hormone and somatosta-
tin secretion in sheep. Endocrinology 139:2662–2669
10. Revhaug A, Lygren I, Lundgren T, Jorde R, Burhol P, Giercksky K 1984
Release of gastrointestinal peptides during E. coli endotoxinaemia. Acta Chir
Scand 150:535–539
11. Karalis K, Mastorakos G, Sano H, Wilder R, Chrousos G 1995 Somatostatin
4838 J Clin Endocrinol Metab, October 2004, 89(10):4833–4839 Seboek et al. • Somatostatin Secretion after Infection
may participate in the antiinflammatory actions of glucocorticoids. Endocri-
nology 136:4133–4138
12. Lin M, Uang W, Ho L 1989 Hypothalamic somatostatin may mediate endo-
toxin-induced fever in the rat. Naunyn Schmiedebergs Arch Pharmacol 339:
608–612
13. Ibanez de Caceres I, Priego T, Martin A, Lopez-Calderon A, Villanua M 2003
The inhibition of inducible nitric oxide synthase reverts arthritic-induced de-
crease in pituitary growth hormone mRNA but not in liver insulin-like growth
factor I mRNA expression. J Neuroendocrinol 15:1178–1184
14. Ahima RS, Flier JS 2000 Adipose tissue as an endocrine organ. Trends En-
docrinol Metab 11:327–332
15. Bastard J, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H,
Hainque B 2000 Elevated levels of interleukin 6 are reduced in serum and
subcutaneous adipose tissue of obese women after weight loss. J Clin Endo-
crinol Metab 85:3338–3342
16. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz
M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin
therapy in the critically ill patients. N Engl J Med 345:1359–1367
17. Bornstein SR, Abu-Asab M, Glasow A, Path G, Hauner H, Tsokos M, Chrou-
sos GP, Scherbaum W 2000 Immunohistochemical and ultrastructural local-
ization of leptin and leptin receptor in human white adipose tissue and dif-
ferentiating human adipose cells in primary culture. Diabetes 49:532–538
18. Hauner H, Skurk T, Wabitsch M 2001 Cultures of human adipose precursor
cells. Methods Mol Biol 155:239–247
19. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B,
Auwerx J, Laville M, Vidal H 1997 Tissue distribution and quantification of
the expression of mRNAs of peroxisome proliferator-activated receptors and
liver X receptor- in humans: no alteration in adipose tissue of obese and
NIDDM patients. Diabetes 46:1319–1327
20. Sugihara H, Yonemitsu N, Miyabara S, Yun K 1986 Primary cultures of
unilocular fat cells: characteristics of growth in vitro and changes in differ-
entiation properties. Differentiation 31:42–49
21. Zhang HH, Kumar S, Barnett AH, Eggo MC 2000 Ceiling culture of mature
human adipocytes: use in studies of adipocyte functions. J Endocrinol 164:
119–128
22. Seufert J, Ebert K, Mu¨ller J, Euler J, Hendrich C, Werner E, Schu¨tze N, Schulz
G, Kenn W, Richtmann H, Palitzsch K, Jakob F 2001 Octreotide therapy for
tumor-induced osteomalacia. N Engl J Med 345:1883–1888
23. Turman MA, O’Dorisio MS, O’Dorisio TM, Apple CA, Albers AR 1997
Somatostatin expression in human renal cortex and mesangial cells. Regul Pept
68:15–21
24. Muller B, Becker KL 2001 Procalcitonin: how a hormone became a marker and
mediator of sepsis. Swiss Med Wkly 131:595–602
25. Dalm VA, van Hagen PM, van Koetsveld PM, Langerak AW, van der Lely
A, Lamberts SW, Hofland LJ 2003 Cortistatin rather than somatostatin as a
potential endogenous ligand for somatostatin receptors in the human immune
system. J Clin Endocrinol Metab 88:270–276
26. Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter M, Keller U, Becker KL,
Muller B 2003 In vitro and in vivo calcitonin-I gene expression in parenchymal
cells: a novel product of human adipose tissue. Endocrinology 144:5578–5584
27. Nakabayashi H, Kobayashi K, Nakabayashi I, Kurata Y 1995 Somatostatin
receptor on the afferent nerve terminals in the rat hepatoportal area. Neurosci
Lett 183:46–49
28. El-Solh A, Sikka P, Bozkanat E, Jaafar W, Davies J 2001 Morbid obesity in
the medical ICU. Chest 120:1989–1997
29. Karalis K, Mastorakos G, Chrousos G, Tolis G 1994 Somatostatin analogues
suppress the inflammatory reaction in vivo. J Clin Invest 93:2000–2006
30. Simon M, Romero B, Calle C 1988 Characterization of somatostatin binding
sites in isolated rat adipocytes. Regul Pept 23:261–270
31. Donahoo W, Jensen D, Yost T, Eckel R 1997 Isoproterenol and somatostatin
decrease plasma leptin in humans: a novel mechanism regulating leptin se-
cretion. J Clin Endocrinol Metab 82:4139–4143
32. Oscar T 1996 Prolonged in vitro exposure of broiler adipocytes to somatostatin
enhances lipolysis and induces desensitization of antilipolysis. Poult Sci 75:
393–401
33. Clasey J, Weltman A, Patrie J, Weltmann JY, Pezzoli S, Bouchard C, Thorner
O, Hartmann ML 2001 Abdominal visceral fat and fasting insulin are impor-
tant predictors of 24-hour GH release independent of age, gender, and other
physiological factors. J Clin Endocrinol Metab 86:3845–3852
34. Koutkia P, Meininger G, Canavan B, Breu J, Grinspoon S 2004 Metabolic
regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in
HIV-lipodystrophy. Am J Physiol Endocrinol Metab 286:296–303
35. Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J,
Greenspoon S 2003 Assessment of growth hormone dynamics in human
immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab 86:
504–510
36. Lafontan M, Berlan M 2003 Do regional differences in adipocyte biology
provide new pathophysiological insights? Trends Pharmacol Sci 24:276–283
JCEM is published monthly by The Endocrine Society (http://www.endo-society.org), the foremost professional society serving the
endocrine community.
Seboek et al. • Somatostatin Secretion after Infection J Clin Endocrinol Metab, October 2004, 89(10):4833–4839 4839
  39 
 
 
 
 
V 
 
 
 
 
Cytokine-induced metabolic effects in human 
adipocytes are independent of endogenous 
nitric oxide 
 
 
Linscheid P, Seboek D, Zulewski H, Scherberich A, Blau N, Keller U and 
Müller B 2005 Am J Physiol Endocrinol Metab- in press 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 doi:10.1152/ajpendo.00374.2005 
 290:1068-1077, 2006. First published Dec 27, 2005;Am J Physiol Endocrinol Metab
Blau, Ulrich Keller and Beat Müller 
Philippe Linscheid, Dalma Seboek, Henryk Zulewski, Arnaud Scherberich, Nenad
adipocytes are independent of endogenous nitric oxide 
Cytokine-induced metabolic effects in human
 You might find this additional information useful...
47 articles, 25 of which you can access free at: This article cites 
 http://ajpendo.physiology.org/cgi/content/full/290/6/E1068#BIBL
including high-resolution figures, can be found at: Updated information and services 
 http://ajpendo.physiology.org/cgi/content/full/290/6/E1068
 can be found at: AJP - Endocrinology and Metabolismabout Additional material and information 
 http://www.the-aps.org/publications/ajpendo
This information is current as of July 20, 2006 . 
  
 http://www.the-aps.org/.
20814-3991. Copyright © 2005 by the American Physiological Society. ISSN: 0193-1849, ESSN: 1522-1555. Visit our website at 
organization. It is published 12 times a year (monthly) by the American Physiological Society, 9650 Rockville Pike, Bethesda MD 
 publishes results of original studies about endocrine and metabolic systems on any level ofAJP - Endocrinology and Metabolism
 o
n
 July 20, 2006 
ajpendo.physiology.org
D
ow
nloaded from
 
Cytokine-induced metabolic effects in human adipocytes are independent
of endogenous nitric oxide
Philippe Linscheid,1 Dalma Seboek,1 Henryk Zulewski,1,2 Arnaud Scherberich,1,3
Nenad Blau,4 Ulrich Keller,1,2 and Beat Mu¨ller1,2
1Department of Research, 2Division of Endocrinology, Diabetology, and Clinical Nutrition, 3Institute for
Surgical Research and Hospital Management, University Hospital, CH-4031 Basel; and 4Division of
Clinical Chemistry and Biochemistry, University Children’s Hospital, Zurich, Switzerland
Submitted 11 August 2005; accepted in final form 20 December 2005
Linscheid, Philippe, Dalma Seboek, Henryk Zulewski, Arnaud
Scherberich, Nenad Blau, Ulrich Keller, and Beat Mu¨ller. Cyto-
kine-induced metabolic effects in human adipocytes are independent
of endogenous nitric oxide. Am J Physiol Endocrinol Metab 290:
E1068–E1077, 2006. First published December 27, 2005;
doi:10.1152/ajpendo.00374.2005.—Nitric oxide (NO) has been rec-
ognized as a potential mediator of inflammation-induced metabolic
alterations, including insulin resistance. However, expression mech-
anisms and potential roles of endothelial and inducible NO synthases
(eNOS and iNOS, respectively) in human adipocytes are poorly
understood. In the present study, we aimed to analyze several aspects
of NO-related gene expression and metabolite synthesis in basal and
inflammation-activated human adipocyte models. eNOS mRNA was
highly expressed in omental and to a lesser extent in human subcu-
taneous adipose tissue biopsies, but not in purified adipocytes, in
mesenchymal stem cell (MSC)- and in preadipocyte-derived adipo-
cytes, respectively. Trace amounts of iNOS mRNA were detected in
adipose tissue samples of donors with abdominal infection, as op-
posed to noninfected subjects. Interferon-, in combination with
interleukin-1 or lipopolysaccharide, evoked a transient (4 h 
time  24 h) iNOS mRNA expression in human MSC and preadipo-
cyte-derived adipocytes, respectively. This induction was preceded by
cytokine-specific mRNAs. In addition, it was accompanied by an
activation of the tetrahydrobiopterin synthesis pathway and by inhi-
bition of peroxisome proliferator-activated receptor-2. In contrast to
murine 3T3-L1-derived adipocytes, iNOS protein and NO oxidation
products remained undetectable in iNOS mRNA-positive human adi-
pocytes. Accordingly, coadministration of NOS inhibitors (i.e., N-
nitro-L-arginine methyl ester, N-monomethyl-L-arginine, and
1400W) had no effects on insulin-mediated glucose uptake and
lipolysis. We conclude that, in human adipocytes, endogenous NO is
not involved in metabolic regulation during either basal or cytokine-
activated conditions.
adipose tissue; nitric oxide synthase; insulin resistance; cytokines;
lipolysis
INFLAMMATORY PROCESSES PLAY A PIVOTAL ROLE in translating
obesity to metabolic disturbances (10, 36, 47). However, de-
spite the overwhelming clinical evidence for such a relation-
ship, very little is known about the molecular mechanisms
linking obesity to insulin resistance and finally diabetes. Ex-
cessive nitric oxide (NO) production has been proposed as a
mediator for insulin resistance in muscle (35, 44), liver, and
adipose tissue (37, 38). Three NO synthase (NOS) isoforms
produce NO in a tightly regulated, cell-specific manner (3, 8,
33). Activity of the constitutively expressed endothelial and
neuronal isoforms is regulated by Ca2-mediated calmodulin
binding. A complex regulation mechanism requires both nu-
clear factor (NF)-B and interferon (IFN)- mediated STAT1
activations for triggering inducible NOS (iNOS) transcription
in humans (19). Reflecting the potential toxicity resulting from
the enzyme’s high activity, the expression is additionally
regulated on mRNA stability and translational and posttrans-
lational levels (8, 40).
Basal endothelial NOS (eNOS) and iNOS expressions were
reported in human adipose tissue and in adipocytes obtained
from collagenase-digested adipose tissue (14, 15, 43). iNOS
expression and activity was induced in white adipose tissue of
lipopolysaccharide (LPS)-treated rats and in murine 3T3-L1
adipocytes subjected to combined LPS, tumor necrosis factor
(TNF)-, and IFN- (25, 39). Tetrahydrobiopterin (BH4) is
essential and rate-limiting on NOS activity in several cells,
including activated 3T3-L1 adipocytes (29).
NO-releasing chemicals (e.g., sodium nitroprusside) and NO
gas increase basal lipolysis in rat adipocytes (20). Catechol-
amine-stimulated lipolysis, however, is inhibited by NO donors
but not by authentic NO gas, indicating additional, not yet
well-defined, regulatory mechanisms on NO-mediated meta-
bolic effects. Administration of N-nitro-L-arginine methyl
ester (L-NAME), an NOS inhibitor, increases lipolysis in
vivo in humans (4). In contrast, diphenyliodonium
(DPI)-mediated NOS blockade decreases both basal and
dibutyryl cAMP-stimulated lipolysis (21). In LPS- and cy-
tokine-challenged 3T3-L1 adipocytes, iNOS-derived NO
was proposed as a negative lipolysis modulator (34). NOS
inhibition resulted in impaired insulin-mediated glucose uptake
in rat adipocytes and myocytes (41). However, iNOS/
knockout mice are protected against obesity-induced insulin
resistance (35).
In view of these complex and partially conflicting find-
ings, we herein aimed to clarify the presence and relevance
of endogenous NO synthesis in human adipocytes. There-
fore, we analyzed NOS expressions in adipose tissue biop-
sies, in freshly isolated and in cultured mature adipocytes, in
preadipocyte-derived adipocytes, and in mesenchymal stem
cell (MSC)-derived adipocytes. In addition, BH4 synthesis
was assessed in basal and activated adipocytes. Finally, we
tested the potential influence of NOS inhibitors on lipolytic
activity and on insulin-mediated glucose transport in human
adipocytes.
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METHODS
Patients. Omental and subcutaneous adipose tissue biopsies were
obtained from four donors requiring elective surgery (mean age 46 yr,
range 19–71). Informed consent was obtained. Two of the patients
had abdominal infections resulting from perforated sigmoid divertic-
ulitis and perforated appendicitis. Harvested tissues were immediately
incubated in RNA-later (Ambion, Austin, TX) to prevent RNA
degradation. The samples were snap-frozen in liquid nitrogen and
stored at 70°C. Tissues were powdered under liquid nitrogen before
RNA extraction using Tri Reagent.
Adipocyte cultures. Human preadipocyte-derived adipocytes were
obtained from patients undergoing plastic surgery, as previously
described (30). Bone marrow aspirates (20–40 ml) were obtained
from healthy donors (18–63 yr) during routine orthopedic surgical
procedures, in accordance with the local ethical committee (Univer-
sity Hospital Basel) and after informed consent. Nucleated cells were
isolated from the aspirate by Ficoll density gradient centrifugation
(Histopaque1; Sigma, Buchs, Switzerland). Human MSC were there-
after selected within the nucleated cells in culture on the basis of
adhesion and proliferation on the plastic substrate. Cells were ex-
panded in DMEM supplemented with 10% FBS and 5 ng/ml basic
fibroblast growth factor (all from Invitrogen, Basel, Switzerland). For
experiments, cells between passages 4 and 10 were seeded in six-well
plates or 100-mm dishes. Adipogenic differentiation was induced by
incubating confluent cells in DMEM-F-12 (Invitrogen) containing 3%
FBS and supplements as follows: 250 	M 3-isobutyl-1-methylxan-
thine, 1 	M dexamethasone, 0.2 nM 3,3,5-triiodo-L-thyronine, 5 	M
transferrin (all from Sigma), 100 nM insulin (Novo Nordisk,
Ku¨snacht, Switzerland), and 1 	M rosiglitazone (GlaxoSmithKline,
Worthing, UK). Typically, 80–90% of MSCs underwent adipogenic
differentiation as assessed by lipid droplets formation. Expression of
adipocyte-specific mRNAs [e.g., peroxisome proliferator-activated
receptor-(PPAR)2, leptin, adiponectin, GLUT4] was confirmed by
RT-PCR. After 15–18 days, supplements were removed by washing
three times with warm PBS. Adipocytes were kept in DMEM-F-12
containing 3% FBS for three additional days before initiation of
experiments in fresh medium.
Human IFN- and interleukin (IL)-1 were purchased from Pepro-
Tech (London, UK). LPS (Escherichia coli 026:B6), N-monometh-
yl-L-arginine (L-NMMA), L-NAME, N-[3-(aminomethyl)benzyl]ac-
etamidine, and 1400W were from Sigma. Sepiapterin was from
Schircks Laboratories (Jona, Switzerland). Viability of adipocytes
after treatments was assessed with trypan blue staining, with viable
cells excluding trypan blue and dead cells staining blue.
RT-PCR. Total RNA was extracted from liquid nitrogen-powder-
ized tissues or adipocyte cultures with TRI Reagent (Molecular
Research Center, Cincinnati, OH). Extracted RNA was quantified
spectrophotometrically at 260 nm with a Biophotometer (Vaudaux-
Eppendorf, Scho¨nenbuch, Switzerland). Ratio of extinction at 260 and
280 nm was between 1.5 and 2.0, and the quality was assessed by gel
electrophoresis. Total RNA (1 	g) was subjected to reverse transcrip-
tion (Omniscript RT kit; Qiagen, Basel, Switzerland). PCR was
performed on a conventional thermal cycler (TGradient; Biometra,
Go¨ttingen, Germany) using PCR Taq core kit (Qiagen). Human
gene-specific, intron-spanning primers and conditions were as indi-
cated in Table 1. Amplification products were visualized on 1.5%
(amplicons 
250 bp) or 2.5% (amplicons 250 bp) agarose gels
containing 0.5 	g/ml ethidium bromide. A 100-bp Molecular Ruler
(Bio-Rad, Reinach, Switzerland) was run as size reference. PCR
product identity was confirmed by nucleotide sequencing (Mi-
crosynth, Balgach, Switzerland).
Determination of total NO. NO is rapidly oxidized to nitrite (NO2)
and nitrate (NO3). After incubation periods up to 72 h, cell culture
supernatants were supplemented with 60 mU nitrate reductase and 50
	M NADPH and kept for 2 h at room temperature in the dark. NO2
were detected by Griess assay (22). NaNO3 dilutions were used as
concentration reference.
Pterin analysis. MSC- and preadipocyte-derived adipocytes were
cultured in 100-mm dishes, treated with IFN--IL-1-LPS for 48 h,
washed with PBS, and scraped in 200 	l of 0.1 M HCl. Cells were
lysed by three cycles of freeze/thaw. Lysis supernatants obtained by
centrifugation and culture supernatants were oxidized for 5 min with
MnO2 and deproteinized by filtration through Ultrafree-MC 5,000
NMWL filters (Millipore, Volketswil, Switzerland). Samples of 200
	l were supplemented with 15 	l of 1 M HCl. Pterins (i.e., BH4 and
neopterin) were analyzed by HPLC as described previously (9). BH4
was measured as total biopterin (sum of biopterin, dihydrobiopterin,
and BH4).
Western blot analysis. MSC-derived adipocytes from two 100-mm
dishes were scraped in 500 	l buffer containing 150 mM NaCl, 10
mM Tris HCl (pH 7.4), 1 mM EGTA, 0.5% Nonidet P-40 (Igepal; all
from Sigma), and 1% Triton and protease inhibitor cocktail (Roche
Diagnostics, Rotkreutz, Switzerland). Lysis was carried out on ice for
30 min. Alternatively, cytosolic lysates were obtained by repeated
freeze/thawing in 25 mM Tris HCl (pH 7.4) supplemented with
protease inhibitor cocktail. After 30 min cold centrifugation at 14,000
rpm, a 21-gauge needle was used to aspirate lysates. When needed,
centrifugation was repeated for 15 min to clear lysates of floating
lipids. Protein concentrations were determined using Bradford reagent
as indicated by the supplier (Sigma). Lysate aliquots containing 40 	g
total protein were mixed 1:1 with Laemmli buffer and run on 7.5%
SDS-PAGE (Ready Gel; Bio-Rad). Proteins were transferred to ni-
trocellulose (Optripan BA-S 85; Schleicher & Schuell, Dassel, Ger-
many) in a Mini Trans-Blot system (Bio-Rad). Blots were blocked for
Table 1. List of human gene-specific primers for RT-PCR analysis
mRNA Sense Primer Antisense Primer
Size,
bp GeneBank No.
Annealing
Temperature, °C
No. of
Cycles
eNOS CACCGCTACAACATCCTGGAG CTGTGTTACTGGACTCCTTCC 799 M95296 55 35
iNOS ACGTGCGTTACTCCACCAACAA CATAGCGGATGAGCTGAGCATT 114 L09210 55 35
GTPCH TTGGTTATCTTCCTAACAA GTGCTGGTCACAGTTTTGCT 226 U19523 50 35
TNF- GGCCCAGGCAGTCAGATCAT GGGGCTCTTGATGGCAGAGA 310 M10988 65 35
IL-1 TTCCCTGCCCACAGACCTTC AGGCCCAAGGCCACAGGTAT 298 BC008678 65 35
IL-6 GCAAAGAGGCACTGGCAGAAA CAGGCTGGCATTTGTGGTTG 284 M54894 60 25
PPAR2 GCGATTCCTTCACTGATAC GCATTATGAGACATCCCCAC 580 NM_015869 55 28
PPAR1 TCTCTCCGTAATGGAAGACC GCATTATGAGACATCCCCAC 474 NM_138712 55 30
Leptin TGCCCATCCAAAAAGTCCA GAAGTCCAAACCGGTGACTTTCT 121 NM_000230 58 35
Adiponectin TGGGCCATCTCCTCCTCA AATAGCAGTAGAACAGCTCCCAGC 102 NM_004797 58 35
-Actin TTCTGACCCATGCCCACCAT CCTCGCCTTTGCCGATCC 198 NM_001101 65 28
eNOS, endothelial nitric oxide synthase; iNOS inducible nitric oxide synthase; GTPCH, GTP cyclohydrolase; TNF-, tumor necrosis factor-; IL-1,
interleukin-1; IL-6, interleukin-6; PPAR2, peroxisome proliferative-activated receptor- transcript variant 2; PPAR1, peroxisome proliferative-activated
receptor- transcript variant 1.
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1 h in PBS with 0.1% Tween 20 and 10% nonfat dry milk and exposed
overnight at 4°C to primary antibody in PBS with 0.1% Tween 20 and
1% nonfat dry milk. A monoclonal mouse anti-iNOS antibody reac-
tive for both human and mouse iNOS (BD Transduction Laboratories,
Basel, Switzerland) was diluted 1:2,500. Monoclonal mouse anti-
PPAR was diluted 1:200 (Santa Cruz, Heidelberg, Germany). Bound
antibodies were visualized by the Immun-star horseradish peroxidase
chemiluminescent kit (Bio-Rad).
Insulin-mediated glucose uptake. On day 1, differentiation medium
was removed from MSC-derived adipocytes. Cells were washed three
times in warm PBS and kept in DMEM-F-12 containing 5 mM
glucose and 3% FBS. Supplements were added on day 2. On day 3, at
t  0 min, 100 nM insulin was added to one-half of the wells. At t 
20 min, 1 	C 2-deoxy-D-[3H(G)]glucose (PerkinElmer, Boston, MA)
was added to all wells. After 15 min, cells were washed three times in
ice-cold PBS and lysed in 0.1% SDS. Radioactivity was measured in
a scintillation counter. Results are expressed as the ratio of insulin and
noninsulin-mediated glucose uptake (RIMGU).
Glycerol release in culture medium. On day 1, differentiation
medium was removed from MSC-derived adipocytes. Cells were
washed three times in warm PBS and kept in phenol red-free DMEM-
F-12 (Invitrogen) containing 3% FBS. Medium was changed on day
2, and supplements were added. On day 3, 800 	l supernatant aliquots
were collected and kept frozen at 20°C until used for glycerol
measurement (Glycerol UV-method; Boehringer Mannheim/R-Bio-
pharm, Darmstadt, Germany).
Statistical analysis. Data are presented as means  SD. Two-group
comparisons were performed using the Mann-Whitney U-test. For
multigroup comparisons, one-way ANOVA was used with Dunnett’s
Multiple Comparison posttest.
RESULTS
eNOS and iNOS mRNA expression in human adipose tissue.
eNOS mRNA was detected in subcutaneous and omental
human adipose tissue. The transcript abundance was higher in
omental fat biospies compared with subcutaneous samples
(Fig. 1A). Lipid-laden mature adipocytes were separated from
stromal cells (e.g., preadipocytes, endothelial cells) by colla-
genase digestion and several cycles washing and centrifugation
at 400 g. Low eNOS mRNA levels were found in adipocyte
preparations after the first wash but not after repeating the
procedure five times (Fig. 1B). In contrast, eNOS mRNA was
abundant in stromal cells in which adipocyte-specific PPAR2
mRNA was absent.
Trace amounts of iNOS mRNA were detected in adipose
tissue biopsies from patients with abdominal infection when 40
PCR cycles were applied instead of the usual 35 cycles (Fig.
1A). In contrast, iNOS mRNA was absent in noninfected
subjects.
Transient iNOS mRNA induction in human adipocytes. In
addition to visible lipid accumulation, the adipocyte character
of MSC-derived adipocytes was documented by RT-PCR
analysis. Several adipocyte marker genes, including adi-
ponectin, leptin, and PPAR2, were induced during adipo-
genic differentiation (Fig. 2). In contrast, adipocyte-unspe-
cific PPAR1 transcripts were also detected in undifferen-
tiated MSC.
Fig. 1. RT-PCR analysis of endothelial (e) and inducible (i)
nitric oxide synthase (NOS) mRNA. A: subcutaneous (s) and
omental (o) adipose tissue biopsies were obtained from donors
with infection (1 and 2) or without infection (3 and 4). Isolated
RNA was subjected to RT-PCR analysis for eNOS and iNOS
mRNAs. Absence of genomic DNA contamination was verified
by performing reactions without RT (RT). B: eNOS, iNOS,
and peroxisome proliferator-activated receptor (PPAR)-2
mRNA were analyzed in mature explanted adipocytes at initial
and final purification steps. In addition, eNOS mRNA content
was assessed in adipocytes kept in ceiling cultures (preadipo-
cyte) and in mesenchymal stem cell (MSC)-derived adipocytes.
c, positive control; M, 100-bp Molecular Ruler.
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iNOS mRNA was induced in MSC-derived adipocytes after
6 h exposure to combined IFN--IL-1 and IFN--LPS but not
by single treatments (Fig. 3A). In contrast, guanosine triphos-
phate cyclohydrolase (GTPCH) mRNA, the rate-limiting en-
zyme for BH4 synthesis, was also induced by single treatments.
TNF-, IL-1, and IL-6 mRNAs were induced by IL-1 and
LPS alone but not by IFN- alone. Administration of IFN--
IL-1 and IFN--LPS did not evoke iNOS mRNA induction
when adipocytes were kept in adipogenic differentiation me-
dium (data not shown).
iNOS mRNA induction was detectable 
4 h after IFN--
IL-1 and IFN--LPS administrations (Fig. 3B). Under iden-
tical conditions, GTPCH, TNF-, IL-1, and IL-6 mRNA
induction was observable after 2 h. iNOS and IL-1 mRNA
were no longer detected after 24 h. GTPCH and TNF- mRNA
expression declined after incubation periods exceeding 10 h.
IFN--IL-1- and IFN--LPS-induced IL-6 mRNA remained
elevated compared with controls for at least 48 h. In contrast,
administration of IFN--IL-1 and IFN--LPS diminished
PPAR2 mRNA abundance.
In preadipocyte-derived adipocytes similar mRNA expres-
sion patterns were observed (Fig. 3C).
NO2 and NO3 analysis in culture supernatants. Putative
cytokine-induced iNOS enzyme activity was assessed by ana-
lyzing NO-derived stable oxidation products NO2 and NO3 in
adipocyte culture supernatants. Detection limit for NO3 after
nitrate reductase treatment was 1 	M as determined in NaNO3
dilutions (data not shown). Murine 3T3-L1 adipocytes served
as controls: NO2 were increased at least 10-fold in 24-h
conditioned supernatants from IFN--TNF--IL-1-treated
3T3-L1-derived adipocytes compared with basal conditions. In
contrast, no NO2/NO3 induction was found in supernatants
from MSC-derived adipocytes incubated for up to 72 h with
several combinations of inflammatory mediators, including
IFN--IL-1, IFN--LPS, IFN--IL-1-TNF-, and IFN--
IL-1-LPS. NO2/NO3 induction was also negative in the
additional presence of exogenous 10 	M sepiapterin, which is
converted intracellularly to iNOS cofactor BH4.
NOS activity was not detected in IFN--IL-1-TNF--
exposed preadipocyte-derived adipocytes, even in the presence
of sepiapterin (data not shown).
BH4 synthesis in MSC- and in preadipocyte-derived adipo-
cytes. Cytokine-induced BH4 synthesis was assessed in MSC-
and in preadipocyte-derived adipocytes. In basal cells, BH4
concentrations were below the detection limit in lysates and
5.4  0.5 nM in supernatants (Fig. 4). Upon 48 h exposure to
combined IFN--IL-1-LPS, BH4 concentration was 67.6 
13.2 nM in cell lysates. Under the same conditions, BH4
secretion was increased 7.1-fold (38.4  2.8 nM) in superna-
tants compared with untreated controls.
In basal cells, neopterin concentrations were 4.4  2.8 nM
in lysates and below the detection limit in supernatants. Neop-
terin concentration was augmented 36.2-fold (159.5  38.13
nM) in cell lysates upon 48 h treatments with IFN--IL-1-
LPS. In the respective supernatants, neopterin concentration
was 14.9  1.4 nM.
iNOS and PPAR protein analysis in human adipocytes. We
aimed to determine cytokine-induced iNOS protein expression
by Western blot analysis. Basal and IFN--TNF--IL-1-
treated 3T3-L1 adipocytes served as negative and positive
controls, respectively (Fig. 5A). iNOS protein was not detected
in protein lysates from MSC-derived adipocytes treated with
IFN--IL-1 for 8, 10, or 24 h. In addition, iNOS was neither
found in IFN--LPS (data not shown) nor in IFN--, IL-1-,
and TNF--treated adipocytes (Fig. 5B). Lysates were probed
in parallel for PPAR protein to confirm integrity of lysates
and the activity of administrated treatments. PPAR1 and
PPAR2 were detected in lysates from basal adipocytes (Fig.
5, A and B). In accordance with mRNA data, PPAR2 protein
was downregulated by inflammatory treatments, including
IFN--IL-1 and IFN--IL-1-TNF-.
Insulin-mediated glucose uptake. The RIMGU was mea-
sured in the presence or absence of IFN--IL-1 and IFN--
LPS, respectively. After 2 h in fresh culture medium, basal
RIMGU was 3.75  0.32 (Fig. 6A). The addition of IFN--
IL-1 and IFN--LPS diminished RIMGUs to 2.0  0.1 (P
0.01) and 1.7  0.1 (P  0.01), respectively.
Upon 10 h exposure to either basal medium, IFN--IL-1,
or IFN--LPS, RIMGUs were 2.23  0.06, 1.49  0.07 (P 
0.01), and 1.30  0.06 (P  0.01), respectively (Fig. 6B).
IFN--IL-1- and IFN-- and LPS-mediated RIMGUs re-
mained virtually unchanged when agents known to block NOS
activity were coadministered (i.e., L-NAME, L-NNMA, and
1400W).
In further experiments we measured insulin-mediated glu-
cose uptake after 24 h.
In untreated control cells, RIMGU was 2.21  0.24 (Fig.
6C). Exposure to IFN- and IL-1 alone slightly reduced
RIMGU to 1.56  0.12 and 1.70  0.21, respectively. Com-
bined IFN--IL-1 administration clearly reduced insulin-
mediated glucose uptake throughout the experiments, with a
RIMGU of 1.184  0.05 (P  0.01). Coadministration of
L-arginine-derived NOS inhibitors L-NAME and L-NMMA
had no influence on basal or IFN-- and IL-1-modulated
RIMGUs.
Glycerol release. Lipolytic activity in MSC-derived adipo-
cytes was assessed by measuring glycerol accumulation in
culture medium. IL-1-induced glycerol release was time de-
pendent for at least 24 h (Fig. 7A). Coadministration of IFN-
Fig. 2. Induction of adipocyte markers in MSC-derived adipocytes. MSC were
subjected to RT-PCR analysis before and after adipogenic differentiation.
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Fig. 3. Induction of iNOS and cytokine mRNAs in human adipo-
cytes. MSC-derived adipocytes were subjected to inflammatory
agents. RT-PCR analysis was performed after 6 h (A) or at the
indicated time points (B). Similar experiments were performed in
preadipocyte-derived adipocytes (C). Results are representatives
from at least 3 separate experiments. TNF, tumor necrosis factor; IL,
interleukin; IFN, interferon; LPS, lipopolysaccharide; , with; ,
without.
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reduced IL-1-mediated glycerol secretion by 38% (P 0.05),
40% (P  0.05), and 47% (P  0.05) after 12, 16, and 24 h,
respectively. Glycerol release remained at basal levels in the
presence of IFN-, L-NAME, or L-NMMA alone (data not
shown). Administration of L-NAME, L-NMMA, and 1400W
had no effect on IL-1- and IFN--modulated lipolysis after 12
and 16 h (Fig. 7B).
DISCUSSION
In the present study, we analyzed expression kinetics and the
potential role of NOS enzymes in several human adipocyte
models before and after inflammatory stimulation. In contrast
to rodent adipocytes, the presented data raise serious doubts on
a relevant endogenous NO production in human adipocytes
under both physiological and inflammatory conditions.
Adipose tissue is a complex conglomerate of several cell
types, including adipocytes, preadipocytes, vascular endothe-
lial cells, smooth muscle cells, macrophages, nerve endings,
and others. Mature adipocytes account for only 16% of adipose
tissue cells (23). In our hands, eNOS mRNA was not present in
the final, purest adipocyte fraction. The contrast to published
data (14, 15) is most likely because of contaminating stromal
cells, which were still present in the adipocyte fraction after
initial washes. To decontaminate adipocytes from adhering
stromal cells, the negative buoyancy, lipid-laden fraction from
collagenase-digested adipose tissue was washed five times.
Moreover, the efficiency of centrifugation was increased by
applying 400 g instead of 200 g as we generally used for
adipose tissue stromal cell isolation (30). Accordingly, the
abundant eNOS mRNA signal found in stromal cells disap-
peared after expansion of preadipocytes and differentiation to
adipocytes. During the process of differentiation, preadipo-
cytes and MSC adopted several characteristics of adipocytes,
including insulin-mediated glucose uptake, inflammation-in-
duced lipolysis, PPAR2, leptin, and adiponectin mRNA ex-
pression. In contrast, eNOS mRNA was not induced. Insulin-
and ANG II-modulated NO formation was recently demon-
strated in human primary preadipocyte preparations (15). How-
ever, this report contained no evidence on functional NOS
expression and NO synthesis in differentiated adipocytes.
Taken together, the above-mentioned observations advocate
that eNOS expression is restricted to the endothelium in adi-
pose tissue. Our finding of increased eNOS mRNA abundance
in omental compared with subcutaneous adipose tissue is in
agreement with previous data (43). We hypothesize that this
finding is attributable to the high density of vascular vessels in
omental fat.
Tight regulation of iNOS activity is cell- and species-
specific (19, 27). In rodent adipose tissue and adipocytes, the
cytokine- and LPS-induced sustained NO production is well
Fig. 4. Tetrahydrobiopterin (BH4) and neopterin synthesis induction in human
adipocytes. Human MSC- and preadipocyte-derived adipocytes were exposed
to IFN--IL-1-LPS for 48 h. BH4 and neopterin were measured both in cell
lysates and in culture supernatants. Data were combined from experiments
performed in MSC (n  4)- and preadipocyte (n  2)-derived adipocytes.
Results are expressed as means  SD. ND, not detectable. *P  0.01
compared with untreated controls.
Fig. 5. iNOS and PPAR protein expression in MSC-derived adipocytes.
Adipocytes were subjected to iNOS mRNA-inducing treatments as indicated.
Whole cell lysates (or cytosolic lysates where indicated) containing 40 	g
(MSC-derived adipocytes) or 10 	g (3T3-L1) total protein were subjected to
iNOS and PPAR2 detection by Western blot. A: adipocytes were exposed for
8, 10, or 24 h to IFN--IL-1. B: adipocytes were treated for 10 h with
IFN--IL-1-TNF-. Results are representatives from 4 (A) and 2 (B) separate
experiments.
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established (25, 29, 34, 39). Obesity is increasingly recognized
as an inflammatory condition (10, 47), and human obesity-
related iNOS induction in adipose tissue has been proposed
(14, 15, 43). In agreement with previous data on iNOS protein
expression in adipose tissue biopsies, we found trace amounts
of iNOS mRNA in some donors (4). Interestingly, rodent
obesity is associated with macrophage accumulation in adipose
tissue (46, 48). Therefore, it may be hypothesized that obesity-
related inflammatory processes, including iNOS expression,
are attributable to macrophages and other nonadipocytes within
adipose tissue. In human preadipocytes, a modest increase in
iNOS mRNA abundance was recently reported during the
initial 8 days of in vitro adipogenesis (15). However, data of
functional iNOS enzyme induction were not provided. The
transcriptional iNOS activation may be explained by differen-
tiation-related NF-B activation, as observed in 3T3-L1 (7).
Primary preadipocyte-derived adipocytes are a well-estab-
lished, albeit laborious, cell model allowing in vitro studies of
Fig. 6. Insulin-mediated glucose uptake is not affected by NOS inhibitors.
MSC-derived adipocytes were exposed to IFN-, IL-1, LPS, N-nitro-L-
arginine methyl ester (L-NAME), N-monomethyl-L-arginine (L-NMMA), and
1400W as indicated for 2 h (A), 10 h (B), and 24 h (C). Glucose uptake was
measured in the presence or absence of 100 nM insulin. Results are expressed
as means  SD of the ratio of insulin- and non-insulin-mediated glucose
uptake (RIMGU). Cells from at least 2 separate donors were used; n indicates
the no. of separate wells. *P  0.01 compared with untreated controls.
Fig. 7. Lipolysis is not affected by NOS inhibitors. IFN-, IL-1, LPS,
L-NAME, L-NMMA, and 1400W were added to MSC-derived adipocytes as
indicated at time  0. Glycerol concentration was measured in culture
supernatants. A: time dependence of IL-1- and IFN-- and IL-1-induced
glycerol release. B: IFN-- and IL-1-induced glycerol release in the presence
or absence of NOS inhibitors. Results are expressed as means  SD from n 
4 (A) and n  6 (B) separate wells. Cells from 2 separate donors were used.
*P  0.05 compared with IL-1 alone.
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human fat cells (24). Expanding MSC cultures appear as a
useful alternative for adipocyte precursor cells. MSC-derived
adipocytes express and secrete several adipocyte markers,
including immunodetectable leptin and adiponectin, and ex-
hibit inducible lipolytic activity (42). In addition to adipocyte-
specific mRNA expression (e.g., PPAR2, leptin, adiponectin),
lipid storage, and lipolytic activity, the herein presented insu-
lin-mediated glucose uptake experiments further document the
adipocyte character of the MSC-derived model. The observed
inflammation-mediated PPAR2 mRNA and protein down-
regulation validates previous observations made in 3T3-L1-
derived adipocytes (17, 45).
To our knowledge, induction of NO generation in human
adipocyte models exposed to inflammatory mediators has not
yet been addressed. In MSC- and in preadipocyte-derived
adipocytes, iNOS mRNA was induced by combined IFN--
IL-1 and IFN--LPS, respectively, but not by IFN-, IL-1,
and LPS alone. IL-1- and LPS-mediated gene induction
occurs mainly via NF-B, whereas STAT1 mediates IFN-
signaling (1, 13). Accordingly, the human NOS-2 gene is
known to depend on both STAT1- and NF-B-mediated pro-
moter activation (19). In agreement with previous human data,
inflammation-induced iNOS mRNA expression was transient
in the present human adipocyte models (12). However, at the
time points with the highest iNOS mRNA abundance, iNOS
protein was not detected by Western blot analysis using a
monoclonal antibody suitable for human iNOS detection (31,
32). Accordingly, we failed to measure cytokine-induced NO
oxidation products. Thus, similar to other human cells, trans-
lational mechanisms appear to block human adipocyte iNOS
expression (31). In human monocytes and macrophages, the
activity of existing iNOS protein is blocked by low BH4
synthesis capacity (28). This appeared not to be the case in our
adipocytes: the inflammation-induced expression of the BH4-
synthesizing enzyme GTPCH evoked the production of both
BH4 and its side product neopterin. The presence of a func-
tional BH4 synthesis pathway was previously described in
rodent (18, 29), but not in human, adipocytes. In the absence of
functional NOS, the role of inflammation-induced BH4 in
human adipocytes remains to be elucidated.
Low NO synthesis may occur at undetectable levels and
modulate glucose metabolism and lipolytic activity. Therefore,
we performed additional experiments with metabolic read outs
(i.e., glucose uptake and glycerol release). MSC-derived adi-
pocytes exposed for 2 h to IFN--IL-1 or IFN--LPS dis-
played markedly reduced insulin-mediated glucose uptake. A
role of iNOS-derived NO can be ruled out since iNOS mRNA
induction initiated approximately after 4-h incuabtions. Further
glucose uptake experiments were performed after 10-h expo-
sures when iNOS mRNA reached highest abundance. How-
ever, the additional presence of NOS inhibitors (i.e., L-NAME,
L-NMMA, and 1400W) had no effect on insulin-mediated
glucose uptake. Similar results were previously shown in
murine 3T3-L1 and T37i adipocytes (38). Interestingly, obesity-
induced insulin resistance is not ameliorated by NOS-2 gene
inactivation in mouse adipose tissue (35). In contrast, muscle
tissue is protected against obesity-linked insulin resistance in
the same animal model. Accordingly, L-NAME-mediated NOS
inhibition prevents cytokine- and LPS-induced insulin resis-
tance in L6 myocytes (6). Thus NO may play a role in glucose
metabolism in muscle. A similar role appears unlikely in
adipocytes.
Complex and partially conflicting data have been presented
on NO as a potential modulator of adipose tissue lipolysis (4,
14, 20, 21, 25, 34, 37–39, 41, 43). The interpretation of
experiments using exogenous NO sources appears to be prob-
lematic. Different NO-generating chemicals (e.g., S-nitroso-N-
acetyl-penicillamine, NO gas, PAPA-NONOate) give raise to
distinct, highly reactive NO-related molecules (e.g., nitroso-
nium, NO, nitroxyl anion). Consequently, experiments using
different NO donors have suggested both pro- and anti-lipolytic
NO-mediated effects (20). Moreover, the proposed NO-mediated
attenuation of isoprotereonol-mediated lipolysis (2) might be
because of extracellular, oxidation-linked inactivation of the
-adrenergic agonist (11, 26). The impact of endogenous NOS
inhibition in adipocytes and adipose tissue has been addressed
in other reports. L-NMMA administration increases lipolysis in
human adipose tissue, as shown in a microdialysis study (4).
The absence of eNOS expression and the ineffective NOS
inhibitor administration in the present adipocyte models indi-
cates an indirect effect possibly mediated by vascular eNOS. In
contrast, basal and dibutyryl cAMP-induced lipolysis were
decreased by DPI, another NOS inhibitor, in isolated rat
adipocytes (21). These conflicting results may be explained by
species specificity, different adipose tissue models, and the
different NOS inhibitors.
Inflammatory cytokines have pro-lipolytic effects (16, 42).
In accordance with this view, IL-1 induced a time-dependent
glycerol release in MSC-derived adipocytes. As opposed to
previous 3T3-F442A adipocyte-related observations, IFN-
had no effect on basal lipolysis in MSC-derived adipocytes.
Surprisingly, glycerol release was markedly reduced in IFN--
and IL-1-administered cells compared with IL-1 alone.
Based on studies in murine adipocyte models, including 3T3-
L1, T37i, and adipose tissue explants from NOS 2/ knock-
out mice, iNOS-derived NO has been proposed as a negative
feedback inhibitor containing excessive inflammation-induced
lipoysis (34). In contrast, the lipolytic activity under inflam-
matory conditions appears to be NO independent in the present
human adipocyte model.
In summary, we conclude that, in human adipocytes, endog-
enous NO does not play a mandatory role during IL-1- and
IFN--induced gene expression and metabolic modulation. In
adipose tissue, however, NO from other sources (e.g., endo-
thelial cells, macrophages) may exert effects on neighboring
adipocytes. The present study provides further support for the
species-specific regulation of adipose tissue metabolism, such
as the previously reported production and release of cytokines
and adipokines (5), emphasizing the importance of investigat-
ing human adipose tissue to improve our understanding of
human physiology.
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ABSTRACT  
 
Replacement of insulin producing cells represents an almost ideal treatment 
for patients with diabetes mellitus type 1. Here we show that human bone 
marrow-derived mesenchymal stem cells (MSC) harbour the potential to 
differentiate into insulin, glucagon and somatostatin expressing cells in vitro. 
MSC from 5 healthy donors and 3 patients with diabetes type 1 were 
expanded and differentiated using defined culture conditions. Upon 
differentiation we observed the expression of various pancreatic genes 
including the transcription factors Isl-1, Ipf-1, Ngn-3, Pax-4, Pax-6, Nkx-2.2 
and Nkx-6.1 as well as the islet proteins insulin, glucagon, somatostatin and 
the glucose transporter glut-2.    
 
 
 
 
 
 
 
 
 
 
Keywords: diabetes, mesenchymal stem cell, differentiation, human, pancreas
 3
Introduction 
 
Stem/progenitor cells with the potential to differentiate into insulin expressing 
cells were described in pancreatic ducts[1], islets of Langerhans [2,3], the liver 
[4,5], the central nervous system [6], the spleen [7] and bone marrow [8,9]. 
Mesenchymal stem cells (MSC) from mouse bone marrow were shown to 
harbour the potential to differentiate into insulin secreting cells in vitro and to 
reverse hyperglycaemia in an animal model of diabetes [9]. Similarly, 
mesenchymal precursor cells from mouse spleen were able to regenerate 
insulin producing cells in a mouse model of autoimmune diabetes [7]. 
Recently human MSC were described to express at low level the islet 
transcription factor Nkx-6.1 and to differentiate into insulin producing cells 
upon adenoviral transduction with vectors over-expressing the transcription 
factors Ipf-1, Hlxb-6 or Foxa-2 [10]. The mechanisms underlying this apparent 
developmental plasticity of MSC are unknown. Interestingly, MSC were also 
shown to bear the potential to adopt a neural phenotype in vitro and in vivo 
[11-14] in rodents and humans [13] suggesting a neuro-endocrine 
developmental capacity of these cells. Expanding MSC express several stem 
cell marker like stem cell factor (SCF) and Thy-1 [15,16] but also nestin 
[13,14,17], a gene initially characterized as a marker of neural stem or 
progenitor cells [18] and later also suggested to be a marker for multipotent 
pancreatic stem cells [3]. Neural precursor cells express beside nestin also 
the side population stem cell marker ABCG2 [19,20]. Nestin and possibly 
ABCG2 expression could therefore represent a possible link between MSC 
and their ability to differentiate into neuro-endocrine cells. ABCG2 expression 
was not yet described in human bone marrow derived MSC.   
Stem/progenitor cells with the capacity to adopt a pancreatic endocrine 
phenotype should follow at least in part the complex program of normal 
pancreas development, for review see [21]. Initiation of pancreas 
development requires the induction of the transcription factor Ipf-1 that is 
prerequisite for pancreas formation in mouse and man [22,23]. Shortly 
thereafter the transcription factor islet-1 (Isl-1) that is required for generation 
of endocrine cells is induced at day E9 [24] followed by induction of the 
transcription factor Ngn-3, another crucial step toward pancreatic endocrine 
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cells [25,26]. In the present study we show that MSC from human bone 
marrow of non-diabetic subjects as well as patients with longstanding type 1 
diabetes are positive for the stem cell markers nestin and ABCG2 and display 
the potential to activate pancreatic developmental genes in response to 
defined culture conditions. This includes the transcription factors Ipf-1, Isl-1, 
Ngn-3, Pax-4, Pax-6, Nkx-2.2, Nkx-6.1 as well as the islet genes insulin, 
glucagon, somatostatin and glut-2. 
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RESEARCH DESIGN AND METHODS  
 
Isolation and expansion of MSC 
Five non-diabetic subjects (age 26 to 64 years) referred to the University 
Hospital for routine orthopaedic surgery were asked to donate 20 ml bone 
marrow during the surgical procedure. Three consecutive c-peptide negative 
patients (age 31, 50 and 53 years) with diabetes mellitus type 1 for 14, 35, 
and 37 years, respectively donated 20 ml bone marrow that was obtained by 
aspiration biopsy. All patients gave informed written consent and the study 
protocol was approved by the local ethics committee for human studies.  
  
After diluting the marrow aspirates with phosphate buffer saline (PBS) at a 
ratio of 1:4, nucleated cells were isolated using a density gradient solution 
(Histopaque, Sigma Chemical, Buchs, CH). The cells were cultured in 
Minimum Essential Medium (MEM) α medium with 5.5 mM glucose containing 
10% fetal bovine serum (FBS), 1% HEPES (1M), 1% sodium pyruvate MEM 
100 mM, 1% penicillin-streptomycin glutamate (10,000 U/ml penicillin; 10,000 
µg/mL streptomycin) (all from Invitrogen AG, Basel, CH). Nucleated cells were 
plated at a density of 100,000 cells/cm2 in the medium supplemented with 5 
ng/mL fibroblast growth factor-2 (FGF, R&D Systems, Wiesbaden, D) and 
cultured in a humidified incubator at 37°C, 5% CO2. FGF was supplemented 
in order to enrich the fraction of true progenitor cells [27]. MSC were cultured 
in 175cm2 Flasks (Becton Dickinson AG, Basel, CH), allowing attachment. 
Medium was changed twice a week. MSC were selected on the basis of 
adhesion and proliferation on the plastic substrate.  
 
MSC culture 
 
After the 3rd passage medium was changed to DMEM with glucose 25 mM 
supplemented with 10% heat inactivated FBS, 5 ng/mL FGF, 1% sodium 
pyruvate MEM 100 mM and 1% penicillin/streptomycin 5000 U/mL (all from 
Invitrogen AG, Basel, CH). Media and supplements were changed every 72 h. 
At a confluency of 95%, cells were collected using trypsin (Invitrogen AG, 
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Basel, Switzerland) and washed twice with serum-free DMEM/F12 medium. 
For induction of differentiation, MSC were replated at a cell density of 2-3 x 
105/well and cultured for 3 days in ultra low attachment 6 well plates (Vitaris 
AG, Baar, Switzerland) allowing the formation of islet-like clusters. MSC from 
non-diabetic subject 1 were analyzed on two occasions, at passage 4 and 
passage 7. The gene expression profile of each differentiation study was 
analyzed every 24 hours for 3 days in every subject or patient. For each 
differentiation day cells from 4 separate wells were harvested and analyzed 
independently and a mean value was calculated. Differentiation medium 
consists of serum-free DMEM/F12 medium with 17.5 mM glucose in the 
presence of  nicotinamide 10mM, activin-A 2 nM, exendin-4 10nM, hepatocyte 
growth factor 100 pM and pentagastrin 10 nM (all from Sigma, Basel, 
Switzerland) as well as B-27 serum-free supplement, N-2 Supplement and 1% 
penicillin/streptomycin 5,000 U/l (all from Invitrogen AG, Basel, Switzerland). 
Betacellulin (Sigma Chemical, Buchs, Switzerland) was added in a 
concentration of 2 nmol/L. 
  
RNA isolation and Reverse transcription (RT) 
 
Total RNA was extracted using TRIzol reagent (Lucerna Chemie AG, Luzern, 
Switzerland) according to the manufacturer’s protocol. RNA samples were 
treated with DNase (Ambion, Cambridgeshire, UK) in order to remove 
possible genomic DNA. RNA was quantified spectrophotometrically at 260 nm 
(Biophotometer, Eppendorf-Vaudaux, Schönenbuch, Switzerland). The quality 
was assessed by gel electrophoresis on an agarose gel containing ethidium 
bromide (EtBr, BioRad Laboratories AG, Reinach, Switzerland). 1 µg of total 
RNA was subjected to reverse transcription (RT) (Omniscript RT kit; Quiagen, 
Basel, Switzerland). Human islet RNA was a gift from Wolfgang Moritz, 
University Hospital Zürich, Switzerland.  
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Polymerase chain reaction (PCR) 
 
PCR was performed on a conventional thermal cycler (TGradient, Biometra, 
Göttingen, Germany) using PCR Taq core kit (Qiagen). Primers were as 
mentioned in table 1. Amplification products were visualized on agarose gels 
containing 0.5 µg/mL ethidium bromide. 100 bp Molecular Ruler (BioRad, 
Reinach, Switzerland) was run as size reference. PCR product identity was 
confirmed by nucleotide sequencing (Microsynth AG, Balgach, Switzerland).  
 
Quantitative Real-Time polymerase chain reaction (PCR) 
 
cDNA, obtained as described above, was subjected to quantitative real-time 
PCR analysis using the ABI 7000 Sequence (Perkin Elmer, USA) detection 
system. Specific primers yielding short PCR products suitable for Sybr-Green 
(Abgene, Epsom, UK) detection were designed using Primer Express 
software (version 2.0; PE Applied Biosystems, Foster City, CA). For 
sequences of primers see Table 1. The reaction consisted of 50 µL, 
containing 25 µL Sybr-Green, 2 µL sense primer (10 µmol/L), 2 µL antisense 
primer (10 µmol/L), 16 µL H2O; and 5 µL cDNA. Conditions were set as 
suggested by the manufacturer. Each cDNA sample tested for quantitative 
gene mRNA expression was also subjected to Hypoxanthine PhosphoRibosyl 
Transferase (HPRT) mRNA analysis. For quantitative analysis of gene 
expression the standard curve method was used with dilution of HPRT up to 
10-8. Results were expressed as the ratio of the respective gene mRNA and 
HPRT mRNA threshold values. Data are expressed as percentage expression 
as compared to day 0. For combined analysis of gene expression on days 0, 
1, 2 and 3 in non-diabetic subjects the mean value of each single 
differentiation experiment (calculated from the results of 4 wells that were 
analyzed independently) was used. The product identity was confirmed by 
sequence analysis and electrophoresis on a 3% agarose gel containing EtBr.  
 
Analysis of mRNA expression of pancreatic developmental genes as 
compared to human islets.  
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cDNA of human islets was a kind gift from Wolfgang Moritz, University 
Hospital Zürich. Real-time PCR was carried out as mentioned above with the 
same primer pairs. Gene copy numbers were calculated as the ratio of the 
respective gene mRNA and HPRT mRNA threshold values. mRNA 
expression of the respective gene in human islets was then expressed as the 
ratio of the respective gene on day 3 of the differentiated MSC.  
 
 
Peptide measurements 
 
Somatostatin concentration was determined in culture supernatants using a 
commercially available somatostatin radioimmunoassay (RIA) kit (functional 
assay sensitivity: somatostatin 5 pg/tube, Phoenix Pharmaceuticals Inc., 
Belmont, CA)  
 
Immunocytochemistry  
 
Cultured MSC were transferred into Lab-Tek chamber slides (Nunc, 
Naperville, IL) and incubated overnight in expansion medium. Islet-like 
clusters were collected after 3 days in differentiation medium. Some of them 
were dissociated by trypsin-ethylenediaminetetraacetic acid (EDTA) in order 
to obtain single cells. Single cells or islet-like clusters were transferred on 
glass slides coated with poly-L-lysine (Sigma, Buchs, Switzerland) and 
incubated overnight in DMEM/F12 medium containing 10% FBS allowing 
them to attach. All cells were then fixed with 4% paraformaldehyde in PBS 
(pH 7.4) for 30 min at room temperature. After several rinses in PBS, cells 
were permeabilized with chilled methanol for 10 min. Unspecific binding was 
prevented by incubation with 10 % heat inactivated FBS in PBS at RT for 30 
min. Fixed cultured MSC were incubated with primary antisera for 3 h at RT or 
overnight at 4°C, rinsed off with PBS and incubated with secondary antisera 
for 1 h at RT. Fixed islet-like clusters or single cells were incubated with 
primary antisera for 60-90 min at 37°C, rinsed off with PBS and incubated with 
secondary goat antisera for 45 min at 37°C. After several washes with PBS, 
cells were coverslipped with non-fluorescing mounting medium. The primary 
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antibodies used were rabbit anti-human C-peptide for dispersed cells (dilution 
1:500) (Linco, St. Charles, MO), sheep anti-human C-peptide for islet like 
cluster (dilution 1:100) (Abcam, Cambridge, MA) and rabbit anti- glucagon 
(dilution 1:100) (Linco, St. Charles, MO). Mouse monoclonal antibody 39.4D5 
raised against Isl1 (dilution 1:100) was obtained from Developmental Studies 
Hybridoma Bank, University of Iowa, IA. The rabbit anti-human Ipf1 (dilution 
1:1,000) was a generous gift from J.F. Habener, Boston, MA. The secondary 
antibodies from Molecular Probes (Invitrogen AG, Basel. Switzerland) were 
goat anti-mouse (dilution 1:1,000), donkey anti-sheep (1:100) and, goat anti-
rabbit (dilution 1:1,000). Goat anti mouse IgG and donkey anti-sheep IgG 
were labeled with alexa fluor 488 dye. Goat anti rabbit IgG was labeled with 
alexa fluor 546 dye. 4, 6-diamidino-2-phenylindole (DAPI, 5 µg/ml) from 
Sigma (Basel, Switzerland) was used to label the nuclei (10 min at 37°C). 
Cells were then examined either by fluorescence microsope (Axiophot, Zeiss, 
Germany) or by confocal microscope (LSM 510, Zeiss, Germany).The 
insulinoma cell line INS-1E was kindly provided by Claes Wollheim, Geneva, 
Switzerland.  
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RESULTS 
 
Isolation of MSC of non-diabetic subjects. Human bone marrow derived MSC 
from five independent donors were isolated on the basis of adhesion to tissue 
culture dishes and proliferation in FGF-2 containing culture medium. The 
initial population of mononuclear cells purified by Ficoll density gradient 
technique was positive for classical markers of haematopoietic cells like CD45 
and c-Kit but also ABCG2 that is known to be expressed in erythroid 
precursors and natural killer lymphocytes (Fig. 1a). These cells were mostly of 
haematopoietic origin. They were negative for Thy-1, nestin and Isl-1. During 
the process of MSC isolation haematopoietic cells don’t adhere to plastic 
surface and are discarded with medium change leading to loss of CD45 
positive cells. Consequently, proliferating MSC were negative for CD45, 
according to their non-haematopoietic origin and showed a strong expression 
of SCF and Thy-1, markers typically expressed in MSC (Fig. 1a). C-kit mRNA 
expression was clearly reduced as compared to initial population of 
mononuclear cells (Fig.1 a). In addition, MSC expressed nestin, ABCG2 and 
Isl-1 mRNA (Fig. 1a) while Ipf-1 was not detected with standard RT-PCR. 
(data not shown). Immunocytochemistry revealed Isl-1 protein in the nuclei of 
approximately 10% to of cultured MSC (Fig. 1b).  
 
Induction of differentiation was performed in serum-free medium (17.5 mM 
glucose) supplemented with exendin-4, pentagastrin, activin-A, betacellulin, 
nicotinamide and hepatocyte growth factor. Over the three day period we 
could observe a sharp step wise decrease in the expression level of the stem 
cell marker ABCG2 (Fig. 2a). This was mirrored by up-regulation of Isl-1, Ipf-
1, Ngn-3 and Pax-6 (Fig. 2a).  In addition, we observed an up-regulation of 
the glucose transporter glut-2, insulin, glucagon and somatostatin (Figure 2b).  
 
After having finished the first series of quantitative real time PCR studies we 
also analyzed the expression of additional transcription factors of the β-cell 
lineage i.e. Pax-4, Nkx2.2 and Nkx6.1 using standard PCR technique. As 
compared to undifferentiated cells these developmental markers were also 
up-regulated at day 3 (Fig. 3).  
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Analysis of islet proteins in differentiated MSC. Formation of islet like clusters 
was observed already 24 hours after initiation of the differentiation process 
(Figure 4a). For immunocytochemistry analysis of Ipf-1 cells in the cluster 
were dissociated, and stained with the Ipf-1 antiserum. Cells that stained 
positive for Ipf-1 after 3 days displayed a nuclear staining pattern (Figure 4b). 
Ipf-1 was not detected in undifferentiated cells (data not shown). C-peptide 
and glucagon positive cells were found in differentiated islet-like cluster (Fig. 
4c-f). Although insulin or glucagon release was not found in differentiated islet 
like clusters we were able to measure somatostatin release into the culture 
medium. Somatostatin was detectable already 24 hours after initiation of 
differentiation and reached plateau levels at days 2 and 3 (Fig. 4g). 
When compared to adult human islets the expression levels for Ipf-1, Isl-1,  
Ngn-3 and Pax-6 found in our islet like cluster reached values of 0.07%, 21%, 
290% and 20% respectively, of the expression levels found in human islets. 
Conversely, the corresponding values for mRNA expression for glut2, 
somatostatin, glucagon and insulin reached 6.1%, 0.2%, 0.3% and less than 
0.01% of the values found in human islets. 
 
Differentiation of bone marrow derived MSC from type 1 diabetic patients. We 
next sought to determine if MSC from type 1 diabetic patients would also be 
able to adopt a pancreatic endocrine phenotype. Bone marrow derived MSC 
from three patients with long-standing type 1 diabetes expressed similar stem 
cell markers during the expansion period together with Isl-1 as did MSC from 
non-diabetic subjects (Fig. 5). In proof of principle experiments induction of 
differentiation resulted in an up-regulation of the transcripts for Ipf-1, Ngn-3 as 
well as glut-2, insulin, somatostatin and glucagon as illustrated in figure 6. 
Although all three patients with diabetes expressed Isl-1 and ABCG2 in 
proliferating MSC and up-regulated insulin, glucagon and somatostatin mRNA 
during the differentiation period we observed a substantial variation in the 
expression level of these genes between patients. C-peptide was also 
detected with immunocytochemistry on single dispersed cells (Fig. 6c)  
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DISCUSSION 
The data presented herein show that human bone marrow-derived MSC are 
able to adopt a pancreatic endocrine phenotype ex vivo in non-diabetic 
subjects as well as patients with longstanding type 1 diabetes. This was 
achieved without genetic modification of the cells and in response to defined 
culture conditions. Initially these cells were cultured in high glucose (25mM) 
and FGF (5ng/ml) and expressed not only the stem cell markers nestin and 
ABCG2 but also the transcription factor Isl-1. ABCG2 is a known marker for 
the side population phenotype stem cells in bone marrow [20] and was 
recently found in pancreatic islet derived precursor cells and neural stem cells 
[19,28]. Together with Isl-1 it may thus point to a subpopulation of MSC with a 
neuro-endocrine developmental potential. During the differentiation 
experiments a strong down-regulation of ABCG2 gene expression was 
observed indicating that the cells indeed changed their developmental state 
from a stem cell to a more differentiated cell type. ABCG2 however is known 
to be expressed not only in stem cells but also in erythroid precursors and 
natural killer lymphocytes [20]. Both cell populations are initially co-purified by 
Ficoll density gradient leading to the positive ABCG2 signal (Fig.1) in the 
primary mononuclear cell population that was isolated from the bone marrow 
and contain mostly haematopoietic cells. During the expansion period 
however only CD45 negative cells continued to proliferate indicating a non-
haematopoietic origin of these cells.  In addition classical markers for MSC 
were up-regulated like Thy-1 and SCF. Similar cells are routinely 
differentiated into adipocytes or osteoblasts in our institution [29,30] 
demonstrating their mesenchymal phenotype.  
The transcription factor Isl-1 is crucial for the development of pancreatic 
endocrine cells. Disruption of Isl-1 expression is associated with absence of 
dorsal mesenchyme and a marked reduction of Ipf-1 gene expression in 
dorsal epithelium in mice [24]. Embryonic explants of the pancreatic anlage 
from Isl-1 (-/-) mice did not generate insulin, glucagon or somatostatin positive 
cells in vitro as did explants from Isl-1 (+/-) animals [24]. Isl-1 expression is 
found at embryonic day 9 in the mouse and is together with Ipf-1 one of the 
earliest pancreatic markers detected during development [24]. We 
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hypothesize that induction of Isl-1 expression in human MSC may represent 
the primary critical event that allows adoption of a pancreatic endocrine 
phenotype. Signals in the culture medium that triggered Isl-1 expression in a 
subpopulation of MSC could be the high glucose concentration, FBS, FGF-2 
or all factors together. The exact mechanisms however, remain to be 
elucidated.  
Beside its crucial role for development of pancreatic endocrine cells Isl-1 is 
also involved in the development of the central nervous system and the heart 
[31-34]. Therefore, some of these Isl-1 positive MSC could also represent 
potential progenitors for motor neurons [31] or cardiomyocytes [34].  
Using serum-free medium supplemented with factors known for their 
beneficial effects on differentiation of pancreatic or hepatic precursors into 
insulin producing cells [35-38] we have induced the activation of various 
crucial pancreatic transcription factors including Ipf-1, Ngn-3, Pax-4, Pax-6, 
Nkx-2.2 and Nkx-6.1 as well as the islet genes insulin, glucagon, somatostatin 
and glut-2. The differentiation process in vitro described herein may represent 
-at least in part- replication of ontogeny in response to the defined culture 
conditions. Noteworthy, these results were obtained in normal subjects as well 
as in patients with diabetes mellitus type 1 and, without genetic manipulation 
of MSC. As a limitation, these cells were not yet able to secret insulin or 
glucagon (data not shown) indicating a certain level of developmental 
immaturity although they did secrete somatostatin. Viewing the very low 
expression of insulin as compared to human islets we are still far away from 
clinically meaningful insulin production in bone marrow derived MSC. But, for 
the first time we show that cultured human MSC may have such potential 
without genetic modification.    
 
The real time PCR studies over 3 days revealed that many pancreatic genes 
were activated already 24h after induction of differentiation. These profound 
changes in the transcriptional program occurred surprisingly fast. But, 
observations of early activation of insulin gene expression were also made in 
mice in vivo in response to hyperglycaemia [39]. Here the authors found 
insulin positive cells in the bone marrow and adipose tissue of hyperglycaemic 
mice already after 3 days. These cells could represent MSC as described in 
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the present study and our previous report showing induction of pancreatic 
developmental genes in human adipose tissue derived MSC [40].   
 
Several studies addressed the possibility that bone marrow derived stem cells 
could contribute to β-cell turnover in vivo. Some of them presented positive 
results and suggested the presence of a circulating pool of stem cells that 
could participate in the process of β-cell neogenesis [8]. These results 
however were not confirmed by others [41] and a recent report questioned the 
entire concept of β-cell stem/progenitor cells with studies using genetic 
lineage tracing experiments [42]. With this approach it has been shown that 
pre-existing β-cells rather than adult stem/progenitor cells retained a 
proliferative capacity and may thus represent the major source of new β-cells 
in adult life, at least in mice [42]. While in vivo studies are not conclusive 
regarding the role of adult stem cells for generation of new β-cells this does 
not exclude the differentiation of adult stem cells into insulin producing cells in 
vitro. It has been shown that mouse mesenchymal stem cells from bone 
marrow cultured in high glucose over 4 months induced several β-cell specific 
genes including insulin and glut-2 [9]. These cells were also able to reverse 
hyperglycaemia in an animal model of diabetes although other crucial 
transcription factors like Pax4 and Isl-1 were not expressed [9]. In accordance 
with this report by Tang et al. our human MSC are also CD45 negative and 
express nestin during the expansion period.  
In summary Isl-1 positive MSC can be isolated from human bone marrow and 
are able to adopt a pancreatic endocrine phenotype in non-diabetic as well as 
type 1 diabetic subjects. These cells could be used as a human model to 
study development of pancreatic endocrine cells ex vivo and may help to 
develop stem cell based therapies for diabetes mellitus type 1.  
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FIGURE LEGENDS 
 
 
Figure 1. Expression of stem cell markers in mononuclear cells and 
MSC. (a) Presence of CD45, c-kit, ABCG2, SCF, Thy1, nestin and Isl-1 
mRNA was analyzed by RT-PCR in freshly isolated mononuclear cells (Ficoll 
separation) and after the 6th passage in expansion medium. (b) 
Immunocytochemistry for the transcription factor Isl-1 (magnification x 200). 
Arrows indicate positive staining in nuclei of MSC. Nuclei were counterstained 
with DAPI. Positive control was carried out with INS1E cells (right panel). 
 
Figure 2. Induction of pancreatic developmental genes in MSC in 
response to defined culture conditions in non-diabetic subjects. Gene 
expression was monitored every 24h for 3 days. Data are normalized to 
HPRT and expressed as percentage expression as compared to day 0. 
Results are means ± SEM of quadruplicates of six independent experiments 
from five independent donors.  
(a) mRNA expression of the side population marker ABCG2 and the 
pancreatic transcription factors, Isl-1, Ipf-1, Ngn-3 and Pax-6 was analyzed by 
real-time PCR. (b) Induction of glut-2, insulin, somatostatin and glucagon 
(logarithmic scale).  
 
Figure 3. Expression of Pax4, Nkx2.2 and Nkx6.1 mRNA was analyzed by 
conventional PCR in separate experiments (n=3). 
 
Figure 4. Analysis of islet like clusters generated from MSC.  
(a) Phase contrast image of islet like clusters after differentiation of MSC 
(magnification x 200). For immunocytochemistry islet-like clusters were 
collected after 3 days in differentiation medium. Some of them were 
dissociated by trypsin-EDTA to obtain single cells that were stained for Ipf-1 
(b). (c-d) Staining of differentiated clusters for c-peptide and glucagon 
(magnification x 400). The panels (e-f) shows the non-specific affinity of the 
secondary antibodies. Images were obtained with a laser scanning confocal 
microscope. Undifferentiated MSC were used as negative control. Nuclear 
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staining in blue with DAPI. (g) Somatostatin release during the differentiation 
period was measured with RIA in supernatants collected each day (n=8). 
 
Figure 5. Expression of stem cell markers in MSC from Type 1 diabetic 
patients. (a) Presence of CD45, c-kit, ABCG2, SCF, Thy1, nestin and Isl-1 
mRNA was analyzed by RT-PCR after the 6th passage in expansion medium.  
 
Figure 6. Example for induction of pancreatic developmental genes in 
MSC of a patient with type 1 diabetes. MSC were kept in differentiation 
medium for 3 days. Data are normalized to HPRT and expressed as 
percentage expression as compared to day 0. Each time point was analyzed 
in quadruplicates. 
(a) mRNA expression of the side population marker ABCG2 and the 
pancreatic transcription factors, Isl-1, Ipf-1, Ngn-3 and Pax-6 was analyzed by 
real-time PCR. (b) Real-time PCR analysis for mRNA of glut-2, insulin, sand 
glucagon. (c) Immunocytochemistry for c-peptide in undifferentiated and 
differentiated MSC. Nuclei are stained with DAPI (magnification x 400). 
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Table 1  
Primer sequences for RT-PCR. All primers were run at 60ºC. 
 
gene sense primer antisense primer amplicon 
accession 
number  cycles
HPRT 5´-TCAGGCAGTATAATCCAAAGATGGT-3´ 5´-AGTCTGGCTTATATCCAACACTTCG-3´ 85bp M26434 40 
Insulin 5´-GCAGCCTTTGTGAACCAACA-3´ 5´-TTCCCCGCACACTAGGTAGAGA-3´ 69bp NM_000207 40 
Ipf-1 5´-TGATACTGGATTGGCGTTGTTT-3´ 5´-TCCCAAGGTGGAGTGCTGTAG-3´ 70bp NM_000209 40 
ABCG2 5´-GGTTACGTGGTACAAGATGATGTTG-3´ 5´-AGCCGAAGAGCTGCTGAGAA-3´ 80bp AY289766 40 
Pax-6 5´-TGCGACATTTCCCGAATTCT-3´ 5´-GATGGAGCCAGTCTCGTAATACCT-3´ 81bp NM_001604 40 
Isl-1 5´-CAACTGGTCAATTTTTCAGAAGGA-3´ 5´-TTGAGAGGACATTGATGCTACTTCAC-3´ 75bp NM_002202 40 
Nestin 5´- CGTTGGAACAGAGGTTGGAG -3´ 5´- TAAGAAAGGCTGGCACAGGT -3´ 396bp BC032580 40 
Glut-2 5´-AGCACTTGGCACTTTTCATCAG-3´ 5´-GCCCAAGATAAATTCAAGACCAAT-3´ 82bp J03810 40 
Ngn-3 5`-CTATTCTTTTGCGCCGGTAGA-3` 5`-CTCACGGGTCACTTGGACAGT-3` 73bp NM_020999 40 
Somatost 5´-GATGCCCTGGAACCTGAAGA-3´ 5´-CCGGGTTTGAGTTAGCAGATCT-3´ 82bp BC032625 40 
Glucagon 5´-CCCAAGATTTTGTGCAGTGGTT-3´ 5´-CAGCATGTCTCTCAAATTCATCGT-3´ 80bp NM_002054 40 
Thy-1 5´-GTCCTTTCTCCCCCAATCTC-3´ 5´-GGGAGACCTGCAAGACTGTT-3´ 239bp NM_033209 40 
SCF 5´-GGTGGCAAATCTTCCAAAAG-3´ 5´-TCTTTCACGCACTCCACAAG-3´ 222bp BC074725 40 
c-kit 5´-GGCATCACGGTGACTTCAAT-3´ 5´-GGTTTGGGGAATGCTTCATA-3´ 244bp L04143 40 
CD45 5´-CAGGCAGCAATGCTATCTCA-3´ 5´-CTGTGATGGTGGTGTTGGAG-3´ 153bp Y00638 40 
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Figure 2a 
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Abstract
Mesenchymal stem cells (MSC) from mouse bone marrow were shown to adopt a pancreatic endocrine phenotype in vitro and to
reverse diabetes in an animal model. MSC from human bone marrow and adipose tissue represent very similar cell populations with
comparable phenotypes. Adipose tissue is abundant and easily accessible and could thus also harbor cells with the potential to differen-
tiate in insulin producing cells. We isolated human adipose tissue-derived MSC from four healthy donors. During the proliferation
period, the cells expressed the stem cell markers nestin, ABCG2, SCF, Thy-1 as well as the pancreatic endocrine transcription factor
Isl-1. The cells were induced to differentiate into a pancreatic endocrine phenotype by defined culture conditions within 3 days. Using
quantitative PCR a down-regulation of ABCG2 and up-regulation of pancreatic developmental transcription factors Isl-1, Ipf-1, and
Ngn3 were observed together with induction of the islet hormones insulin, glucagon, and somatostatin.
 2006 Elsevier Inc. All rights reserved.
Keywords: Mesenchymal stem cells; Isl-1; Human; Adipose tissue; Nestin; ABCG2; Differentiation; Insulin; Glucagon
Mesenchymal stem cells have been initially described as
clonal, plastic adherent cells from bone marrow [1] capable
of differentiating into adipocytes, chondrocytes, and osteo-
blasts [2,3]. They have been later identified in various other
tissues including muscle, brain, and adipose tissue [4–6]. In
addition to their ability to differentiate into adipocytes,
osteoblast, and chondrocytes, these stem cells were also
found to adopt a neural and hepatic phenotype in vitro
and in vivo [7–12]. Proliferating MSC express the stem cell
marker nestin [9,11,13], a gene initially characterized as a
marker of neural stem or progenitor cells [14] and later also
suggested to be a marker for multipotent pancreatic stem
cells [15]. MSC from mouse bone marrow were recently
shown to harbor the potential to differentiate into insulin
secreting cells in vitro and to reverse hyperglycemia in an
animal model of diabetes [16]. Similarly, mesenchymal
CD45-negative precursor cells from mouse spleen were able
to regenerate insulin producing cells in a mouse model of
autoimmune diabetes [17]. The mechanisms underlying this
apparent developmental plasticity of MSC are unknown.
MSC from human bone marrow and adipose tissue repre-
sent a very similar cell population with comparable pheno-
types [6,18–20]. Thus, MSC with the potential to adopt a
pancreatic endocrine phenotype could also exist in human
adipose tissue. In the light of the actual worldwide diabetes
epidemic, the generation of insulin producing cells from
adipose tissue-derived stem cells represents an attractive
treatment option for patients who have lost their residual
insulin production. In the present study, we show that
MSC from human adipose tissue express the stem cell
markers nestin and ABCG2, and display the potential to
activate pancreatic developmental genes in response to
0006-291X/$ - see front matter  2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2006.01.072
* Corresponding author. Fax: +41 61 265 5100.
E-mail address: henryk.zulewski@unibas.ch (H. Zulewski).
1 These two authors contributed equally to the study.
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defined culture conditions. This includes the transcription
factors Ipf-1, Isl-1, Ngn-3, and Pax-6 as well as the islet
proteins insulin, glucagon, and somatostatin.
Materials and methods
Isolation and expansion of human adipose tissue-derived MSC. Human
adipose tissue was obtained from patients undergoing plastic surgery in
accordance with the Local Ethics Committee (University Hospital Basel,
Switzerland). Adipose tissue-derived MSC were isolated and expanded as
previously described [21]. Culture medium contained DMEM supple-
mented with 10% fetal bovine serum (FBS) and 5 ng/mL fibroblast growth
factor (bFGF), 1% sodium pyruvate MEM 100 mM, and 1% penicillin/
streptomycin 5000 U/mL (all from Invitrogen, Basel, Switzerland). MSC
were cultured in 175 cm2 Flasks (Becton–Dickinson AG, Basel, Switzer-
land). Medium was changed twice a week. At a confluence of 95%, cells
were collected using trypsin (Invitrogen AG, Basel, Switzerland) and
washed twice with DMEM/F12 medium.
For induction of differentiation, the cells were seeded at a cell density
of 2–3 · 105/well of a 6-well plate and cultured for 3 days in ultra-low
attachment plates (Vitaris AG, Baar, Switzerland). MSC from four donors
were analyzed at passages 4–7. The gene expression profile of each dif-
ferentiation study was analyzed every 24 h for 3 days in every subject. For
each differentiation day cells from four separate wells were harvested and
analyzed independently and a mean value was calculated. Differentiation
medium consisted of serum-free DMEM/F12 medium with 17.5 mM
glucose in the presence of nicotinamide 10 mM, activin-A 2 nM, exendin-4
10 nM, hepatocyte growth factor 100 pM, and pentagastrin 10 nM (all
from Sigma, Basel, Switzerland) as well as B-27 serum-free supplement,
N-2 Supplement, and 1% penicillin/streptomycin 5000 U/L (all from
Invitrogen AG, Basel, Switzerland).
RNA isolation and reverse transcription. Total RNA was extracted
using TRIzol reagent (Lucerna Chemie AG, Luzern, Switzerland)
according to the manufacturer’s protocol. RNA samples were treated
with DNase (Ambion, Cambridgeshire, UK) in order to remove
possible contaminating genomic DNA. RNA was quantified spectro-
photometrically at 260 nm (Biophotometer, Eppendorf-Vaudaux,
Scho¨nenbuch, Switzerland). The quality was assessed by gel electro-
phoresis on agarose gel containing ethidium bromide (EtBr, Bio-Rad
Laboratories AG, Reinach, Switzerland). One microgram of total RNA
was subjected to reverse transcription (RT) (Omniscript RT kit; Qia-
gen, Basel, Switzerland).
Polymerase chain reaction. Polymerase chain reaction (PCR) was
performed on a conventional thermal cycler (TGradient, Biometra,
Go¨ttingen, Germany) using PCR Taq core kit (Qiagen). Human gene-
specific, intron spanning primers were used as mentioned in Table 1
with exception of primer for Ipf-1 and insulin that were used for real-
time PCR. Amplification products were visualized on agarose gels
containing 0.5 lg/mL EtBr. 100 bp Molecular Ruler (Bio-Rad, Reinach,
Switzerland) was run as size reference. PCR product identity was
confirmed by nucleotide sequencing (Microsynth AG, Balgach,
Switzerland).
Quantitative real-time polymerase chain reaction. cDNA, obtained as
described above, was subjected to quantitative real-time PCR analysis
using the ABI 7000 Sequence (Perkin-Elmer, USA) detection system.
Specific primers yielding short PCR products suitable for Sybr-Green
(Abgene, Epsom, UK) detection were designed using Primer Express
software (version 2.0; PE Applied Biosystems, Foster City, CA). For
sequences of primers, see Table 1. The reaction consisted of 50 lL, con-
taining 25 lL Sybr-Green, 2 lL sense primer (10 lmol/L), 2 lL antisense
primer (10 lmol/L), 16 lL H2O, and 5 lL cDNA. Conditions were set as
suggested by the manufacturer. Each cDNA sample tested for quantitative
gene mRNA expression was also subjected to hypoxanthine-phosphori-
bosyltransferase (HPRT) mRNA analysis. Results were expressed as the
ratio of the respective gene mRNA and HPRT mRNA threshold values.
Gene induction in differentiated cells is expressed as percentage of values
found in undifferentiated MSC. The product identity was confirmed by T
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sequence analysis and electrophoresis on a 3% agarose gel containing
EtBr.
Peptide measurements. Somatostatin concentration was determined in
culture supernatants using a commercially available somatostatin radio-
immunoassay (RIA) kit (functional assay sensitivity: somatostatin 5 pg/
tube, Phoenix Pharmaceuticals, Belmont, CA).
Immunocytochemistry. Cultured MSC were transferred on glass slides
and incubated overnight in expansion medium. Islet-like clusters were
collected after 3 days in differentiation medium and dissociated by trypsin-
ethylenediaminetetraacetic acid (EDTA) in order to obtain single cells.
Single cells were transferred on glass slides coated with poly-L-lysine
(Sigma, Buchs, Switzerland) and incubated overnight in DMEM/F12
medium containing 10% FBS allowing them to attach. Cells were then
fixed with 4% paraformaldehyde in PBS (pH 7.4) for 30 min at room
temperature. After several rinses in PBS, cells were permeabilized with
chilled methanol for 10 min. Unspecific binding was prevented by incu-
bation with 10% heat-inactivated FBS in PBS at RT for 30 min. Cells were
incubated with primary antisera for 60–90 min at 37 C, rinsed off with
PBS, and incubated with secondary goat antisera for 45 min at 37 C.
After several washes with PBS, cells were coverslipped with non-fluo-
rescing mounting medium. The primary antibody rabbit anti-human
c-peptide (dilution 1:500) was from Linco, St. Charles, MO. Mouse anti-
Isl-1 (dilution 1:100) (number 39.4D5) was obtained from Developmental
Studies Hybridoma Bank, University of Iowa, IA. The rabbit anti-human
Ipf-1 (dilution 1:1000) was a generous gift from J.F. Habener, Boston,
MA. The secondary antibodies from Molecular Probes (Invitrogen AG,
Basel, Switzerland) were goat anti-mouse (dilution 1:1000) and goat anti-
rabbit (dilution 1:1000). Goat anti-mouse IgG was labeled with Alexa
fluor 488 dye. Goat anti-rabbit IgG was labeled with Alexa fluor 546 dye.
4,6-Diamidino-2-phenylindole (DAPI, 5 lg/mL) from Sigma was used to
label the nuclei (10 min at 37 C). Cells were examined by fluorescence
microscope (Axiophot, Zeiss, Germany).
Results
Human adipose tissue-derived MSC from four donors
were isolated and proliferated in bFGF containing culture
medium. The initial cell population was positive for stem cell
factor (SCF) and its receptor (c-kit). This cell populationwas
negative for ABCG2, nestin, Thy-1, and Isl-1 as assessed by
RT-PCR (Fig. 1A). Proliferating MSC, however, expressed
ABCG2, nestin, Thy-1, and Isl-1 mRNA (Fig. 1A). Using
immunocytochemistry we found Isl-1 protein in the nuclei
of approximately 10% of cultured MSC (Fig. 1B). The mes-
enchymal characteristic of adipose tissue-derived MSC was
described by previous studies [6,18–20] and confirmed with
internal control experiments showing adoption of adipocytic
and osteocytic phenotypes of these cells in response to stan-
dard protocols (data not shown).
Induction of pancreatic endocrine differentiation with
our defined culture conditions was associated with step-
wise decrease in the expression level of the stem cell
marker ABCG2 as analyzed by quantitative real-time
PCR. This was mirrored by up-regulation of Isl-1, Ipf-
1, and Ngn-3 expression during the observed 3-day peri-
od (Fig. 2). Interestingly, expression of Pax-6 was also
found in proliferating MSC and was not further induced
by the 3-day differentiation procedure. Genes known to
be positively regulated by Ipf-1 like insulin and somato-
statin were also induced during the differentiation period.
In addition, an activation of glucagon gene expression
was observed (Fig. 3).
Nuclear staining for Ipf-1 was found in approximately
10% of the cells after 3 days (Figs. 4A and B). Ipf-1 was
not detected by immunocytochemistry in undifferentiated
cells. C-peptide positive cells were found in differentiated
MSC (Figs. 4C and D). In addition, we found a release
of somatostatin into the medium that reached plateau lev-
els at day 3 (Fig. 4E).
Discussion
The present study demonstrates that human adipose
tissue-derived MSC are able to adopt a pancreatic endo-
crine phenotype ex vivo. This was achieved without
genetic modification and in response to defined culture
conditions. Initially, these cells were cultured in high glu-
cose (25 mM) and bFGF (5 ng/mL) and expressed after
expansion not only the stem cell markers nestin, ABCG2,
SCF, and Thy-1 but also the pancreatic transcription fac-
tor Isl-1 (Fig. 1). ABCG2 is a known marker for the side
population phenotype stem cells in bone marrow [22]
and was recently found in pancreatic islet-derived precur-
sor cells and neural stem cells [23,24]. Together with Isl-1
it may thus point to a subpopulation of MSC with
Fig. 1. Expression of stem cell markers in adipose tissue-derived MSC.
(A) Presence of ABCG2, SCF, c-kit, nestin, Thy1, and Isl-1 mRNA was
analyzed by RT-PCR in primary cell isolates and MSC (passage 6) in
expansion medium. (B) Immunocytochemistry for the transcription factor
Isl-1 (magnification 400·). Arrows indicate positive staining. Nuclei were
counterstained with DAPI (in blue). (For interpretation of the references
to color in this figure legend, the reader is referred to the web version of
this paper.)
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neuro-endocrine developmental potential. The transcrip-
tion factor Isl-1 is crucial for the development of pancre-
atic endocrine cells. Disruption of Isl-1 expression is
associated with absence of dorsal mesenchyme and a
marked reduction of Ipf-1 gene expression in dorsal epi-
thelium in mice [25]. Embryonic explants of the pancre-
atic anlage from Isl-1 (/) mice did not generate
insulin, glucagon or somatostatin positive cells in vitro
as did explants from Isl-1 (+/) animals [25]. Isl-1
expression is together with Ipf-1 one of the earliest pan-
creatic transcription factors detected during development
[25]. Induction of Isl-1 expression in our human MSC
Fig. 3. Induction of the islet genes insulin, glucagon, and somatostatin in adipose tissue-derived MSC in response to defined culture conditions.
Fig. 2. Induction of pancreatic developmental genes in adipose tissue-derived MSC in response to defined culture conditions. Gene expression was
monitored every 24 h for 3 days. Data are normalized to HPRT and expressed as percentage expression as compared to day 0. Results are means ± SEM
of quadruplicate of four independent experiments from four independent donors. mRNA expression of pancreatic transcription factors Isl-1, Ipf-1, Ngn-3,
and the side population marker ABCG2 and Pax-6 was analyzed by real-time PCR.
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may represent a critical event that allows adoption of a
pancreatic endocrine phenotype. Other early markers of
pancreas development like Ipf-1 and Ngn-3 were not
detected by PCR in undifferentiated cells.
Using serum-free medium supplemented with factors
known for their beneficial effects on differentiation of pre-
cursor cells into insulin producing cells (i.e., exendin-4,
pentagastrin, activin-A, betacellulin, nicotinamide, and
hepatocyte growth factor) [26–29] we have induced an acti-
vation of pancreatic transcription factors including Ipf-1,
Isl-1, Ngn-3, as well as the islet proteins insulin, glucagon,
and somatostatin. The real-time PCR studies revealed an
activation of some of these pancreatic genes already 24 h
after induction of differentiation (Figs. 2 and 3). Similar
early induction of insulin gene expression was reported
recently in mice in vivo in response to hyperglycemia
[30]. Here, insulin positive cells were identified in adipose
tissue, spleen, and also bone marrow of hyperglycemic mice
after 3 days.
Several studies addressed the possibility that bone mar-
row-derived stem cells could contribute to b-cell turnover
in vivo. Some of them presented positive results, suggest-
ing a circulating pool of stem cells that could participate
in the process of b-cell neogenesis [31]. These results, how-
ever, were not confirmed by others [32] and a recent
report questioned the entire concept of b-cell stem/pro-
genitor cells with studies using genetic lineage tracing
experiments [33]. With this approach it has been shown
that pre-existing b-cells rather than adult stem/progenitor
cells retained a proliferative capacity and may thus repre-
sent the major source of new b-cells in adult life, at least
in mice [33]. While in vivo studies are not conclusive, this
does not exclude the differentiation of adult stem cells
into insulin producing cells in vitro. It has been shown
that mouse mesenchymal stem cells from bone marrow
cultured in high glucose over 4 months induced several
b-cell-specific genes including insulin and Ipf-1 [16]. These
cells were also able to reverse hyperglycemia in an animal
model of diabetes [16].
In summary, Isl-1 positive MSC can be isolated from
human adipose tissue and are able to adopt a pancreatic
endocrine phenotype. These cells could be used as a human
model to develop stem cell-based therapies for diabetes
mellitus.
Acknowledgments
We are very grateful to Ka¨thi Dembinski and Susy Vos-
meer for excellent technical assistance. The 39.4D5 anti-
body developed by the Thomas M. Jessell, Columbia
University New York, was obtained from the Developmen-
tal Studies Hybridoma Bank, University of Iowa, Depart-
ment of Biological Sciences, Iowa City, IA 52242. This
work was supported by grants of the Juvenile Diabetes Re-
search Foundation International (Grant No. 5 - 2001-857
to H.Z.), Gebert Ru¨f Foundation (GRS-014/05 to H.Z.)
and the Swiss National Research Foundation (NRP46
Grant 404640-101232 to H.Z. and Research Grant 32-
068209.02 and 3200B0-109413 to B.M.).
References
[1] A.J. Friedenstein, R.K. Chailakhyan, N.V. Latsinik, A.F. Panasyuk,
I.V. Keiliss-Borok, Stromal cells responsible for transferring the
microenvironment of the hemopoietic tissues. Cloning in vitro and
retransplantation in vivo, Transplantation 17 (1974) 331–340.
[2] R.F. Pereira, K.W. Halford, M.D. O’Hara, D.B. Leeper, B.P.
Sokolov, M.D. Pollard, O. Bagasra, D.J. Prockop, Cultured adherent
cells from marrow can serve as long-lasting precursor cells for bone,
cartilage, and lung in irradiated mice, Proc. Natl. Acad. Sci. USA 92
(1995) 4857–4861.
[3] M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas,
J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, D.R.
Marshak, Multilineage potential of adult human mesenchymal stem
cells, Science 284 (1999) 143–147.
[4] Y. Jiang,B.N. Jahagirdar,R.L.Reinhardt,R.E. Schwartz,C.D.Keene,
X.R. Ortiz-Gonzalez, M. Reyes, T. Lenvik, T. Lund, M. Blackstad, J.
Du, S. Aldrich, A. Lisberg, W.C. Low, D.A. Largaespada, C.M.
Fig. 4. Immunocytochemistry for Ipf-1 and C-peptide in undifferentiated
and differentiated adipose tissue-derivedMSC. Single cells were stained for
Ipf-1 (A and B, magnification 400·) and c-peptide (C and D, magnification
200·). Undifferentiated MSC were used as negative control (A and C).
Nuclear staining was performed in blue with DAPI. (E) Somatostatin
release during the differentiation period was measured with RIA in
supernatants collected on day 0 and 3 (n = 8). (For interpretation of the
references to color in this figure legend, the reader is referred to the web
version of this paper.)
K. Timper et al. / Biochemical and Biophysical Research Communications 341 (2006) 1135–1140 1139
Verfaillie, Pluripotency of mesenchymal stem cells derived from adult
marrow, Nature 418 (2002) 41–49.
[5] Y. Jiang, B. Vaessen, T. Lenvik,M. Blackstad,M. Reyes, C. Verfaillie,
Multipotent progenitor cells can be isolated from postnatal murine
bone marrow, muscle, and brain, Exp. Hematol. 30 (2002) 896.
[6] P.A. Zuk, M. Zhu, P. Ashjian, D.A. De Ugarte, J.I. Huang, H.
Mizuno, Z.C. Alfonso, J.K. Fraser, P. Benhaim, M.H. Hedrick,
Human adipose tissue is a source of multipotent stem cells, Mol. Biol.
Cell 13 (2002) 4279–4295.
[7] S.A. Azizi, D. Stokes, B.J. Augelli, C. DiGirolamo, D.J. Prockop,
Engraftment and migration of human bone marrow stromal cells
implanted in the brains of albino rats—similarities to astrocyte grafts,
Proc. Natl. Acad. Sci. USA 95 (1998) 3908–3913.
[8] E. Mezey, K.J. Chandross, G. Harta, R.A. Maki, S.R. McKercher,
Turning blood into brain: cells bearing neuronal antigens generated
in vivo from bone marrow, Science 290 (2000) 1779–1782.
[9] D. Woodbury, E.J. Schwarz, D.J. Prockop, I.B. Black, Adult rat and
human bone marrow stromal cells differentiate into neurons, J.
Neurosci. Res. 61 (2000) 364–370.
[10] Y. Jiang, D. Henderson, M. Blackstad, A. Chen, R.F. Miller, C.M.
Verfaillie, Neuroectodermal differentiation from mouse multipotent
adult progenitor cells, Proc. Natl. Acad. Sci. USA 100 (Suppl. 1)
(2003) 11854–11860.
[11] G. Munoz-Elias, A.J. Marcus, T.M. Coyne, D. Woodbury, I.B.
Black, Adult bone marrow stromal cells in the embryonic brain:
engraftment, migration, differentiation, and long-term survival, J.
Neurosci. 24 (2004) 4585–4595.
[12] Y. Sato, H. Araki, J. Kato, K. Nakamura, Y. Kawano, M. Kobune,
T. Sato, K. Miyanishi, T. Takayama, M. Takahashi, R. Takimoto, S.
Iyama, T. Matsunaga, S. Ohtani, A. Matsuura, H. Hamada, Y.
Niitsu, Human mesenchymal stem cells xenografted directly to rat
liver are differentiated into human hepatocytes without fusion, Blood
106 (2005) 756–763.
[13] W. Vogel, F. Grunebach, C.A. Messam, L. Kanz, W. Brugger, H.J.
Buhring, Heterogeneity among human bone marrow-derived mesen-
chymal stem cells and neural progenitor cells, Haematologica 88
(2003) 126–133.
[14] U. Lendahl, L.B. Zimmerman, R.D. McKay, CNS stem cells express
a new class of intermediate filament protein, Cell 60 (1990) 585–595.
[15] H. Zulewski, E.J. Abraham, M.J. Gerlach, P.B. Daniel, W. Moritz, B.
Muller, M. Vallejo, M.K. Thomas, J.F. Habener, Multipotential
nestin-positive stem cells isolated from adult pancreatic islets differ-
entiate ex vivo into pancreatic endocrine, exocrine, and hepatic
phenotypes, Diabetes 50 (2001) 521–533.
[16] D.Q. Tang, L.Z. Cao, B.R. Burkhardt, C.Q. Xia, S.A. Litherland,
M.A. Atkinson, L.J. Yang, In vivo and in vitro characterization of
insulin-producing cells obtained from murine bone marrow, Diabetes
53 (2004) 1721–1732.
[17] S. Kodama, W. Kuhtreiber, S. Fujimura, E.A. Dale, D.L. Faustman,
Islet regeneration during the reversal of autoimmune diabetes in
NOD mice, Science 302 (2003) 1223–1227.
[18] D.A.DeUgarte,K.Morizono,A. Elbarbary, Z.Alfonso, P.A.Zuk,M.
Zhu,J.L.Dragoo,P.Ashjian,B.Thomas,P.Benhaim,I.Chen,J.Fraser,
M.H. Hedrick, Comparison of multi-lineage cells from human adipose
tissue and bonemarrow, Cells Tissues Organs 174 (2003) 101–109.
[19] R.H. Lee, B. Kim, I. Choi, H. Kim, H.S. Choi, K. Suh, Y.C. Bae, J.S.
Jung, Characterization and expression analysis of mesenchymal stem
cells from human bone marrow and adipose tissue, Cell. Physiol.
Biochem. 14 (2004) 311–324.
[20] A. Dicker, K. Le Blanc, G. Astrom, V. van Harmelen, C. Gother-
strom, L. Blomqvist, P. Arner, M. Ryden, Functional studies of
mesenchymal stem cells derived from adult human adipose tissue,
Exp. Cell Res. 308 (2005) 283–290.
[21] P. Linscheid, D. Seboek, E.S. Nylen, I. Langer, M. Schlatter, K.L.
Becker, U. Keller, B. Muller, In vitro and in vivo calcitonin I gene
expression in parenchymal cells: a novel product of human adipose
tissue, Endocrinology 144 (2003) 5578–5584.
[22] S. Zhou, J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath,
J.J. Morris, I. Lagutina, G.C. Grosveld, M. Osawa, H. Nakauchi,
B.P. Sorrentino, The ABC transporter Bcrp1/ABCG2 is expressed in
a wide variety of stem cells and is a molecular determinant of the side-
population phenotype, Nat. Med. 7 (2001) 1028–1034.
[23] A. Lechner, C.A. Leech, E.J. Abraham, A.L. Nolan, J.F.
Habener, Nestin-positive progenitor cells derived from adult
human pancreatic islets of Langerhans contain side population
(SP) cells defined by expression of the ABCG2 (BCRP1) ATP-
binding cassette transporter, Biochem. Biophys. Res. Commun.
293 (2002) 670–674.
[24] J. Cai, A. Cheng, Y. Luo, C. Lu, M.P. Mattson, M.S. Rao, K.
Furukawa, Membrane properties of rat embryonic multipotent neural
stem cells, J. Neurochem. 88 (2004) 212–226.
[25] U. Ahlgren, S.L. Pfaff, T.M. Jessell, T. Edlund, H. Edlund,
Independent requirement for ISL1 in formation of pancreatic
mesenchyme and islet cells, Nature 385 (1997) 257–260.
[26] I. Rooman, J. Lardon, L. Bouwens, Gastrin stimulates beta-cell
neogenesis and increases islet mass from transdifferentiated but
not from normal exocrine pancreas tissue, Diabetes 51 (2002)
686–690.
[27] E.J. Abraham, C.A. Leech, J.C. Lin, H. Zulewski, J.F. Habener,
Insulinotropic hormone glucagon-like peptide-1 differentiation of
human pancreatic islet-derived progenitor cells into insulin-producing
cells, Endocrinology 143 (2002) 3152–3161.
[28] H. Mashima, H. Ohnishi, K. Wakabayashi, T. Mine, J. Miyagawa, T.
Hanafusa, M. Seno, H. Yamada, I. Kojima, Betacellulin and activin
A coordinately convert amylase-secreting pancreatic AR42J cells into
insulin-secreting cells, J. Clin. Invest. 97 (1996) 1647–1654.
[29] L. Yang, S. Li, H. Hatch, K. Ahrens, J.G. Cornelius, B.E. Petersen,
A.B. Peck, In vitro trans-differentiation of adult hepatic stem cells
into pancreatic endocrine hormone-producing cells, Proc. Natl. Acad.
Sci. USA 99 (2002) 8078–8083.
[30] H. Kojima, M. Fujimiya, K. Matsumura, T. Nakahara, M. Hara, L.
Chan, Extrapancreatic insulin-producing cells in multiple organs in
diabetes, Proc. Natl. Acad. Sci. USA 101 (2004) 2458–2463.
[31] A. Ianus, G.G. Holz, N.D. Theise, M.A. Hussain, In vivo
derivation of glucose-competent pancreatic endocrine cells from
bone marrow without evidence of cell fusion, J. Clin. Invest. 111
(2003) 843–850.
[32] A. Lechner, Y.G. Yang, R.A. Blacken, L. Wang, A.L. Nolan, J.F.
Habener, No evidence for significant transdifferentiation of bone
marrow into pancreatic beta-cells in vivo, Diabetes 53 (2004) 616–
623.
[33] Y. Dor, J. Brown, O.I. Martinez, D.A. Melton, Adult pancreatic
beta-cells are formed by self-duplication rather than stem-cell
differentiation, Nature 429 (2004) 41–46.
1140 K. Timper et al. / Biochemical and Biophysical Research Communications 341 (2006) 1135–1140
  42 
 
 
 
 
VIII  
 
 
 
 
Lentiviral vectors efficiently transduce human 
mesenchymal stem cell- and preadipocyte 
derived mature adipocytes 
 
 
Seboek D, Linscheid P, Firm C, Zulewski H, Salmon P, Russo AF, Keller 
U, Müller B (submitted) 
 
 
 
 
 
 
 
 
 
 
Lentiviral vectors efficiently transduce human mesenchymal stem cell- and 
preadipocyte derived mature adipocytes 
 
 
Dalma Seboek1, Philippe Linscheid1, Christina Firm3, Henryk Zulewski1,2, Patrick Salmon4, 
Andrew F. Russo3, Ulrich Keller1,2, Beat Müller1,2 
Dept. of Research1, Div. of Endocrinology, Diabetes and Clinical Nutrition2, University 
Hospital, CH-4031 Basel, Switzerland, Dept. Physiology and Biophysics, University of Iowa, 
Iowa City, IA 522423, Department of Microbiology and Molecular Medicine, Faculty of 
Medicine, CH-1211 Geneva, Switzerland4 
 
 
 
Running title: Lentiviral vectors transduce human adipocytes 
 
 
 
 
 
 
 
Corresponding author:  
Dalma Seboek, Department of Research, University Hospitals Basel, Hebelstrasse 20 
4031 Basel, Switzerland, Tel.: +41  61 265 2360, Fax.: +41 61 265 2350 
E-mail: Dalma.Seboek@unibas.ch 
 
Abbreviations: central polypurin tract (cPPT), Feline immunodeficiency virus (FIV), herpes 
simplex virus (HSV), Human immunodeficiency virus (HIV), multiplicity of infection (moi), 
murine leukemia virus (MLV), mesenchymal stem cell (MSC), green fluorescent protein 
(GFP) 
 
 
Abstract 
Adipose tissue is thought to play a crucial role in translating obesity into associated metabolic 
diseases. In the present study we aimed to establish a procedure for introducing genetic 
information into both human mesenchymal stem cell (MSC)- and human preadipocyte-
derived adipocytes. Expression of the green fluorescent protein (GFP) reporter gene was 
assessed after exposure to lentiviruses (53RPK PGK GFP and FIV CMV GFP VSVG). 
Preserved adipocyte function was evaluated by insulin-induced glucose uptake. 
Adipocytes expressed GFP after 5 days post-transduction. Up to 60% of mature adipocytes 
were GFP positive. Transduction of undifferentiated bone marrow-derived MSCs and 
preadipocytes did not affect their capacity to adopt an adipocyte phenotype upon 
differentiation. Insulin-induced glucose uptake was not affected in transduced mature 
adipocytes. Transduction efficiency by adenoviral-mediated gene transfer into both 
differentiated and undifferentiated cells was similar to lentiviral infection. However, this 
procedure was associated with over 50% cell death within the first 5 days. 
Lentiviral vectors provide an effective gene transfer techniques for the genetic modification of 
MSC- and preadipocyte-derived human adipocytes without apparent loss of cell-specific 
functions. This technique may provide a basis for further studies on the biology of adipose 
tissue and has the potential to become a target for gene therapy in obesity-related disorders. 
 
 
Keywords: human immunodeficieny virus, felin immunodeficinecy virus, adenovirus, glucose 
uptake 
 
Introduction:  
Adipose tissue is increasingly recognised as an endocrine organ secreting hormones, 
cytokines and other signalling molecules (1). Obesity-associated pathologies, including type 
2 diabetes, hypertension and atherosclerosis, have a high prevalence in modern societies 
(2). Improvement of the understanding of the physiological function of adipocytes is a 
prerequisite for understanding the molecular mechanisms that underpin these diseases (3). 
Rodent cell models including the 3T3-L1 cell line have been used in numerous studies. 
However, physiological differences between human and murine adipocytes undermine the 
transfer of knowledge obtained with murine cells (4). Human preadipocyte- and 
mesenchymal stem cell (MSC)-derived adipocytes represent an attractive alternative to 
rodent models (5). Introducing genetic information in non-dividing mature adipocytes is not 
an easy task. Gene transfer into murine 3T3-L1 cell line has been achieved by 
electroporation (6) and different viral vectors (7). A transduction efficiency of up to 15% 
transduced cells was achieved by electroporation in human mature adipocytes (8). Fiber-
modified adenovirus vectors mediate efficient but transient gene transfer into undifferentiated 
and differentiated human MSC(9). 
Human immunodeficiency virus (HIV) and HIV-derived pseudotyped lentiviral vectors 
efficiently infect and integrate into the genome of human cells, irrespective of the state of cell 
proliferation (10-19). In addition, retroviral vectors based on murine leukemia virus (MLV) are 
attractive gene delivery systems. The major drawback of MLV-derived vectors is there 
inability to transduce non-dividing cells (20). Feline immunodeficiency virus (FIV), a vector 
used for lentiviral vaccine development and antiviral therapy, is another appealing candidate 
for vector development. It has been shown to efficiently transduce dividing and non-dividing 
cells (21). Using the herpes simplex virus (HSV) based gene vector system promising results 
were achieved in human preadipocytes and rabbit adipose tissue (22). In this study, 
differentiation of preadipocytes was not hampered by the transduction procedure. 
Undifferentiated adipose tissue-derived mesenchymal progenitor cells have been 
successfully transduced with adenoviral, oncoretroviral and lentiviral vectors (23).  
Herein, we present a method that allows stable lentiviral-mediated transduction of human 
mature MSC- and preadipocytes-derived adipocytes. We show that the method is efficient 
and does not compromise adipocyte physiology. Infected adipocytes display a stable 
transduction and cell viability for prolonged periods of time. 
Materials and Methods 
Cell cultures 
Human preadipocyte-derived adipocytes were obtained from patients undergoing plastic 
surgery as previously described (24). Bone marrow aspirates (20-40 mL) were obtained from 
healthy donors (18-63 years) during routine othopaedic surgical procedures, in accordance 
with the local ethics committee (University Hospital Basel, Switzerland) and after informed 
consent. Nucleated cells were isolated from the aspirate by Ficoll density gradient 
centrifugation (Histopaque1, Sigma, Buchs, Switzerland). Human mesenchymal stem cells 
(MSC) were selected within the nucleated cells in culture by adhesion and proliferation on the 
plastic substrate. Cells were expanded in DMEM supplemented with 10% fetal bovine FBS and 
5 ng/mL bFGF (all from Invitrogen, Basel, Switzerland). For experiments, cells between 
passages 4 and 10 were seeded in 6 well plates. Adipogenic differentiation was induced by 
incubating confluent cells in DMEM/F12 (Invitrogen) containing 3% FBS and supplements as 
follows: 250 µM 3-isobutyl-1-methylxanthine (IBMX), 1 µM dexamethasone, 0.2 nM 3,3,5-
triiodo-L-thyronine, 5 µM transferrin (all from Sigma), 100 nM insulin (Novo Nordisk, Küsnacht, 
Switzerland), 1 µM rosiglitazone (GlaxoSmithKline, Worthing, UK). Typically, 80% to 90% of 
MSCs underwent adipogenic differentiation as assessed by lipid droplets formation. 
Expression of adipocyte-specific mRNAs (e.g. PPARγ2, PPARγ1, leptin, adiponectin) was 
confirmed by RT-PCR.  
Human embryonic kidney cell line 293T (ATCC; SD3515) was cultured in DMEM (Invitrogen) 
with 10% FBS in 100 mm petridishes. All media contained 100 U/ml penicillin and 100 µg/mL 
streptomycin (Invitrogen). 
 
Generation of recombinant lentiviruses. 
Lentivirus production was carried in 293T cells cotransfected with a plasmid containing 
enhanced green fluorescent protein (GFP) under the control of the phosphoglyceratekinase 
(PGK) promoter (53RPA-PGK-GFPas). The envelope vector was pMD2.G and the packaging 
vector psPAX2. Transient transfection of the plasmid set into 293T cells was achieved by the 
calcium phosphate method as described previously (http://tronolab.com). All schematics of 
the plasmids are awailable online. Virus containing supernatants were collected on day 2 and 
3 post transfection and kept in -80°C freezer until the start of the experiments.  
Ready to use feline immunodeficiency-virus derived lentivirus containing GFP under the 
control of the cytomegalovirus promoter (FIV CMV GFP VSVG) was prepared as described 
previously (21). Detailed schematics are presented in the study by Johnston JC et al (21). 
 
Generation of adenovirus 
The adenovirus vector used contained enhanced GFP under the control of the CMV 
promoter (AD5 CMV eGFP). It expresses the nontoxic gene derived from jellyfish Aequoria 
Victoria. AD5 CMV eGFP was prepared as described by Vasquez et al (25). 
 
Infection of cells 
Infection of differentiated MSC- and preadipocyte-derived adipocytes was carried out 
overnight with aliquots of the cell medium derived from the infected 293T cells containing the 
lentivirus (53RPK PGK GFP). Infection with FIV CMV GFP VSVG and AD5 CMV eGFP was 
carried out over night in serum free growth medium. On the following day, infected 
adipocytes were washed with pre-warmed PBS and maintained in adipogenic differentiation 
medium with 3% FBS for up to one month.  
 
Microscopy 
Transduction efficiency was visualized by fluorescence microscopy (Olympus IX 50). The 
microscope was equipped with an Olympus U-TVO 5XC camera. 
 
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
Total RNA was extracted from adipocyte cultures with TRI Reagent® (Molecular Research 
Center, Inc., Cincinnati, OH). Extracted RNA was quantified spectrophotometrically at 260 nm 
with a Biophotometer (Vaudaux-Eppendorf AG, Schönenbuch Switzerland). Ratio of the 
absorbance at 260 nm and 280 nm was between 1.5 and 2.0 and the quality was assessed by 
gel electrophoresis. 1 µg total RNA was subjected to reverse transcription (OmniscriptTM RT kit, 
Qiagen, Basel, Switzerland). PCR was performed on a conventional thermal cycler (TGradient, 
Biometra, Göttingen, Germany) using PCR Taq core kit (Qiagen). Human gene-specific, intron 
spanning primers and conditions were as follows: adiponectin (102-bp product; GenBank 
accession no. NM_004797), 5’-TGGGCCATCTCCTCCTCA-3’ (sense) and 5’-
AATAGCAGTAGAACAGCTCCCAGC-3’ (antisense); leptin (121-bp product; GenBank 
accession no. NM_000230), 5’-TGCCCATCCAAAAAGTCC-3’ (sense) and 5’-
GAAGTCCAAACCCGTGACTTTCT-3’ (antisense); PPARγ2 (580-bp product, GenBank 
accession no. NM_015869), 5’-GCGATTCCTTCACTGATAC-3’ (sense) and 5’-
GCATTATGAGACATCCCCAC-3’ (antisense); PPARγ1 (474-bp product, GenBank accession 
no. NM_138712), 5’-TCTCTCCGTAATGGAAGACC-3’ (sense) and 5’-
GCATTATGAGACATCCCCAC-3’ (antisense); β-actin (198-bp product, GenBank accession 
no. NM_001101), 5’-TTCTGACCCATGCCCACCAT-3’ (sense) and 5’-
ATGGATGATGATATCGCCGCGCTC-3’ (antisense).65 28 
The annealing temperature was 58°C for adiponectin and leptin (35 cycles), 55°C for 
PPARAγ2 and PPARγ1 (28 and 30 cycles, respectively), for β-actin 65°C (28 cycles). 
Amplification products were visualized on 1.5% (amplicons > 250 bp) or 2.5% (amplicons <250 
bp) agarose gels containing 0.5 µg/mL ethidium bromide. 100 bp Molecular Ruler (BioRad, 
Reinach, Switzerland) was used as size reference. PCR product identity was confirmed by 
nucleotide sequencing (Microsynth AG, Balgach, Switzerland).  
 
FACS 
GFP expression was determined by fluorescent activated cell sorter (FACS) analysis. 
Adherent cells were detached with trypsin-EDTA and washed with PBS prior to analyses.  
 
 
 
Insulin-mediated glucose uptake 
Three days prior to glucose uptake experiment differentiation medium was removed from 
differentiated and transduced adipocytes. Cells were washed three times in warm PBS and 
kept in DMEM/F12 containing 5 mM glucose and 3% FBS. On day 3, at timepoint 0, 100 nM 
insulin was added to half of the wells. At t = 20 min 1 µC deoxy-d-glucose, 2-[3H(G)] 
(PerkinElmer, Boston, MA) was added to all wells. After 15 min cells were washed three times 
in ice cold PBS and lysed in 0.1 % SDS. Radioactivity was measured by scintillation counting.  
 
Statistics 
Results are presented as means ± SEM. Analyses of variance with post-hoc analysis for least 
square differences was carried out.  
Results:  
Bone marrow-derived MSCs and preadipocytes were differentiated into mature adipocytes 
and expression of adipocyte-specific markers was assessed by RT-PCR before and after 
adipogenic differentiation. Adiponectin, leptin and PPARγ2 mRNA expression was detected 
in MSC- and preadipocyte-derived adipocytes, but not in undifferentiated cells. In contrast, 
PPARγ1 mRNA was also expressed before and after adipogenic differentiation (Figure 1). 
Two lentiviral vectors encoding the GFP reporter gene were used (53PRK-PGK-GFP and 
FIV CMV GFP VSVG) for transduction experiments of MSC- and preadipocyte-derived 
adipocytes. Adipocytes were exposed overnight to the culture medium derived from lentivirus 
producing 293T cells, and subsequently washed and maintained in differentiation medium for 
adipocytes. Visible GFP expression in the cytoplasm was evident after the third day of 
infection. Five days post-infection GFP expression reached a steady state level (Figure 2a-d) 
and remained constant for at least 30 days. No significant perturbation of cell viability was 
observed in the 30 day period (not shown). 
To determine transduction efficiency of the two lentiviruses, FACS analyses were carried out. 
10%-50% of the cells were detected positive (Figure 3). The high variability of the FACS 
analysis may be attributable to the difficult trypsinization procedure of differentiated 
adipocytes. Furthermore, fat droplets let these cells float in the cuvettes used for FACS 
analysis. Hence, it was difficult to keep the cells in homogene suspension over time. For this 
reason, transduced cells were also counted under the microscope. Comparing total cell 
number as visualized with DAPI staining and transduced cells, visualized with GFP, up to 
60% of differentiated cells were GFP positive. 
In further experiments, MSC- and preadipocyte-derived adipocytes were exposed overnight 
to adenovirus at different multiplicity of infection (moi) ranging from 10 to 800. GFP 
expression was visible on day 1 post-infection. However, adenovirus exposure appeared to 
have toxic side effects as adipocytes began to detach 3 or 4 days, and after 7 days all cells 
were dead (data not shown).  
In undifferentiated cell cultures (MSC and preadipocytes) 40% of the cells showed GFP 
expression after lentiviral infection. Transduction of undifferentiated MSCs did not affect their 
capacity to adopt an adipocyte phenotype upon differentiation (data not shown). However, 
undifferentiated cells, within the culture of the differentiated adipocytes did not show any 
GFP expression (data not shown). 
The metabolic integrity of the transduced adipocytes was evaluated after 14 days of 
infection. Glucose uptake in transduced and not transduced adipocytes were measured in 
the presence or absence of 100 nM insulin, respectively (Figure 4). As compared to basal 
glucose uptake, insulin-mediated glucose uptake increased 2.34-fold in MSC- and 2.07-fold 
in preadipocyte-derived adipocytes transduced with 53PRK-PGK-GFP, respectively. In MSC- 
and in preadipocyte-derived adipocytes transduced with FIV CMV GFP VSVG the insulin-
mediated increases were 1.74-fold and 1.65-fold, respectively. Similar results were obtained 
in non-transduced control adipocytes. 
 
Discussion 
Adipocytes are difficult to be transduce by common chemical methods due to negative 
buoyancy, quiescence and physical fragility. Herein, we have successfully established a 
lentivirus-based method for post-differentiation transduction of human adipocytes.  
Lentiviruses have the ability to transduce a wide variety of cells, both proliferating and 
quiescent (10-19). After infecting the host, they integrate into the genome. Sustained gene 
expression is mediated by HIV pol region-derived promoter central polypurin tract (cPPT) 
(26). Lentiviral transduction of undifferentiated adipose tissue-derived preadipocytes was 
previously demonstrated (23). Infected cells were differentiated into adipogenic and 
osteogenic lineages. However, an infection-related influence on the differentiation process 
cannot be excluded and functional studies were not presented in these previous reports. This 
potential drawback can be excluded by the herein demonstrated post-differentiation 
transduction procedure. The method allows stable and sustained inclusion of genetic 
information as we observed GFP-expression 4 to 30 days after infection.  
Differentiated adipocytes were previously transduced by HSV-mediated lentiviral gene 
transfer. However, after only 12 days (latest time point investigated) only about 10-20% of 
the cells remained GFP positive (22). A laborious lentivirus-based method has been used for 
transduction of human primary mature adipocytes. However, only about 15% of the cells 
were successfully transduced. Moreover, cells could only be kept 20 h in culture post 
transduction (8). Adenoviruses are alternative candidates for transduction of non-dividing 
cells. However, the coxsackie virus and adenovirus receptor (CAR) is only scarcely 
expressed in several cell cultures types (27-30). Therefore, we subjected MSC and 
preadipocyte-derived adipocytes to high adenovirus titers for efficient transduction. In 
accordance with previous data in murine 3T3-L1 adipocytes (7), adenovirus treatment had 
cytotoxic effects on human adipocytes. Introduction of fiber-modified adeno vectors might 
circumvent these problems (9). Adenoviral vectors can be extremely efficient in some cell 
types, such as hepatocytes, but remain episomal and non-replicating and therefore 
progressively lost over time.(31) Similarly, MLV-derived retroviral vectors require cell division 
and nuclear membrane dissolution for genome integration.(16, 20, 32-34) 
Typically, about 20% of MSCs and preadipocytes remained undifferentiated after subjecting 
them to adipogenic medium. Intriguingly, lentiviral- and adenoviral-mediated transduction 
were strictly limited to differentiated adipocytes. This observation correlates with previous 
results also obtained in differentiated human adipocytes (35). Hence, it is tempting to 
speculate that differentiated adipocytes might have more efficient plasma membrane binding 
and internalization components for the adenovirus as compared to preadipocytes.  
The titer of lentivirus was only determined for the FIV-derived vector. Successful transduction 
was achieved with a low of moi 2. Increased virus concentration did not result in higher 
transduction efficiency. Titrating lentivectors by determining the concentration of vector 
genome RNA in the supernatant may overestimate the vector titer by 1’000-10’000 fold 
because such analysis counts defective or otherwise non-infectious particles as well as free- 
floating vector genomes in the supernatant (36, 37). Therefore, with the HIV-derived virus we 
used always the supernatants directly regardless of the virus amount. We could not observe 
any differences in transduction efficiency. Most importantly, insulin-mediated glucose uptake 
experiments performed 14 days post-infection demonstrated that the adipocytes were still 
fully functional. These results were independent of the origin of the adipocyte (i.e. MSC-or 
preadipocyte- derived adipocytes) and the type of lentivirus. FIV-derived transduction 
systems include characteristics inherent in lentivirus vectors, such as large coding capacity, 
stable gene transfer and the ability to infect non-dividing cells. Due to their non-human origin 
their use might be safer as compared to HIV-derived lentiviruses.  
 
In conclusion, based on our data lentiviral vectors are the gene-transfer system of choice for 
genetic modification of MSC- and preadipocyte-derived human adipocytes without apparent 
loss of cell specific functions. The availability of an efficient vector system may stimulate the 
use of adipose tissue, the largest endocrine gland, as a target for gene therapy in obesity 
and related disorders. 
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Titles and legends to figures 
Figure 1: Induction of adipocyte markers in MSC- and preadipocyte derived adipocytes 
MSC and preadipocytes were subjected to RT-PCR analysis of leptin, adiponectin, PPARγ2 
and PPARγ1 before and after adipogenic differentiation. M indicates 100 bp molecular weight 
marker. 
 
Figure 2: Transduction of human MSC- and preadipocyte-derived adipocytes. a) Mature 
MSC derived adipocytes and b) preadipocyte derived human adipocytes were exposed to 
lentiviral vectors containing GFP under a PGK promoter (53RPA PGK GFP). c) Mature MSC 
derived adipocytes and d) preadipocyte derived adipocytes were transduced with a lentiviral 
vector containing GFP under a CMV promoter (FIV CMV GPF VSVG). Pictures were taken 4 
days after transduction with the Olympus IX 50 fluorescent microscope.  
 
Figure 3: FACS analysis of transduced MSC- derived adipocytes. The upper panels 
show total cell counts and the area defined as living mature adipocytes. 10% - 12 % of total 
cell count was used for statistical analyses. Lower panel show GFP positive cells as 
compared to non transduced cells. a) mature adipocytes without transduction were used as 
control cells to optimize FACS conditions. b) mature adipocytes were transduced with 
53RPK-PGK-GFP lentivirus. 30.39 % of the cells were GFP positiv. c) mature adipocytes 
were transduced with with FIV CMV GFP VSVG lentivirus. 9.58% of cells were GFP positive. 
 
Figure 4: Insulin-induced glucose uptake assay. a) MSC- and b) preadipocyte-derived 
human adipocytes were exposed to 53RPK PGK GFP. c) MSC- and d) preadipocyte-derived 
adipocytes were exposed to FIV CMV GFP VSVG at moi 2 pfu/cell for two weeks. 
Transduced cells were stimulated by insulin (100nM) for 20 min and assayed for intracellular 
3H deoxy glucose uptake. Glucose uptake is expressed in cpm. Results are expressed as 
means ± SEM from three separate experiments performed in triplicate.  
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mediators of the immuno-endocrine activity 
Dalma Seboek, Philippe Linscheid, Igor Langer, Henryk Zulewski, Ulrich Keller, Beat Müller 
 
 
November 28 – 29, 2003  SGED 
Schweizerische Gesellschaft für Endokrinologie und Diabetologie, Bern, Switzerland 
Oral presentation: Human adipose tissue is a source of procalcitonin in human 
sepsis 
Philippe Linscheid, Dalma Seboek, Igor Langer, Mirjam Schlatter, Ulrich Keller, Beat 
Müller 
Poster: Human adipose tissue epxresses somatostatin and its receptors- new 
mediators of the immuno-endocrine activity  
Dalma Seboek, Philippe Linscheid, Igor Langer, Henryk Zulewski, Ulrich Keller, Beat 
Müller 
 
 
June 16 – 20, 2004   ENDO  
The Endocrine socyiety’s 86th annual meeting, New Orleans, USA 
Poster: Inflammatatory stimulation induces somatostatin expression and 
secretion in human asipocytes 
Dalma Seboek, Philippe Linscheid, Igor Langer, Mirjam Christ-Crain, Henryk Zulewski, Ulrich 
Keller, Beat Müller 
 
 
September 4 – 8, 2004  ELSO 
European life scientist organisation, Nice, France 
Poster: Lentiviral vectors efficiently transduce mature adipocytes derived from 
human mesenchymal stem cells  
Dalma Seboek, Christina Firm, Philippe Linscheid, Henryk Zulewski, Adrew Russo, Ulrich 
Keller, Beat Müller 
 
 
 
  48 
November 26 - 27, 2004  SGED 
Schweizerische Gesellschaft für Endokrinologie und Diabetologie, Bern, Switzerland 
Poster: Lentiviral vectors efficiently transduce mature adipocytes derived from 
human mesenchymal stem cells  
Dalma Seboek, Christina Firm, Philippe Linscheid, Henryk Zulewski, Adrew Russo, Ulrich 
Keller, Beat Müller 
Oral Presentation: Isolation, immortalization and characterization of 
multipotent mesenchymal stem cells from human islets of Langerhans that 
express nestin, ABCG2 and islet-1 
Michael Eberhardt, Patrick Salmon, Philippe Linscheid, Dalma Seboek, Marc von Mach, Beat 
Müller, Didier Trono, Henryk Zulewski 
 
 
April 26, 2005   SGIM 
Schweizerische Gesellschaft für Innere Medizin, Basel, Switzerland 
Poster: Human Isl-1 positive mesenchymal stem cells differentiate into insulin, 
somatostatin and glucagon expressing cells 
Dalma Seboek, Katharina Timper, Michael Eberhardt, Philippe Linscheid, Ulrich Keller, Beat 
Müller and Henryk Zulewski 
 
 
June 4 – 7, 2005   ENDO  
The Endocrine socyiety’s 87th annual meeting, San Diego, USA 
Poster: Lentiviral vectors efficiently transduce mature human adipocytes 
Dalma Seboek, Christina Firm, Philippe Linscheid, Henryk Zulewski, Andrew Russo, Ulrich 
Keller, Beat Müller 
Poster: Nitric oxide synthase activity in human adipocytes? 
Philippe Linscheid, Dalma Seboek, Nenad Blau, Ulrich Keller and Beat Müller 
 
June 10 – 14, 2005   ADA 
65th Scientific Session of the American Diabetes Association, San Diego, USA 
Poster: Differentiation of human bone marrow- derived stem cells into insulin, 
amylin, somatostatin and glucagon expressing islet-like clusters in vitro  
Dalma Seboek, Katharina Timper, Michael Eberhardt, Philippe Linscheid, Ulrich Keller, Beat 
Müller and Henryk Zulewski 
Poster: Differentiation of human preadipocytes into insulin, amylin, 
somatostatin and glucagon expressing islet like clusters in vitro  
Katharina Timper, Dalma Seboek, Philippe Linscheid, Michael Eberhardt, Ulrich Keller, Beat 
Müller and Henryk Zulewski 
 
 
August 20 – 24, 2005  Inflammation 
7th World Congress on Inflammation, Melbourne, Australia 
Poster: Calcitonin peptides are produced by human adipocytes during 
inflammation and exert autocrine/paracrine effects 
Philippe Linscheid, Dalma Seboek, Ulrich Keller and Beat Müller 
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September 12-15, 2005   EASD 
41st The European Association for the Study of Diabetes, Athen, Greece 
Poster: Coordinated activation of pancreatic developmental genes during 
differentiation of human bone marrow- derived stem cells into insulin, amylin, 
glucagon and somatostatin expressing cells. 
Dalma Seboek, Katharina Timper, Michael Eberhardt, Philippe Linscheid, Ulrich Keller, Beat 
Müller and Henryk Zulewski 
Oral Presentation: Engineering of multipotent human stem cells from 
pancreatic islets of Langerhans 
Michael Eberhardt, Patrick Salmon, Philippe Linscheid, Dalma Seboek, Marc von Mach, 
Andrea Barbero, Ivan Martin, Beat Müller, Didier Trono, Henryk Zulewski 
 
 
November 18 – 19, 2005-12-21 SGED 
Schweizerische Gesellschaft für Endokrinologie und Diabetologie, Bern, Switzerland 
Oral presentation: Differentiation of human mesenchymal stem cells and 
preadipocytes into insulin, somatostatin and glucagon expressing islet like 
clusters in vitro  
Dalma Seboek, Katharina Timper, Michael Eberhardt, Philippe Linscheid, Mirjam Christ-
Crain, Ulrich Keller, Beat Müller and Henryk Zulewski 
Poster: Bone marrow derived mesenchymal stem cells isolated from patients 
with diabetes mellitus type 1 are able to adopt a pancreatic endocrine 
phenotype in vitro 
Michael Eberhardt, Dalma Seboek, Andrea Barbero, Philippe Linscheid, Katharina Timper, 
Ivan Martin, Ulrich Keller, Beat Müller and Henryk Zulewski 
 
 
December 16, 2005   SSCNP 
2nd annual meeting of the swiss stem cell network, Basel, Switzerland 
Oral presentation: Differentiation of human mesenchymal stem cells and 
preadipocytes into insulin, somatostatin and glucagon expressing islet like 
clusters in vitro  
Dalma Seboek, Katharina Timper, Michael Eberhardt, Philippe Linscheid, Mirjam Christ-
Crain, Ulrich Keller, Beat Müller and Henryk Zulewski 
 
